"#",Jurisdiction,Kind,Publication Number,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Title,Applicants,Inventors,URL,Type,Full Text,Cited Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,PubMed Id(s),DOI(s),Non-Patent Citations
1,WO,A2,WO 2008/009960 A2,093-144-008-355-452,2008-01-24,2008,GB 2007002764 W,2007-07-20,GB 0614568 A 20060721,Anti-testosterone Antibodies,HAPTOGEN LTD;;UNIV ABERDEEN;;BROADBENT IAN;;CHARLTON KEITH;;PORTER ANDREW;;STRACHAN GILLIAN;;KENYON ANDREW;;MCEWAN LAIN,BROADBENT IAN;;CHARLTON KEITH;;PORTER ANDREW;;STRACHAN GILLIAN;;KENYON ANDREW;;MCEWAN LAIN,https://lens.org/093-144-008-355-452,Patent Application,yes,5,4,4,20,C07K16/26;;C07K2317/21;;C07K2317/76,C07K16/00,,9661815,10.1016/S1380-2933(98)00002-5,
2,US,A1,US 2006/0258632 A1,066-185-105-955-080,2006-11-16,2006,US 41840206 A,2006-05-04,EP 02090315 A 20020904,Methods And Agents For Treating Cardiovascular Diseases,FRAUNHOFER GES FORSCHUNG,BORLAK JURGEN;;THUM THOMAS,https://lens.org/066-185-105-955-080,Patent Application,yes,1,10,10,103,A61K31/56,A61K31/57;;A61K31/56;;A61P9/00,514/177.000,,,
3,US,A1,US 2004/0110733 A1,120-693-751-095-318,2004-06-10,2004,US 30956202 A,2002-12-04,EP 02090315 A 20020904,Methods And Agents For Treating Cardiovascular Diseases,FRAUNHOFER GES FORSCHUNG,BORLAK JURGEN;;THUM THOMAS,https://lens.org/120-693-751-095-318,Patent Application,yes,5,10,10,2,A61K31/56,A61K31/56;;A61P9/00,514/171,,,
4,US,B1,US 7595056 B1,099-114-088-850-867,2009-09-29,2009,US 44963403 A,2003-05-30,US 38424902 P 20020530,Methods Of Rejuvenating Leydig Cells And Enhancing Testosterone Production In A Male Subject,UNIV TENNESSEE RES FOUNDATION,MENDIS-HANDAGAMA S M L CHAMINDINDRANI,https://lens.org/099-114-088-850-867,Granted Patent,yes,1,1,1,6,A61K38/24;;A61K2300/00,A61K39/00;;A01N37/18,424/198.1;;514/2,10673146;;10993816;;11113606;;11133664;;11259276;;11514326;;11967198;;12940521;;15010708;;15231695;;15503339;;16489520;;17579202;;18838102;;2689782;;3280599;;536771;;7606687;;7706982;;7860426;;7989483;;8126345;;8243304;;8747831;;9283947,10.1095/BIOLREPROD64.4.1273;;10.1095/BIOLREPROD65.3.660;;10.1210/JC.79.6.1763;;10.1172/JCI113412;;10.1210/JC.2006-2704;;10.1016/S0531-5565(99)00069-8;;10.1016/S0531-5565(00)00158-3;;10.1515/CCLM.2003.142;;10.1095/BIOLREPROD66.5.1359;;10.1002/AJPA.20079;;10.1677/JOE.0.1440293;;10.1007/S00508-005-0504-Y;;10.1016/0022-4731(89)90486-X;;10.1016/J.MCE.2008.09.005;;10.1210/EN.133.6.2773;;10.1210/EN.2004-0639;;10.1095/BIOLREPROD63.4.977;;10.1095/BIOLREPROD64.1.107,"Elmlinger et al. 2003 Clin Chem Lab Med. 41:934-941.;;Antony et al. 1995. J Endocrin. 144:293-300.;;Mendis-Handagama et al. 2001. J Andrology 22, Supplement. p. 174, abstract 080.;;St. Germain DL. 2001. in Endocrinology, 4th ed. vol. 2, pp. 13230-1326.;;Mooradian 1995. Clinics in Geriatic Medicine 11(2):159-169.;;Jarow et al. 1994. J of Andrology. 15:456-461.;;Zirken et al. 2000. Biology of Reproduction 63:977-981.;;Hermann et al. (1999. Experimental Gerontology 34:923-933.;;Murray et al 1993. World J Urol. 11:37-40.;;Lipson et al 1979. J of Nuclear Medicine 20:1124-1130.;;Briblescas 2005. Am J. Phys Anthrop. 127:114-121.;;Chamindrani Mendis-Handagama et al. Differentiation of the audult Leydig Cell population in the postnatal testis. Biology of Reproduction, vol. 65, (2001), pp. 660-671.;;Mariotti et al. The aging thyroid. Endocrine Reviews, vol. 16, No. 6, (1995), pp. 686-715.;;Mulligan et al. Male Menapause. Drugs of Today, vol. 34, No. 5, (1998), pp. 455-461.;;Urban et al. Attenuated release of biologically active luteinizing hormone in healthy aging men. Journal of Clinical Investigation, vol. 81, (1988), pp. 1020-1029.;;Veldhuis et al. Differential resposes of biologically active luteinizing hormone secretion in older versus young men to interruption of androgen negative feedback. Journal of Clinical Endocrinology and Metabolism, vol. 79, No. 6, (1994), pp. 1763-1770.;;Veldhuis et al. Pathophysiological features of the pulsatile secretion of biologically active luteinizing hormone in man. Journal of Steroid Biochemistry and Molecular Biology, vol. 33, No. 4B, (1989), pp. 739-749.;;Weissel, Michael. Disturbances of thyroid function in the elderly. Wien Klin Wochenschr, vol. 118, Nos. 1-2, (2006), pp. 16-20.;;Kim et al., ""Changes in the Testis Interstitium of Brown Norway Rats with Aging and Effects of Luteinizing and Thyroid Hormones on the Aged Testes in Enhancing the Steroidogenic Potential,"" Biology of Reproduction, vol. 66 pp. 1359-1366 (2002).;;Bonavera et al., ""In the Male Brown-Norway (BN) Male Rat, Reproductive Aging Is Associated With Decreased LH-Pulse Amplitude and Area,"" Journal of Andrology, vol. 18. No. 4, pp. 359-365 (Jul./Aug. 1997).;;Chen et al., ""Dibutyryl Cyclic Adenosine Monophosphate Restores the Ability of Aged Leydig Cells to Produce Testosterone at the High Levels Characteristic of Young Cells,"" Endocrinology, vol. 145, No. 10, pp. 4441-4446 (2004).;;Gruenewald et al., ""The Brown Norway Rat as a Model of Male Reproductive Aging: Evidence for Both Primary and Secondary Testicular Failure,"" J. Gerontol., vol. 49, No. 2, B42-50 (1994). Abstract.;;Matsumoto et al., ""Aging and the neuroendocrine regulation of reproduction and body weight,"" Experimental Gerontology, vol. 35, pp. 1251-1265 (2000).;;Midzak et al., ""Leydig cell aging and the mechanisms of reduced testosterone synthesis,"" Molecular and Cellular Endocrinology, In Press, Corrected Proof, Available online Aug. 5, 2008 (Sep. 17, 2008).;;Syed et al., ""Selective Loss of Sertoli Cell and Germ Cell Function Leads to a Disruption in Sertoli Cell-Germ Cell Communication During Aging in the Brown Norway Rat,"" Biology of Reproduction, vol. 64, pp. 107-112 (2001).;;Schoenfeld et al., ""Continuously Proliferative Stem Germ Cells Partially Repopulate the Aged, Atrophic Rat Testis after Gonadotropin-Releasing Hormone Agonist Therapy,"" Biology of Reproduction, vol. 64, pp. 1273-1282 (2001).;;Takahashi, ""Age Attenuates Testosterone Secretion Driven by Amplitude-Varying Pulses of Recombinant Human Luteinizing Hormone during Acute Gonadotrope Inhibition in Healthy Men,"" The Journal of Clinical Endocrinology & Metabolism, vol. 92, No. 9, pp. 3626-3632 (2007).;;Veldhuis et al., ""The Aging Male Hypothalamic-Pituitary-Gonadal Axis: Pulsatility and feedback,"" Molecular and Cellular Endocrinology, In Press, Accepted Manuscript, Available online Sep. 17, 2008.;;Wang et al., ""Reproductive Aging in the Male Brown-Norway Rat: A Model for the Human,"" Endocrinology, vol. 133, No. 6, pp. 2773-2781 (1993)."
5,US,B2,US 7138246 B2,059-214-848-675-051,2006-11-21,2006,US 6860605 A,2005-02-28,US 6860605 A 20050228;;US 54885104 P 20040301;;US 54904504 P 20040301;;US 62070504 P 20041021;;US 62078304 P 20041021,Methods For Identifying Or Screening For Agents That Modulate 17beta-hsd3,SQUIBB BRISTOL MYERS CO,LORENZI MATTHEW V;;SPIRES THOMAS;;YOU DAN;;WEINMANN ROBERTO;;GOTTARDIS MARCO,https://lens.org/059-214-848-675-051,Granted Patent,yes,1,4,19,3,G01N33/743,G01N33/53;;G01N33/567;;G01N33/74,435/7.1;;435/7.2;;435/7.21;;436/63;;436/86;;436/89;;436/501;;436/518;;530/300;;530/350;;530/387.9,10926083;;11806715;;2149506;;2821659;;6574004;;7988017;;8075637;;8263129;;8547185;;9111629,10.1016/0960-0760(90)90441-M;;10.1038/NG0594-34;;10.1210/JC.77.6.1472;;10.1021/JM010286Y;;10.1016/S0090-4295(97)00029-0;;10.1016/S0010-7824(83)80022-5;;10.1007/S003459900099;;10.1677/ERC.0.0030243;;10.1016/0039-128X(86)90038-3;;10.1016/0960-0760(95)00209-X,"Fiet et al. (Clinical Chemistry 40(12) 2296-2305, 1994).;;Geissler et al., ""Male Pseudohermaphroditism Caused by Mutations of Testicular 17beta-Hydroxysteroid Dehydrogenase 3"", Nat. Gen., vol. 7, pp. 34-39 (1994).;;Gheiler et al., ""Current Concepts in Androgen Deprivation Therapy -Is There a 'best' Endocrine Treatment?"", World J. Urol., vol. 18, pp. 190-193 (2000).;;Inano et al., ""Testicular 17beta-Hydroxysteroid Dehydrogenase: Molecular Properties and Reaction Mechanism"", Steroids, vol. 48, pp. 1-26 (1986).;;Labrie, ""At the Cutting Edge-Intracrinology"", Mol. Cell. Endocrinol. vol. 78, pp. C113-C118 (1991).;;Labrie et al., ""History of LHRH Agonist Combination Therapy in Prostate Cancer"", Endocr.-Relat. Cancer, vol. 3, pp. 243-278 (1996).;;Liu et al., ""Androgens Regulate Proliferation of Human Prostate Cancer Cells in Culture by Increasing Transforming Growth Factor-alpha (TGF-alpha) and Epidermal Growth Factor (EGF)/TGF-alpha Receptor"" J. Clin. Endocrinol, vol. 77, pp. 1472-1478 (1993).;;Luu-The et al., ""Characteristics of Human Types 1, 2 and 3 17beta-Hydroxysteroid Dehydrogenase Activities: Oxidation/Reduction and Inhibition"", J. Steroid Biochem. Molec. Biol., vol. 55, No. 5/6, pp. 581-587 (1995).;;Maltais, R. et al., ""Synthesis and Optimization of a New Family of Type 3 17beta-Hydroxysteroid Dehydrogenase Inhibotors by Parallel Liquid Phase Chemistry"", J. Med. Chem., vol. 45, pp. 640-653 (2002).;;Pittaway, ""Inhibition of Testosterone Synthesis in the Canine Testis In Vitro"", Contraception, vol. 27, No. 4, pp. 431-436 (1983).;;Simard et al., ""Comparison of In Vitro Effects of the Pure Antiandrogens OH-Flutamide, Casodex and Nilutamide on Androgen-Sensitive Parameters"", J. Urol., vol. 49, pp. 580-586 (1997).;;Van Weerden et al., ""Effects of Low Testosterone Levels and of Adrenal Androgens on Growth of Prostate Tumor Models in Nude Mice"", J. Steroid Biochem. Mol. Biol., vol. 37, No. 6, pp. 903-907 (1990)."
6,US,A1,US 2005/0191707 A1,151-261-503-153-481,2005-09-01,2005,US 6860605 A,2005-02-28,US 6860605 A 20050228;;US 54885104 P 20040301;;US 54904504 P 20040301;;US 62070504 P 20041021;;US 62078304 P 20041021,Methods For Identifying Or Screening For Agents That Modulate 17beta-hsd3,LORENZI MATTHEW V.;;SPIRES THOMAS;;YOU DAN;;WEINMANN ROBERTO;;GOTTARDIS MARCO,LORENZI MATTHEW V;;SPIRES THOMAS;;YOU DAN;;WEINMANN ROBERTO;;GOTTARDIS MARCO,https://lens.org/151-261-503-153-481,Patent Application,yes,5,4,19,3,G01N33/743,G01N33/53;;G01N33/74,435/7.100,,,
7,US,A1,US 2011/0207172 A1,194-614-882-464-79X,2011-08-25,2011,US 201013119915 A,2010-06-15,IT MI20091168 A 20090701,Process For The Preparation Of Testosterone,FOGAL STEFANO;;BERGANTINO ELISABETTA;;MOTTERLE RICCARDO;;CASTELLIN ANDREA;;ARVOTTI GIANCARLO,FOGAL STEFANO;;BERGANTINO ELISABETTA;;MOTTERLE RICCARDO;;CASTELLIN ANDREA;;ARVOTTI GIANCARLO,https://lens.org/194-614-882-464-79X,Patent Application,yes,1,9,9,4,C12P33/00;;C12N9/0006;;C12Y101/01062,C12P33/16;;C12N9/04,435/55;;435/190,15994074;;18057449;;9927279,10.1016/J.COPBIO.2005.06.004;;10.1007/S12010-007-8003-4,"Dufort et al. Endocrinology. 1999 Feb;140(2):568-74.;;Chica et al. Curr Opin Biotechnol. 2005 Aug;16(4):378-84.;;Sen et al. Appl Biochem Biotechnol. 2007 Dec;143(3):212-23.;;Accession P70694, 15-JUL-1999."
8,US,A1,US 2015/0111825 A1,113-117-315-746-277,2015-04-23,2015,US 201414526334 A,2014-10-28,US 29633910 P 20100119;;US 29641510 P 20100119,Osteocalcin As A Treatment For Male Reproductive Disorders,UNIV COLUMBIA,KARSENTY GERARD;;DUCY PATRICIA F,https://lens.org/113-117-315-746-277,Patent Application,yes,0,6,6,31,A61K38/39,A61K38/39,514/10.2;;514/9.8,,,
9,WO,A1,WO 2011/000693 A1,024-191-542-192-744,2011-01-06,2011,EP 2010058411 W,2010-06-15,IT MI20091168 A 20090701,Process For The Preparation Of Testosterone,ITALIANA SINT SPA;;FOGAL STEFANO;;BERGANTINO ELISABETTA;;MOTTERLE RICCARDO;;CASTELLIN ANDREA;;ARVOTTI GIANCARLO,FOGAL STEFANO;;BERGANTINO ELISABETTA;;MOTTERLE RICCARDO;;CASTELLIN ANDREA;;ARVOTTI GIANCARLO,https://lens.org/024-191-542-192-744,Patent Application,yes,6,9,9,4,C12P33/00;;C12N9/0006;;C12Y101/01062,C12P33/00,,11940569;;16052337;;16125408;;5432063;;9263127;;9927279,10.1016/J.PEP.2005.07.007;;10.1074/JBC.M111726200;;10.1038/227680A0;;10.1210/EN.140.2.568;;10.1023/A:1026379109403;;10.1007/S10295-005-0002-2,"DUFORT ET AL: ""Characteristics of a highly labile human type 5 17-beta-hydroxysteroid dehydrogenase"", ENDOCRINOLOGY, vol. 140, 1999, pages 568 - 574, XP002569809;;CÈBE ET AL: ""Rapid and easy thermodynamic optimization of the 5'-end of mRNA dramatically increases the level of wild type protein expression in Escherichia coli"", PROTEIN EXPRESSION AND PURIFICATION, vol. 45, 2006, pages 374 - 380, XP024908634;;LU ET AL: ""Purification, reconstitution, and steady-state kinetics of the trans-membrane 17-beta-hydroxysteroid dehydrogenase 2"", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 277, 2002, pages 22123 - 22130, XP002569506;;BRINKMANN ET AL: ""Inhibition of tryptase TL2 from human T4+ lymphocytes and inhibition of HIV-1 replication in H9 cells by recombinant aprotinin and bikunin homologues"", JOURNAL OF PROTEIN CHEMISTRY, vol. 16, 1997, pages 651 - 660, XP019283886;;CHURCHILL ET AL: ""Rapid purification of recombinant listeriolysin 0 (LL0) from Escherichia coli)"", JOURNAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, vol. 32, 2005, pages 355 - 363, XP019357745;;STEFANO ET AL: ""Biocatalyzed synthesis of testosterone"", CHEMICAL ENGINEERING TRANSACTIONS, vol. 20, April 2010 (2010-04-01), pages 61 - 66, XP002594215;;DUFORT ET AL., ENDOCRYNOLOGY, vol. 140, no. 2, 1999, pages 568 - 574;;NATURE, vol. 227, 1970, pages 680 - 685"
10,US,B2,US 8592178 B2,124-008-212-646-94X,2013-11-26,2013,US 201013119915 A,2010-06-15,IT MI20091168 A 20090701,Process For The Preparation Of Testosterone,FOGAL STEFANO;;BERGANTINO ELISABETTA;;MOTTERLE RICCARDO;;CASTELLIN ANDREA;;ARVOTTI GIANCARLO;;ITALIANA SINT SPA,FOGAL STEFANO;;BERGANTINO ELISABETTA;;MOTTERLE RICCARDO;;CASTELLIN ANDREA;;ARVOTTI GIANCARLO,https://lens.org/124-008-212-646-94X,Granted Patent,yes,0,9,9,4,C12P33/00;;C12N9/0006;;C12Y101/01062,C12P33/16;;C07H21/04;;C12N1/20;;C12N9/00;;C12N9/04;;C12N15/00,435/55;;435/183;;435/190;;435/252.3;;435/320.1;;536/23.2,11940569;;15994074;;16052337;;16125408;;18057449;;9263127;;9927279;;10500239,10.1016/J.PEP.2005.07.007;;10.1074/JBC.M111726200;;10.1016/J.COPBIO.2005.06.004;;10.1210/EN.140.2.568;;10.1007/S12010-007-8003-4;;10.1007/S10295-005-0002-2;;10.1016/s0167-4781(99)00106-2,"Chica et al. Curr Opin Biotechnol. Aug. 2005;16(4):378-84.;;Sen et al. Appl Biochem Biotechnol. Dec. 2007;143(3):212-23.;;Accession P70694, Jul. 15, 1999.;;Dufort et al. Endocrinology. Feb. 1999;140(2):568-74.;;Dufort et al., ""Characteristics of a Highly Labile Human Type 5 17-beta-hydroxysteroid Dehydrogenase"" Endocrinology, vol. 140, pp. 568-574, 1999.;;Cèbe et al., ""Rapid and Easy Thermodynamic Optimization of the 5' -end of mRNA Dramatically Increases the Level of Wild Type Protein Expression in Escherichia coli."" Protein Expression and Purification, vol. 45, pp. 374-380, 2006.;;Lu et al., ""Purification, Reconstitution and Steady-State Kinetics of the Trans-Membrane 17-beta-hydroxysteroid, Dehydrogenase 2."" The Journal of Biological Chemistry, vol. 277, pp. 22123-22130, 2002.;;Brinkmann et al., ""Inhibition of Tryptase TL2 from Human T4+ Lymphocytes and Inhibition of HIV-1 Replication in H9 Cells by Recombinant Aprotinin and Bikunin Homologues."" Journal of Protein Chemistry, vol. 16, pp. 651-660, 1997.;;Churchill et al., ""Rapid Purification of Recombinant Listeriolysin 0 (LL0) from Escherichia coli."" Journal of Industrial Microbiology and Biotechnology, vol. 32, pp. 355-363, 2005.;;Stefano et al., ""Biocatalyzed Synthesis of Testosterone."" Chemical Engineering Transactions, vol. 20, pp. 61-66, Apr. 2010.;;P. Rheault et al., ""Structure and Activity of the Murine Type 5 17beta-hydroxysteroid Dehydrogenase Gene,""Biochimica et Biophysica Acta, vol. 1447, No. 1, pp. 17-24 (1999)."
11,US,B2,US 7754220 B2,101-550-472-644-655,2010-07-13,2010,US 54797406 A,2006-05-04,JP 2003067283 A 20030312;;JP 2003311892 A 20030903,Methods Of Inhibiting Secretion Of Follicle-stimulating Hormone And Testosterone,TAKEDA PHARMACEUTICAL,OHTAKI TETSUYA;;MATSUI HISANORI;;MATSUMOTO HIROKAZU;;KITADA CHIEKO,https://lens.org/101-550-472-644-655,Granted Patent,yes,11,8,10,25,G01N33/689;;A61K31/00;;A61K31/7088;;A61K38/1709,A61K38/16;;A61K31/00;;A61K31/7088;;A61K38/17;;A61P5/08;;A61P15/08;;A61P35/00;;G01N33/68,424/198.1;;514/12,11287240;;11385580;;11387329;;11457843;;11994395;;12397184;;12470245;;12574233;;15013429;;15157736;;15217982;;16242330;;16879969;;2496866;;3543765;;370132;;7798016,10.1210/JC.2002-021235;;10.1039/P19790000379;;10.1016/J.BBRC.2004.01.021;;10.1073/PNAS.192565799;;10.1677/JOE.0.1450113;;10.1210/JC.87.5.2399;;10.1074/JBC.M102743200;;10.1016/J.BBAEXP.2004.02.005;;10.1016/J.BMC.2006.07.009;;10.1016/J.BMCL.2005.09.054;;10.1074/JBC.M104847200;;10.1136/BMJ.298.6676.809;;10.1210/EN.2004-0431;;10.1038/35079135;;10.1016/S0958-1669(00)00202-0,"Tomita et al, Bioorganic & Med. Chem. 14:7595-7603, 2006.;;Kotani et al, J. Biol. Chem. 276(37):34631-34636, 2001.;;Cleland et al, April, Current Opinion in Biotechnology 12: 212-219, 2001.;;Rudinger in J.A. Parsons, ed. ""Peptide hormones"", University Park Press, 1976.;;Ngo et al., In Merz et al., ed. ""The protein folding problem and tertiary structure prediction"", Birkhauser, 1994.;;Evans et al, J. Endocrinol. 145(1):113-119, 1995; Abstract only.;;Homburg et al, British Med. J. 298(6676):809-812, 1989.;;Andreyko et al, Obstet. Gynecol. Surv. 42(1):1-21, 1987; Abstract only.;;A. Dutta et al., ""Polypeptides, Part 15. Synthesis and Biological Activity of alpha-Aza-analogues of Luliberin modified in Positions 6 and 10"", Journal of the Chemical Society, Perkin Transactions I, No. 2, pp. 379-388 (1979).;;T. Ohtaki et al., ""Metastasis Suppressor Gene KiSS-1 Encodes Peptide Ligand of a G-Protein-Coupled Receptor"", Nature, vol. 411, pp. 613-617 (2001).;;M. Kotani et al., ""The Metastasis Supressor Gene KiSS-1 Enclodes Kisspeptins, the Natural Ligands of the Orphan G Protein-Coupled Receptor GPR54"", The Journal of Biological Chemistry, vol. 276: No. 37, pp. 34631-34636 (2001).;;M. Ringel et al., ""Metastin Receptor is Overexpressed in Paillary Thyroid Cancer and Activates MAP Kinase in Thyroid Cancer Cells"", The Journal of Clinical Endocrinology & Metabolism, 87(5): 2399-2402 (2002).;;S. Han et al., ""Orphan G Protein-Coupled Receptors MrgA1 and MrgC11 are Distinctively Activated by RF-amide-related Peptides Through the Galphaq/11 Pathway"", PNAS, vol. 99, No. 23, pp. 14740-14745 (2002).;;A. Niita et al., ""Genome Information Convergent Type of Drug Development Research: Depolymerization of the Cancer Metastasis Suppressor Gene, KiSS-1 (Metastin)"", Yuki 2B-13-2, 53rd, Nihon Yakugaku kai, Kinki Shibu Sokai, Taikai, Koen Yoshi-shu (2003).;;T. Masui et al., ""Metastin and Its Variant Forms Suppress Migration of Pancreatic Cancer Cells"", Biochemical and Biophysical Resaerch Communications, 315, pp. 85-92 (2004).;;Y. Terao et al., ""Express of KiSS-1, a Metastasis Suppressor Gene, in Trophoblast Giant Cells of the Rat Placenta"", Biochimica et Biophysica Acta, 1678, pp. 102-110 (2004).;;M.L. Gottsch et al., ""A Role for Kisspeptins in the Regulation of Gonadotropin Secretion in the Mouse"", Endocrinology, 145(9), pp. 4073-4077 (2004).;;Niida et al., ""Design and synthesis of downsized metastin (45-54) analogs with maintenance of high GPR54 agonistic activity,"" Bioorganic & Medicinal Chemistry Letters (2006) 16:134-137.;;Tomita et al., ""Structure-activity relationship study on small peptidic GPR54 agonists,"" Bioorganic & Medicinal Chemistry (2006) 14:7595-7603.;;Venkatesan et al., ""Synthesis and Enzyme Inhibitory Activities of Novel Peptide lsosteres,"" Current Medicinal Chemistry (2002) 9:2243-2270.;;Muir et al., ""AXOR12, a Novel Human G Protein-coupled Receptor, Activated by the Peptide KiSS-1,"" Journal of Biological Chemistry (2001), 276(31):28969-28975.;;Supplementary European Search Report for corresponding European application EP04719659, dated May 26, 2009.;;The Journal of Clinical Endocrinology & Metabolism, ""Dramatic Elevation of Plasma Metastin Concentrations in Human Pregnancy: Metastin as a Novel Plascenta-Derived Hormone in Humans,"" 88(2):914-919 (2003)."
12,WO,A3,WO 2008/009960 A3,052-777-162-555-746,2008-07-10,2008,GB 2007002764 W,2007-07-20,GB 0614568 A 20060721,Anti-testosterone Antibodies,HAPTOGEN LTD;;UNIV ABERDEEN;;BROADBENT IAN;;CHARLTON KEITH;;PORTER ANDREW;;STRACHAN GILLIAN;;KENYON ANDREW;;MCEWAN LAIN,BROADBENT IAN;;CHARLTON KEITH;;PORTER ANDREW;;STRACHAN GILLIAN;;KENYON ANDREW;;MCEWAN LAIN,https://lens.org/052-777-162-555-746,Search report,yes,0,4,4,20,C07K16/26;;C07K2317/21;;C07K2317/76,C07K16/26;;A61K39/395;;C12N15/13,,,,"HEMMINKI A ET AL: ""Fine tuning of an anti-testosterone antibody binding site by stepwise optimisation of the CDRs"" IMMUNOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, NL, vol. 4, no. 1, June 1998 (1998-06), pages 59-69, XP004127387 ISSN: 1380-2933;;JANA C K ET AL: ""Antibody binding characteristics of geometrical isomers of testosterone 3-(O-carboxymethyl)oxime - Study of the characteristics of antibodies against 17alpha-hydroxyprogesterone and testosterone and of their evolution with time"" STEROIDS: STRUCTURE, FUNCTION, AND REGULATION, ELSEVIER SCIENCE PUBLISHERS, NEW YORK, NY, US, vol. 64, no. 3, March 1999 (1999-03), pages 228-232, XP004172198 ISSN: 0039-128X;;DATABASE USPTO Proteins [Online] 13 June 2005 (2005-06-13), ""Sequence 89 from patent US 6903194."" XP002465156 retrieved from EBI accession no. USPOP:AAY78242 Database accession no. AAY78242;;DATABASE Geneseq [Online] 23 July 1998 (1998-07-23), ""Light chain of a human antibody."" XP002465157 retrieved from EBI accession no. GSP:AAW53585 Database accession no. AAW53585;;DATABASE EMBL [Online] 11 July 2000 (2000-07-11), ""Synthetic construct HCV non-structural protein 4A single chain Fv antibody mRNA, complete cds."" XP002465158 retrieved from EBI accession no. EMBL:AF271151 Database accession no. AF271151;;DATABASE EMBL [Online] 24 December 2000 (2000-12-24), ""602144348F1 NIH_MGC_48 Homo sapiens cDNA clone IMAGE:4297954 5', mRNA sequence."" XP002465159 retrieved from EBI accession no. EMBL:BF663230 Database accession no. BF663230"
13,WO,A3,WO 2004/022066 A3,179-983-388-558-598,2005-01-06,2005,EP 0309238 W,2003-08-20,EP 02090315 A 20020904,Method And Means For The Treatment Of Vascular And Cardiac Diseases,FRAUNHOFER GES FORSCHUNG;;BORLAK JUERGEN;;THUM THOMAS,BORLAK JUERGEN;;THUM THOMAS,https://lens.org/179-983-388-558-598,Search report,yes,0,10,10,103,A61K31/56,A61K31/56;;A61P9/00,,,,"ENGLISH KATHERINE M ET AL: ""Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study."" CIRCULATION, Bd. 102, Nr. 16, 17. Oktober 2000 (2000-10-17), Seiten 1906-1911, XP002228289 ISSN: 0009-7322;;SHAPIRO J ET AL: ""Testosterone and other anabolic steroids as cardiovascular drugs."" AMERICAN JOURNAL OF THERAPEUTICS. MAY 1999, Bd. 6, Nr. 3, Mai 1999 (1999-05), Seiten 167-174, XP009004530 ISSN: 1075-2765"
14,WO,A1,WO 2010/055208 A1,155-819-902-541-591,2010-05-20,2010,FI 2009050910 W,2009-11-12,FI 20086073 A 20081112,Modified Avidins Binding To Small Ligands,VALTION TEKNILLINEN;;PALDANIUS TIINA;;HYTOENEN VESA;;TAKKINEN KRISTIINA;;KULOMAA MARKKU;;NORDLUND NINA,PALDANIUS TIINA;;HYTOENEN VESA;;TAKKINEN KRISTIINA;;KULOMAA MARKKU;;NORDLUND NINA;;NORDLUND HENRI,https://lens.org/155-819-902-541-591,Patent Application,yes,0,2,2,29,C40B50/06;;C07K14/465;;C12N15/1037;;C40B40/08;;C40B40/10,C07K14/465;;C07K14/775;;C12N5/10;;C12N15/10;;C12N15/63;;G01N33/53;;G01N33/68,,10669603;;15939877;;16175628;;17086379;;17643280,10.1007/S00018-006-6288-Z;;10.1006/JMBI.1999.3465;;10.1002/PROT.20604;;10.1073/PNAS.0503112102;;10.1016/J.COPBIO.2007.04.010,"SKERRA A.: 'Alternative non-antibody scaffolds for molecular recognition' CURRENT OPINION IN BIOTECHNOLOGY vol. 18, 2007, pages 295 - 304, XP022244962;;HYTONEN V.P. ET AL: 'Dual-affinity avidin molecules' PROTEINS: STRUCTURE, FUNCTION AND BIOINFORMATICS vol. 61, 2005, pages 597 - 607, XP002431540;;ASLAN F. M. ET AL: 'Engineered single-chain dimetric streptavidins with an unexpected strong preference for biotin-4-fluorescein' PNAS vol. 102, no. 24, 14 June 2005, pages 8507 - 8512, XP002383753;;LAITINEN 0. H. ET AL: 'Genetically engineered avidins and streptavidins' CELLULAR AND MOLECULAR LIFE SCIENCES vol. 63, 2006, pages 2992 - 3017, XP019471723;;SIDHU S.S. ET AL: 'High copy display of large proteins on phage for functional selections' J. MOL. BIOL. vol. 296, 2000, pages 487 - 495, XP004461555"
15,US,A1,US 2013/0064821 A1,184-600-829-414-283,2013-03-14,2013,US 201213584263 A,2012-08-13,AU 2007 901628 A 20070327,Methods And Compositions For Treating Prostate Cancer,HOVENS CHRISTOPHER;;CORCORAN NIALL;;COSTELLO ANTHONY,HOVENS CHRISTOPHER;;CORCORAN NIALL;;COSTELLO ANTHONY,https://lens.org/184-600-829-414-283,Patent Application,yes,1,8,8,4,C07K14/575;;A61K38/00;;C07K14/721,A61K38/16;;A61K39/395;;A61P35/00,424/135.1;;424/145.1;;424/158.1;;514/10.2,,,
16,US,A1,US 2010/0092477 A1,078-484-488-267-781,2010-04-15,2010,US 56859009 A,2009-09-28,AU 2007 901628 A 20070327,Methods And Compositions For Treating Prostate Cancer,HOVENS CHRISTOPHER;;CORCORAN NIALL;;COSTELLO ANTHONY,HOVENS CHRISTOPHER;;CORCORAN NIALL;;COSTELLO ANTHONY,https://lens.org/078-484-488-267-781,Patent Application,yes,1,8,8,4,C07K14/575;;A61K38/00;;C07K14/721,A61K39/395;;A61K31/7088;;A61K38/16;;A61P5/24;;A61P35/04;;C07H21/04;;C07K14/00;;C07K16/00;;C12N15/63,424/141.1;;530/387.3;;530/350;;530/388.1;;530/389.1;;536/23.4;;536/23.53;;435/320.1;;424/130.1;;514/12;;X514 44  R,15037741,,"Shaffer et al. (PNAS April, 2004 101(14): 4758-4763);;Janeway et al. (Immunobiolgy:The Immune System in Health and Disease. 5th ed. New York 2001, 4-15 to 4-20)"
17,US,A1,US 2002/0165208 A1,052-216-452-179-507,2002-11-07,2002,US 94242901 A,2001-08-29,US 22894700 P 20000829,Compositions And Methods Relating To Hypertension,CAPDEVILA JORGE H.;;WATERMAN MICHAEL;;HOLLA VIJAKUMAR,CAPDEVILA JORGE H;;WATERMAN MICHAEL;;HOLLA VIJAKUMAR,https://lens.org/052-216-452-179-507,Patent Application,yes,3,4,4,9,C12N9/0077;;A61K38/00,A61K38/00;;C12N9/02;;C12N15/12,514/169,,,
18,WO,A1,WO 2015/148549 A1,188-777-620-128-509,2015-10-01,2015,US 2015/0022301 W,2015-03-24,US 201461970883 P 20140326,Ultrasensitive Androgen Receptor Bioassay,UNIV CALIFORNIA,SCHAUFELE FRED,https://lens.org/188-777-620-128-509,Patent Application,yes,0,1,1,9,G01N33/743;;C07K14/721;;C07K2319/60;;C12N15/85;;C12Q1/68,C07K19/00;;C07K14/705;;C12N15/62;;C12N15/63;;C12N15/85;;C12Q1/02;;G01N35/00,,18057027;;17170104;;15994236;;18601531;;9092797,10.1242/JCS.005801;;10.1074/jbc.r600026200;;10.1073/pnas.0408819102;;10.1117/1.2940366;;10.1210/me.11.4.450,"KOFOED ET AL.: ""Dimerization between aequorea fluorescent proteins does not affect interaction between tagged estrogen receptors in living cells"", JOURNAL OF BIOMEDICAL OPTICS, vol. 13, no. 3, 2008, pages 031207, XP055227831;;SCHAUFELE ET AL.: ""The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 102, no. 28, 2005, pages 9802 - 9807, XP055227833;;TAN ET AL.: ""Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells"", MOLECULAR ENDOCRINOLOGY, vol. 11, no. 4, 1997, pages 450 - 459, XP055227834;;LANGE ET AL.: ""Classical nuclear localization signals: definition, function, and interaction with importin alpha"", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 282, no. 8, 2007, pages 5101 - 5105, XP002674492;;SHANER ET AL.: ""Advances in fluorescent protein technology"", JOURNAL OF CELL SCIENCE, vol. 120, no. 24, 2007, pages 4247 - 4260, XP003026481"
19,US,A1,US 2006/0275807 A1,104-861-362-891-142,2006-12-07,2006,US 43242406 A,2006-05-10,US 67949705 P 20050510,Novel Steroid 5alpha-reductase,MOHLER JAMES L;;TITUS MARK;;KOZYREVA OLGA;;FORD O H III;;KAWINSKI ELSBIETA;;LI YUN,MOHLER JAMES L;;TITUS MARK;;KOZYREVA OLGA;;FORD O H III;;KAWINSKI ELSBIETA;;LI YUN,https://lens.org/104-861-362-891-142,Patent Application,yes,0,6,6,10,C12Q1/26;;C07K2319/21;;C07K2319/40;;C12N9/001;;C12N2799/022;;G01N33/57434,C12Q1/68;;C12N9/02;;C12N15/861;;G01N33/574,435/6.000;;435/7.230;;435/189.000;;435/456.000;;435/183.000,,,
20,US,A1,US 2006/0148725 A1,001-621-638-755-882,2006-07-06,2006,US 11272305 A,2005-04-21,US 11272305 A 20050421;;US 56443004 P 20040421;;US 34269301 P 20011221,Selective 11beta Hsd Inhibitors And Methods Of Use Thereof,RHODE ISLAND HOSPITAL,MORRIS DAVID J;;BREM ANDREW S,https://lens.org/001-621-638-755-882,Patent Application,yes,0,1,8,7,A61K31/57;;A61K31/573;;A61K31/704,A61K48/00;;A61K31/57;;A61K31/573;;A61K31/704,514/26.000;;514/44.000;;514/177.000;;514/178.000;;514/179.000,,,
21,WO,A1,WO 2014/197979 A1,126-711-099-106-542,2014-12-18,2014,CA 2014050467 W,2014-05-21,US 201361834993 P 20130614;;US 201461953336 P 20140314,Therapeutics For The Induction Of Endogenous Steroidogenesis And Methods Associated With Their Identification,UNIV MCGILL,PAPADOPOULOS VASSILIOS;;AGHAZADEH YASAMAN;;FAN JINJIANG,https://lens.org/126-711-099-106-542,Patent Application,yes,0,6,6,30,C07K7/08;;A61K31/713;;A61K38/00;;C07K7/06;;C07K14/47;;C07K14/705;;C07K2319/10;;C12N15/113;;C12N2310/14;;C12N2320/30;;C12P33/00;;G01N33/5023;;G01N33/5044;;G01N33/743,C07K14/47;;A61K31/713;;A61K38/17;;A61P5/26;;C07K7/06;;C07K7/08;;C07K19/00;;C12N5/071;;C12P33/00;;C12Q1/02,,,,
22,CA,A1,CA 2767052 A1,067-151-714-169-721,2011-01-06,2011,CA 2767052 A,2010-06-15,IT MI20091168 A 20090701,Process For The Preparation Of Testosterone,ITALIANA SINT SPA,FOGAL STEFANO;;BERGANTINO ELISABETTA;;MOTTERLE RICCARDO;;CASTELLIN ANDREA;;ARVOTTI GIANCARLO,https://lens.org/067-151-714-169-721,Patent Application,no,0,9,9,4,C12P33/00;;C12N9/0006;;C12Y101/01062,C12P33/00,,,,
23,US,A1,US 2003/0148987 A1,058-424-167-067-607,2003-08-07,2003,US 32756602 A,2002-12-20,US 34269301 P 20011221,Selective 11beta-hsd Inhibitors And Methods Of Use Thereof,MORRIS DAVID J.;;BREM ANDREW S.,MORRIS DAVID J;;BREM ANDREW S,https://lens.org/058-424-167-067-607,Patent Application,yes,12,7,8,7,C12N15/1137;;A61K31/568;;A61K31/5685;;A61K31/57;;A61K31/573;;A61K38/00;;A61K45/06;;C12Y101/01146,A61K31/568;;A61K31/5685;;A61K31/57;;A61K31/573;;A61K38/00;;A61K45/06;;C12N15/113,514/44;;514/177,,,
24,US,B2,US 8883739 B2,189-919-390-707-894,2014-11-11,2014,US 201113574196 A,2011-01-19,US 29641510 P 20100119;;US 29633910 P 20100119,Osteocalcin As A Treatment For Male Reproductive Disorders,KARSENTY GERARD;;DUCY PATRICIA F;;UNIV COLUMBIA,KARSENTY GERARD;;DUCY PATRICIA F,https://lens.org/189-919-390-707-894,Granted Patent,yes,1,6,6,31,A61K38/39,A61K38/16;;A61K38/17;;A61K38/22;;A61K38/39,514/21.3;;514/9.8,10196355;;10233961;;10655585;;10976047;;1316261;;1323131;;1409642;;1482093;;15194188;;15613016;;15753290;;17693256;;19050760;;2027751;;2138240;;2165023;;2410914;;2531466;;2547998;;2829430;;2835501;;2847025;;3703680;;5420325;;5474325;;598381;;6095038;;6357679;;6774781;;6967872;;7515101;;7527035;;7584077;;7598953;;762070;;7721873;;7842013;;8390686;;8391471;;8493530;;8523528;;8596952;;8602510;;8876146;;8878571;;8980475;;9223473;;9306402;;9330631;;9383569;;9420292;;9500613;;9736926;;9804418;;9811504;;9918109;;9928669;;9971834;;7584090;;10582779;;10902858;;20947496;;6175544;;14656471;;8951793;;16199532;;2691199;;18818749;;210046;;16968703;;10856920;;14623515;;10051101;;3620562;;18653675;;2298858;;17848414;;12959969;;17463055;;18718516,10.1073/PNAS.90.12.5873;;10.1093/NAR/19.7.1437;;10.1021/CEN-V075N022.P035;;10.1016/0022-2836(70)90057-4;;10.1126/SCIENCE.272.5259.263;;10.1038/NM0398-354;;10.1095/BIOLREPROD23.1.243;;10.1016/0960-894X(94)80003-0;;10.1371/JOURNAL.PONE.0003858;;10.1126/SCIENCE.2531466;;10.1080/15257779408012174;;10.1038/35000016;;10.1073/PNAS.89.15.7257;;10.1111/J.1749-6632.1992.TB38648.X;;10.1073/PNAS.93.21.11395;;10.1084/JEM.179.6.1867;;10.1038/NBT0997-871;;10.1038/27579;;10.1016/0042-6822(88)90491-6;;10.1007/978-3-642-75608-5_5;;10.1126/SCIENCE.337487;;10.1021/JA00221A089;;10.1021/JS980064W;;10.1007/BF02721371;;10.1016/J.CELL.2007.05.047;;10.1093/NAR/14.8.3487;;10.1111/J.1432-1033.1977.TB11985.X;;10.1126/SCIENCE.8493530;;10.1016/S1367-5931(98)80129-4;;10.1126/SCIENCE.271.5257.1854;;10.1073/PNAS.82.15.5131;;10.1016/J.GENE.2004.03.003;;10.1111/J.1538-7836.2004.00968.X;;10.1002/JMR.300080109;;10.1016/0378-1119(90)90018-M;;10.1073/PNAS.0501076102;;10.1089/DNA.1983.2.183;;10.1074/JBC.270.16.9459;;10.1007/BF00039378;;10.1021/JO00836A048;;10.1016/0168-9525(95)90594-4;;10.1016/s0040-4020(01)86295-5;;10.1246/cl.1984.805;;10.1002/anie.199210081;;10.1002/anie.199104231;;10.1021/bk-1994-0580.ch007;;10.1002/9780470515396.ch6;;10.1093/humupd/5.5.393;;10.1258/0004563001899573;;10.1074/jbc.m110.158063;;10.1016/0303-7207(82)90167-8;;10.1016/j.mce.2003.09.006;;10.1016/0925-4773(96)00586-2;;10.1021/bk-1994-0580.ch003;;10.1074/jbc.m505186200;;10.1093/toxsci/46.1.61;;10.3109/03008208909049995;;10.1371/journal.pone.0003285;;10.1016/0014-5793(78)81204-6;;10.1074/jbc.m605086200;;10.1016/s1043-2760(00)00254-x;;10.1016/s0960-0760(03)00360-1;;10.1530/ror.0.0040038;;10.1095/biolreprod36.5.1191;;10.1093/humupd/dmn029;;10.1210/jcem-70-2-467;;10.1093/molehr/gam065;;10.1210/en.2003-0563;;10.1210/en.2007-0248;;10.1089/oli.1.1998.8.451;;10.1016/j.heares.2008.07.009,"Andrology, at http://www.springer.com/medicine/urology/book/978-3-540-78354-1, accessed Nov. 25, 2013.;;Berkner, K.L. et al., ""The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis"", J of Thrombosis and Haemostasis (2004), vol. 2, pp. 2118-2132.;;Comhaire, F.H. et al., ""Mechanisms and effects of male genital tract infection on sperm quality and fertilizing potential: the andrologist's viewpoint"", Human Reproduction Update (1999), vol. 5:5, pp. 393-398.;;Mauro, L. J. et al., ""Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation"", J. of Biological Chemistry (1994), vol. 269:48, pp. 306959-30667.;;Mesmaeker, A.D. et al., ""Comparison of Rigid and Flexible Backbones in Antisense Oligonucleotides"", Bioorganic & Medicinal Chem. Ltrs. (1994), vol. 4:3, pp. 395-398.;;Pi, M. et al., ""GPRC6A Mediates the Non-Genomic Effects of Steroids"" J. Biol. Chem. (2010), vol. 285:51, pp. 39953-39964.;;Houghten, R. et al., ""General Method for the Rapid Solid-Phase Synthesis of Large Numbers of Peptides: Specificity of Antigen-Antibody Interaction at the Level of Individual Amino Acids"", Proc. Natl. Acad. Sci. USA (1985) vol. 82, pp. 5131-5135.;;Hunter, M. et al., ""The Functional Activity of Adult Mouse Leydig Cells in Monolayer Culture"", Mol. Cell. Endocrinology (1982), vol. 25, pp. 35-47.;;Huse, W. et al., ""Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda"", Science (1989), vol. 246, pp. 1275-1281.;;Jamin, S. et al., ""Genetic Studies of the AMH/MIS Signaling Pathway for Mullerian Duct Regression"", Mol. Cell. Endocrinology (2003), vol. 211, pp. 15-19.;;Johanson, K. et al., ""Binding Interactions of Human Interleukin 5 with Its Receptor a Subunit"", J. Biol. Chem. (1995), vol. 270:16, pp. 9459-9471.;;Johnston, J. et al, ""Minimum Requirements for Efficient Transduction of Dividing and Non-dividing Cells by Feline Immunodeficiency Virus Vectors"", J. Virology (1999), vol. 73:6, pp. 4991-5000.;;Johnston, J. et al., ""Productive Infection of Human Peripheral Blood Mononuclear Cells by Feline Immunodeficiency Virus: Implications for Vector Development"", J. Virology (1999), vol. 73:3, pp. 2491-2498.;;Kaplitt, M. et al., ""Long-Term Gene Expression and Phenotypic Correction Using Adeno-Associated Virus Vectors in the Mammalian Brain"", Nature Genetics (1994), vol. 8, pp. 148-154.;;Karlin, S. et al., ""Applications and Statistics for Multiple High-Scoring Segments in Molecular Sequences"", Proc. Natl. Acad. Sci. USA (1993), vol. 90, pp. 5873-5877.;;Kiedrowski, G. et al., ""Parabolic Growth of a Self-Replicating Hexadeoxynucleotide Bearing a 3'-5'- Phosphoamidate Linkage"", Angew Chem. Intl. Ed. English (1991), vol. 30:4, pp. 423-426.;;Kim, V. et al., ""Minimal Requirement for a Lentivirus Vector Based on Human Immunodeficiency Virus Type 1"", J. Virology (1998), vol. 72:1, pp. 811-816.;;Krogsgaard-Larsen, P. et al., ""Design and Application of Prodrugs"" A Textbook of Drug Design and Development, Ed., Harwood Academic (1991) Chapter 5, pp. 113-191.;;Laface, D. et al., ""Gene Transfer into Hematopoietic Progenitor Cells Mediated by an Adeno-Associated Virus Vector"", J. Virology (1988), vol. 162, pp. 483-486.;;Lebkowski, J. et al., ""Adeno-Associated Virus: a Vector System for Efficient Introduction and Integration of DNA into a Variety of Mammalian Cell Types"", Mol. Cell. Biol. (1988) vol. 8:10, pp. 3988-3996.;;Lee, K. et al., ""Identification of a Developmentally Regulated Protein Tyrosine Phosphatase in Embryonic Stem Cells that is a Marker of Pluripotential Epiblast and Early Mesoderm"", Mech. Dev. (1996) vol. 59, pp. 153-164.;;Lee, A. et al., ""Measurement of Osteocalcin"", Ann. Clin. Biochem. (2000), vol. 37, pp. 432-446.;;Lee, N. K. et al., ""Endocrine Regulation of Energy Metabolism by the Skeleton"", Cell (2007), vol. 130, pp. 456-469.;;Letsinger, R. et al., ""Phosphoramidate Analogs of Oligonucleotides"", J. Organic Chemistry (1970), vol. 35:11, pp. 3800-3803.;;Letsinger, R. et al., ""Effects of Pendant Groups at Phosphorus on Binding Properties of d-ApA Analogues"", Nucl. Acids Res. (1986) vol. 14:8, pp. 3487-3499.;;Letsinger, R. et al., ""Cationic Oligonucleotides"" J. Am. Chem. Soc. (1988) vol. 110, pp. 4470-4471.;;Jung, P. et al., ""Hybridization of Alternating Cationic/Anionic Oligonucleotides to RNA Segments"", Nucleoside & Nucleoside (1994), vol. 13 (6 &7), pp. 1597-1605.;;Luo, F. et al., ""Adeno-Associated Virus 2-Mediated Transfer and Functional Expression of a Gene Encoding the Human Granulocyte-Macrophage Colony-Stimulating Factor"", Blood: The Journal of the American Society of Hematology, (1994), Abstract #1196, pp. 303a.;;Maddry, J. et al., ""Synthesis of Nonionic Oligonucleotide Analogues"", Chapter 3, pp. pp. 40-51, in SC Symposium Series 580, Carbohydrate Modifications in Antisense Research (1994), Eds. Yogesh S. Sanghvi and P. Dan Cook.;;Mag, M. et al., ""Synthesis and Selective Cleavage of an Oligodeoxynucleotide Containing a Bridged Internucleotide 5'-Phosphorothioate Linkage"", Nucleic Acids Res. (1991), vol. 19:7, pp. 1437-1441.;;Mather, J. ""Establishment and Characterization of Two Distinct Mouse Testicular Epithelial Cell Lines"", Biol. Reprod. (1980), vol. 23, pp. 243-252.;;McLaughlin, S. et al., ""Adeno-Associated Virus General Transduction Vectors: Analysis of Proviral Structure"", J. Virology (1988), vol. 62:6, pp. 1963-1973.;;Meier, C. et al., ""Peptide Nucleic Acids (PNAs)-Unusual Properties of Nonionic Oligonucleotide Analogues"" Chem. Int. Ed. Engl. (1992) vol. 31, 1008-1009.;;Mesmaeker, A.D. et al., ""Novel Backbone Replacements for Oligonucleotides"", Chapter 2, pp. 24-37 in ASC Symposium Series 580, Carbohydrate Modifications in Antisense Research (1994), Eds. Yogesh S. Sanghvi and P. Dan Cook.;;Morgan, R. ""Human Gene Therapy"", BioPharm, (1993), vol. 6:1, pp. 32-35.;;Mulligan, R. ""The Basic Science of Gene Therapy"", Science (1993), vol. 260, pp. 926-932.;;Naldini, L. et al., ""In vivo Gene Delivery and Stable Transduction of Non-dividing Cells by a Lentiviral Vector"", Science (1996), vol. 272, pp. 263-267.;;Needleman, S. et al., ""A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins"", J. Mol. Biol. (1970), vol. 48, pp. 444-453.;;Nelson, L. et al.,""Estrogen Production and Action"", J. Am. Acad. Dermatol. (2001), vol. 45:3, pp. S116-S124.;;Ohi, S. et al., ""Construction and Replication of an Adeno-Associated Virus Expression Vector that Contains Human B-Globin cDNA"", Gene (1990), vol. 89, pp. 279-282.;;Pauwels, R. et al., ""Biological Activity of New 2-5A Analogues"", Chemica Scripta (1986), vol. 26, pp. 141-145.;;Pi, M. et al, ""GPRC6A Null Mice Exhibit Osteopenia, Feminization and Metabolic Syndrome"", PLoS One (2008), vol. 3:12-e3858, pp. 1-10.;;Pi, M. et al., ""Identification of a Novel Extracellular Cation-Sensing G-Protein-Coupled Receptor"", J. Biol. Chem. (2005), vol. 280:48, pp. 40201-40209.;;Poeschla, E. et al., ""Development of HIV Vectors for Anti-HIV Gene Therapy"", Proc. Natl. Acad. Sci. USA (1996), vol. 93, pp. 11395-11399.;;Poeschla, E. et al., ""Efficient Transduction of Non-Dividing Human Cells by Feline Immunodeficiency Virus Lentiviral Vectors"", Nat. Med. (1998), vol. 4:3, pp. 354-357.;;Poser, J. et al., ""Isolation and Sequence of the Vitamin K-Dependent Protein from Human Bone"", J. Biol. Chem. (1980), vol. 255:18, pp. 8685-8691.;;Poser, J. et al., ""A Method for Decarboxylation of y-Carboxyglutamic Acid in Proteins"", J. Biol. Chem. (1979), vol. 254:2, pp. 431-436.;;Powlin, S. et al., ""Ex Vivo and in Vitro Testis and Ovary Explants: Utility for Identifying Steroid Biosynthesis Inhibitors and Comparison to a Tier I Screening Battery"", Toxicol. Sci. (1998), vol. 46, pp. 61-74.;;Price, P., ""Gla-Containing Proteins of Bone"", Connect. Tissue Res. (1989), vol. 21, pp. 51-57 (discussion 57-60).;;Qin, J. et al., ""Essential Roles of COUP-TFII in Leydig Cell Differentiation and Male Fertility"", PLoS One (2008), vol. 3:9:e3285, pp. 1-11.;;Rattan, S. et al., ""Protein Synthesis, Posttranslational Modifications, and Aging"", Ann. New York Acad. Sci. (1992) vol. 663, pp. 48-62.;;Rawls, R. ""Optimistic about Antisense: Promising Clinical Results and Chemical Strategies for Further Improvements Delight Antisense Drug Researchers"", Chemical & Engineering News (1997), pp. 35-39.;;Russell, D. et al., ""Foamy Virus Vectors"", J. Virology (1996), vol. 70:1, pp. 217-222.;;Samulski, R. et al., ""Helper-Free Stocks of Recombinant Adeno-Associated Viruses: Normal Integration Does Not Require Viral Gene Expression"", J. Virology (1989), vol. 63:9, pp. 3822-3828.;;Sawai, H. et al, ""Synthesis and Properties of Oligoadenylic Acids Containing 2'-5' Phosphoramide Linkage"", Chemistry Letters (1984), pp. 805-808.;;Schumacher, T. et al, ""Identification of D-Peptide Ligands through Mirror-Image Phage Display"", Science (1996), vol. 271, pp. 1854-1857.;;Schumacher, M. et al., ""Rapid Isolation of Mouse Leydig Cells by Centrifugation in Percoll Density Gradients with Complete Retention of Morphological and Biochemical Integrity"", FEBS Lett. (1978), vol. 91:2, pp. 333-338.;;Seifter, S. et al., ""Analysis for Protein Modifications and Non-Protein Co-Factors"", Methods in Enzymol. (1990), vol. 182, pp. 626-646.;;Sheng, Y. et al., ""Gonadotropin-Regulated Testicular RNA Helicase (GRTH/Ddx25) Is a Transport Protein Involved in Gene-Specific mRNA Export and Protein Translation During Spermatogenesis"", J. Biol. Chem. (2006), vol. 281:46, pp. 35048-35056.;;Shelling, A. et al., ""Targeted Integration of Transfected and Infected Adeno-Associated Virus Vectors Containing the Neomycin Resistance Gene"", Gene Therapy (1994), vol. 1:3, pp. 165-169.;;Simon, R. et al., ""Peptoids: A Modular Approach to Drug Discovery"", Proc. Natl. Acad. Sci. (1992), vol. 89, pp. 9367-9371.;;Simpson, E. et al., ""The Role of Local Estrogen Biosynthesis in Males and Females"", Trends Endocrinol. Metab. (2000), vol. 11:5, pp. 184-188.;;Simpson E, ""Sources of Estrogen and Their Importance"", J. Steroid Biochem. Mol.Biol. (2003), vol. 86, pp. 225-230.;;Sinha, A. (Hikim), et al., ""Hormonal and Genetic Control of Germ Cell Apoptosis in the Testis"", Reviews of Reprod. (1999), vol. 4, pp. 38-47.;;Springer, M. et al, ""High-Efficiency Retroviral Infection of Primary Myoblasts"", Somatic Cell Mol. Genetics (1997), vol. 23:3, pp. 203-209.;;Sprinzl, M. et al., ""Enzymatic Incorporation of ATP and CTP Analogues into the 3' End of tRNA"", Eur. J. Biochem. (1977), vol. 81, pp. 579-589.;;Srinivasakumar, N. et al., ""The Effect of Viral Regulatory Protein Expression on Gene Delivery by Human Immunodeficiency Virus Type 1 Vectors Produced in Stable Packaging Cell Lines"", J. of Virology (1997), vol. 71:8, pp. 5841-5848.;;Suarez, S. et al., ""Initiation of Hyperactivated Flagellar Bending in Mouse Sperm within the Female Reproductive Tract"", Biol. of Reprod. (1987), vol. 36, pp. 1191-1198.;;Suarez, S., ""Control of Hyperactivation in Sperm"", Human Reprod. Update (2008), vol. 14:6, pp. 647-657.;;Svoboda, P. et al., ""Selective Reduction of Dormant Maternal mRNAs in Mouse Oocytes by RNA Interference"", Development (2000), vol. 127:19, pp. 4147-4156.;;Taylor, A. et al., ""Multiple Osteocalcin Fragments in Human Urine and Serum as Detected by a Midmolecule Osteocalcin Radioimmunoassay"", J. Clin. Endocrin. Metab. (1990), vol. 70:2, pp. 467-472.;;Timmons, L. et al., ""Specific Interference by Ingested dsRNA"", Nature (1998), vol. 395,:6705 p. 854.;;Tratschin, J et al., ""A Human Parvovirus, Adeno-Associated Virus, as a Eucaryotic Vector: Transient Expression and Encapsidation of the Procaryotic Gene for Chloramphenicol Acetyltransferase"", Mol. Cell. Biol., (1984), vol. 4:10, pp. 2072-2081.;;Tsai-Morris et al., ""Polymorphism of the GRTH/DDX25 Gene in Normal and Infertile Japanese Men: a Missense Mutation Associated with Loss of GRTH Phosphorylation"", Mol. Human Reprod. (2007) vol. 13:12, pp. 887-892.;;Wang, G. et al., ""Effects of Insulin-Like Growth Factor I on Steroidogenic Enzyme Expression Levels in Mouse Leydig Cells"", Endocrinology (2003), vol. 144:11, pp. 5058-5064.;;Walters, K. et al., ""Female Mice Haploinsufficient for an Inactivated Androgen Receptor (AR) Exhibit Age-Dependent Defects That Resemble the AR Null Phenotype of Dysfunctional Late Follicle Development, Ovulation, and Fertility"", Endocrinology (2007), vol. 148:8, pp. 3674-3684.;;Walsh, C. et al., ""Regulated High Level Expression of a Human gamma-Globin Gene Introduced into Erythroid Cells by an Adeno-Associated Virus Vector"", Proc. Natl. Acad. Sci. USA (1992), vol. 89, pp. 7257-7261.;;Wei, J. et al., ""Expression of the Human Glucocerebrosidase and Arylsulfatase A Genes in Murine and Patient Primary Fibroblasts Transduced by an Adeno-Associated Virus Vector"", Gene Therapy (1994), vol. 1:4, pp. 261-268.;;Wellendorph, P. et al., ""Molecular Cloning, Expression, and Sequence Analysis of GPRC6A, a Novel Family C G-Protein-Coupled Receptor"", Gene (2004), vol. 335, pp. 37-46.;;Wianny, F. et al., ""Specific Interference with Gene Function by Double-Stranded RNA in Early Mouse Development"", Nature Cell Biology (2000), vol. 2:2, pp. 70-75.;;Wold, F., ""Posttranslational Covalent Modification of Proteins: Perspectives and Prospectives"", in Posttranslational Covalent Modification of Proteins, edited by B. C. Johnson, Ed., Academic Press, New York 1-12 (1983).;;Wu, M. et al., ""Packaging Cell Lines for Simian Foamy Virus Type 1 Vectors"", J. of Virology (1999), vol. 73:5, pp. 4498-4501.;;Yoder, M. et al., ""In Vivo Gene Transfer in Murine Hematopoietic Reconstituting Stem Cells Mediated by the Adeno-Associated Virus 2-Based Vectors"", Blood, (1993) vol. 82:10, Supplemental 1, Abstract No. 1373, p. 347a.;;Zhang, X. et al., ""Genome-Wide Analysis of cAMP-Response Element Binding Protein Occupancy, Phosphorylation, and Target Gene Activation in Human Tissues"", Proc. Natl. Acad. Sci. U S A. (2005), vol. 102:12, pp. 4459-4464.;;Zhao, Q. et al., ""Cellular Distribution of Phosphorothioate Oligonucleotide Following Intravenous Administration in Mice"", Antisense Nucleic Acid Drug Dev. (1998), vol. 8:6, pp. 451-458.;;Zhou, S. et al., Adeno-Associated Virus 2-Mediated Gene Transfer in Murine Hematopoietic Progenitor Cells, Exp. Hematol. (1993), vol. 21:7, pp. 928-933.;;Zhou, S. et al., Adeno-Associated Virus 2-Mediated High Efficiency Gene Transfer into Immature and Mature Subsets of Hematopoietic Progenitor Cells in Human Umbilical Cord Blood, J. Exp. Med. (1994), vol. 179, pp. 1867-1875.;;Zufferey, R. et al., ""Multiply Attenuated Lentiviral Vector Achieves Efficient Gene Delivery in Vivo"", Nat. Biotechnol. (1997) vol. 15:9, pp. 871-875.;;Muzyczka, N. ""Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells"", Curr. Topics in Micro. and Immo. (1992), vol. 158, pp. 97-129.;;Adelman, J. et al., ""In Vitro Deletional Mutagenesis for Bacterial Production of the 20,000-Dalton Form of Human Pituitary Growth Hormone"", DNA (1983), vol. 2:3, pp. 183-193.;;Agrawal, S. et al., ""Pharmacokinetics of Oligonucleotides"", CIBA Found. Symp. (1997), vol. 209, pp. 60-78.;;Agrawal, S. et al., ""Antisense Therapeutics"" Current Opinion in Chemical Biology, (1998), vol. 2 pp. 519-528.;;Anderson, K. et al., ""Inhibition of Human Cytomegalovirus Immediate-Early Gene Expression by an Antisense Oligonucleotide Complementary to Immediate-Early RNA"", Antimicrobiol. Agents Chemotherapy (1996), vol. 40:9, pp. 2004-2011.;;Ausubel, et al., ""Hybridization Analysis of a DNA Blot with a Radiolabeled DNA Probe"" eds., Current Protocols in Molecular Biology (1989), vol. I, Green Publishing Associates, Inc., and John Wiley & sons, Inc., New York, at pp. 2.10.2-2.10.3.;;Basura, G. et al., ""Ontogeny of Serotonin and Serotonin 2A Receptors in Rat Auditory Cortex"", Hearing Research (2008), vol. 244, pp. 45-50.;;Baulcombe, D., ""RNA as a Target and an Initiator of Post-Transcriptional Gene Silencing in Trangenic Plants"", Plant Mol. Biol. (1996), vol. 32, pp. 79-88.;;Beaucage, S. et al., ""The Functionalization of Oligonucleotides Via Phosphoramidite Derivatives"" Tetrahedron (1993) vol. 49:10, pp. 1925-1963.;;Bennett, D. et al., ""Kinetic Characterization of the Interaction of Biotinylated Human Interleukin 5 with an Fc Chimera of its Receptor a Subunit and Development of an ELISA Screening Assay using Real-Time Interaction Biosensor Analysis"", J. Mol. Recog. (1995), vol. 8, pp. 52-58.;;Bentley, M., et al., ""Reductive Amination Using Poly(ethylene Glycol) Acetaldehyde Hydrate Generated in Situ: Applications to Chitosan and Lysozyme"", J. Pharm. Sci. (1998), vol. 87:11, pp. 1446-1449.;;Bolli, M. et al., ""alpha-Bicyclo-DNA: Synthesis, Characterization, and Pairing Properties of x-DNA-Analogues With Restricted Conformational Flexibility in the Sugar-Phosphate Backbone"", Chapter 7, pp. 100-116 , in ASC Symposium Series 580, Carbohydrate Modifications in Antisense Research (1994), Eds. Yogesh S. Sanghui and P. Dan Cook."
25,US,A1,US 2016/0108087 A1,120-931-204-860-704,2016-04-21,2016,US 201414897782 A,2014-05-21,US 201461953336 P 20140314;;US 201361834993 P 20130614,Therapeutics For The Induction Of Endogenous Steroidogenesis And Methods Associated With Their Identification,UNIV MCGILL,PAPADOPOULOS VASSILIOS;;AGHAZADEH YASAMAN;;FAN JINJIANG,https://lens.org/120-931-204-860-704,Patent Application,yes,0,6,6,30,C07K7/08;;A61K31/713;;A61K38/00;;C07K7/06;;C07K14/47;;C07K14/705;;C07K2319/10;;C12N15/113;;C12N2310/14;;C12N2320/30;;C12P33/00;;G01N33/5023;;G01N33/5044;;G01N33/743,C07K7/08;;C07K7/06;;C12N15/113;;G01N33/50,,,,
26,US,A1,US 2013/0028902 A1,180-024-218-730-182,2013-01-31,2013,US 201113574196 A,2011-01-19,US 29641510 P 20100119;;US 29633910 P 20100119,Osteocalcin As A Treatment For Male Reproductive Disorders,UNIV COLUMBIA;;KARSENTY GERARD;;DUCY PATRICIA F,KARSENTY GERARD;;DUCY PATRICIA F,https://lens.org/180-024-218-730-182,Patent Application,yes,1,6,6,31,A61K38/39,A61K38/22;;A61K31/366;;A61K31/713;;A61K39/395;;A61P15/08;;A61P15/10;;A61P15/16;;G01N33/566,424/139.1;;514/9.8;;514/456;;X514 44  A;;435/7.92,,,"Andrology, at http://www.springer.com/medicine/urology/book/978-3-540-78354-1, accessed 25 November 2013."
27,WO,A2,WO 2004/022066 A2,151-772-054-222-115,2004-03-18,2004,EP 0309238 W,2003-08-20,EP 02090315 A 20020904,Method And Means For The Treatment Of Vascular And Cardiac Diseases,FRAUNHOFER GES FORSCHUNG;;BORLAK JUERGEN;;THUM THOMAS,BORLAK JUERGEN;;THUM THOMAS,https://lens.org/151-772-054-222-115,Patent Application,yes,0,10,10,103,A61K31/56,A61K31/56;;A61P9/00,,10423660;;11034937,10.1097/00045391-199905000-00008,
28,US,A1,US 2016/0083445 A1,095-521-473-426-651,2016-03-24,2016,US 201514953759 A,2015-11-30,IL 20020209 A 20090802;;US 201414146237 A 20140102,Novel Polypeptides,TWO TO BIOTECH LTD,SANDLER TAMARA;;DEVARY ORLY,https://lens.org/095-521-473-426-651,Patent Application,yes,0,3,39,23,C07K7/08;;A61K38/00;;A61K38/10;;A61K38/17;;C07K14/521,C07K14/52,,,,
29,JP,A,JP 2003061671 A,199-204-183-224-113,2003-03-04,2003,JP 2001254378 A,2001-08-24,JP 2001254378 A 20010824,Strain In Which Gene Of Enzyme Participating In Testosterone Metabolism System Is Broken,RIKAGAKU KENKYUSHO,HORINOUCHI MASAE;;YAMAMOTO TAKAKO;;HAYASHI TOSHIAKI;;KUDO TOSHIAKI,https://lens.org/199-204-183-224-113,Patent Application,no,2,1,1,11,,C12N15/09;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/00;;C12P33/00,,,,
30,US,B2,US 8241845 B2,064-658-633-940-813,2012-08-14,2012,US 40459009 A,2009-03-16,US 67949705 P 20050510,Steroid 5α-reductase,MOHLER JAMES L;;TITUS MARK;;KOZYREVA OLGA;;FORD III O HARRIS;;KAWINSKI ELSBIETA;;LI YUN;;HEALTH RESEARCH INC,MOHLER JAMES L;;TITUS MARK;;KOZYREVA OLGA;;FORD III O HARRIS;;KAWINSKI ELSBIETA;;LI YUN,https://lens.org/064-658-633-940-813,Granted Patent,yes,0,6,6,10,C12Q1/26;;C07K2319/21;;C07K2319/40;;C12N9/001;;C12N2799/022;;G01N33/57434,C12Q1/68;;C12N9/02;;C12N15/53;;C12Q1/26,435/6;;435/25;;435/189,15436478,,"Sweat, et al.; Preparation and Characterization of the Enzyme Which Converts Testosterone to Androstenedione; The Journal of Biological Chemistry; 185(1), 1950; pp. 75-84."
31,CA,A1,CA 2467769 A1,127-385-943-371-663,2005-12-11,2005,CA 2467769 A,2004-06-11,CA 2467769 A 20040611,Methods And Formulations For Testosterone Suppression,YM BIOSCIENCES INC,KEANE PAUL MICHAEL;;BINNIE CRAIG;;THOMPSON SEAN E L;;STIERNHOLM NICLAS B J,https://lens.org/127-385-943-371-663,Patent Application,no,0,1,16,11,A61K38/09;;A61K9/0019;;A61K31/675;;A61K33/06;;A61K39/0006;;A61K39/0011;;A61K39/015;;A61K39/39;;A61K45/06;;A61K2039/55505;;A61K2039/55566;;A61K2039/6037;;A61K2300/00,A61K31/675;;A61K33/06;;A61K38/09;;A61K38/16;;A61K38/22;;A61K39/00;;A61K39/015;;A61K39/39;;A61K45/06;;A61K47/02;;A61P5/28,,,,
32,WO,A9,WO 2008/009960 A9,128-391-507-152-525,2008-05-29,2008,GB 2007002764 W,2007-07-20,GB 0614568 A 20060721,Anti-testosterone Antibodies,HAPTOGEN LTD;;UNIV ABERDEEN;;BROADBENT IAN;;CHARLTON KEITH;;PORTER ANDREW;;STRACHAN GILLIAN;;KENYON ANDREW;;MCEWAN LAIN,BROADBENT IAN;;CHARLTON KEITH;;PORTER ANDREW;;STRACHAN GILLIAN;;KENYON ANDREW;;MCEWAN LAIN,https://lens.org/128-391-507-152-525,Patent Application,no,0,4,4,20,C07K16/26;;C07K2317/21;;C07K2317/76,C07K16/26;;A61K39/395;;C12N15/13,,,,
33,US,A1,US 2005/0202407 A1,128-831-065-920-000,2005-09-15,2005,US 99851904 A,2004-11-29,US 99851904 A 20041129;;US 52598603 P 20031201,Methods And Assays For Screening Anti-neoplastic Therapeutic Agents,BAYLOR COLLEGE MEDICINE,THOMPSON TIMOTHY C,https://lens.org/128-831-065-920-000,Patent Application,yes,0,1,1,6,G01N33/5011;;G01N33/5088;;G01N33/743,C12Q1/00,435/4.000,,,
34,US,A1,US 2010/0136572 A1,160-529-893-174-499,2010-06-03,2010,US 45204708 A,2008-07-10,FR 0705211 A 20070719,Method Of Assaying Apolipoprotein Ai For The In Vitro Diagnosis Of Colorectal Cancer,BIOMERIEUX SA,ATAMAN-ONAL YASEMIN;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;POIRIER FLORENCE,https://lens.org/160-529-893-174-499,Patent Application,yes,3,14,14,41,G01N33/57419;;G01N2333/775,G01N33/53,435/7.1;;436/501,14563446;;15313933;;16237736;;3141545;;3917876;;23150310,10.1002/PMIC.200500093;;10.1158/0008-5472.CAN-04-0746,"Laine, Methods in Molecular Biology, 1992, 10:201-205.;;Kozak et al., Proteomics, 2005, 5, 4589-4596.;;Bury et al., Clin. Chem. 1985, 31(2):247-251.;;Zhang et al., Cancer Research 2004, 64:5882-5890.;;Hogle et al., J. Lipid Res., 1988, 29:1221-1229.;;Pelsers et al., Clin. Biochem. 2003, 36:529-535."
35,US,B1,US 7001882 B1,114-281-091-110-894,2006-02-21,2006,US 98086202 A,2002-02-27,DE 19926068 A 19990608,Muteins Of Bilin-binding Protein,PIERIS PROTEOLAB AG,SCHLEHUBER STEFFEN,https://lens.org/114-281-091-110-894,Granted Patent,yes,4,6,6,29,C07K14/43563,C07K14/00;;C07K14/435;;C12N15/00;;C12N15/12,514/8;;514/2;;530/350;;530/395;;530/378.3;;435/69.7;;435/440,10051566;;10764576;;8761444,10.1006/JMBI.2000.3646;;10.1073/PNAS.96.5.1898;;10.1111/J.1432-1033.1994.TB18567.X,"Beste et al., ""Small Antibody-Like Proteins with Prescribed Ligand Specificities Derived From the Lipocalin Fold,"" Biochemistry, Proceeding of the National Academy of Science of the United States, vol. 96, No. 5, pp. 1898-1903, Mar. 2, 1999.;;Flower, ""The Lipocalin Protein Family: Structure and Function,"" Biochemical Journal, vol. 318, pp. 1-14, 1996.;;Schmidt et al, ""The Bilin-Binding Protein of Pieris brassicae cDNA Sequence and Regulation of Expression Reveal Distinct Features of this Insect Pigment Protein,"" European Journal of Biochemistry, vol. 219, No. 3, FEBS, pp. 855-863, 1994.;;Schlehuber et al., ""A Novel Type of Receptor Protein, Based on the Lipocalin Scaffold, with Specificity for Digoxigenin,"" Journal of Molecular Biology, vol. 297, No. 5, Academic Press, pp. 1105-1120, Apr. 14, 2000."
36,JP,A,JP 2003061670 A,121-979-883-902-302,2003-03-04,2003,JP 2001254377 A,2001-08-24,JP 2001254377 A 20010824,Enzyme Gene Participating In Testosterone Metabolism System,RIKAGAKU KENKYUSHO,HORINOUCHI MASAE;;YAMAMOTO TAKAKO;;HAYASHI TOSHIAKI;;KUDO TOSHIAKI,https://lens.org/121-979-883-902-302,Patent Application,no,0,1,1,11,,C12N15/09;;C12N1/15;;C12N1/19;;C12N1/21;;C12N5/10;;C12N9/04,,,,
37,US,B2,US 6780984 B2,133-326-982-553-029,2004-08-24,2004,US 90639301 A,2001-07-16,US 90639301 A 20010716;;US 21876100 P 20000717,Method For Prognosing Cancer And The Proteins Involved,UNIV NORTHWESTERN,WANG ZHOU;;XIAO WUHAN,https://lens.org/133-326-982-553-029,Granted Patent,yes,23,5,5,36,G01N33/57434;;A01K2217/05;;A01K2217/075;;A61K38/00;;C07K14/4702;;C12Q1/6886;;C12Q2600/118;;C12Q2600/136,A61K38/00;;C07K14/47;;C12N15/12;;C12Q1/68;;G01N33/574,536/23.1;;536/23.1;;435/320.1;;435/252.1;;435/69.1,11418481;;1699952;;1903357;;2315699;;2778827;;6928659;;7981747;;8589278;;9371789;;9751517,10.1182/BLOOD.V98.1.201;;10.1093/JNCI/81.18.1406;;10.1073/PNAS.77.2.1039;;10.1083/JCB.111.5.2129;;10.1016/0888-7543(91)90410-G;;10.1126/SCIENCE.2315699;;10.1038/NBT0394-320;;10.1210/EN.139.10.4337;;10.1073/PNAS.94.24.12999;;10.1038/NG0493-283;;10.1002/cyto.990090420,"Wang et al (PNAS, 94:12999-13004).*;;Sambrook et al (Molecular Cloning, a Laboratory manuary, 1989, Cold Springer Harbor PRess, p. 16.3-4).*;;Lazer et al (Mol. Cell. Bio., 1988, 8:1247-1252).*;;Harris et al (J. Am. Soc. Nephrology, 1995, 6:1125-1133).*;;Ahn et al (Nature Genetics, 3(4):283-291).*;;Cawthon et al (Genomics, 9(3):446-460).*;;Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4).*;;Dermer (Bio/Technology, 1994, 12:320).*;;Bowie et al (Science, 1990, 247:1306-131).*;;Burgess et al (J Cell Bio., 1990, 111:2129-2138).*;;Cifone et al., Proc. Nat. Acad. Sci. USA. 77:1039-43 (1980).;;Li et al., J. Nat. Can. Inst., 81:1406-12 (1989).;;Simone et al., Blood, 98:201-209 (2001).;;Wang et al., Proc. Natl. Acad. Sci., 94:12999-13004 (1997).;;Zhu et al., Endocrinology, 139:4337-4344 (1998).;;Accession No.: AK016628, released Feb. 8, 2001.;;Accession No.: AF272973, released May 21, 2001."
38,WO,A1,WO 2010/053199 A1,032-631-195-516-826,2010-05-14,2010,JP 2009069134 W,2009-11-10,US 11283608 P 20081110,"Pharmaceutical Composition For Treating Prostate Cancer, And Method For Treating Prostate Cancer",UNIV NIHON;;HIDAI CHIAKI,HIDAI CHIAKI,https://lens.org/032-631-195-516-826,Patent Application,yes,1,1,1,13,A61K48/005;;A61K38/443;;C07K14/475;;C07K2319/00;;C12N9/0006,A61K48/00;;A61K38/00;;A61K38/04;;A61K38/43;;A61P13/08;;A61P35/00;;C12N9/04;;C12N15/09;;C12R1/91,,12604227;;17701220;;19018576,10.1007/S00441-007-0456-9;;10.1007/S00449-008-0278-5;;10.1016/S0009-2797(02)00179-5,"RIZNER, T.L. ET AL.: 'Role of human type 3 3alpha-hydroxysteroid dehydrogenase (AKR1C2) in androgen metabolism of prostate cancer cells' CHEM BIOL INTERACT vol. 143-144, 2003, pages 401 - 9;;HIDAI, C. ET AL.: 'Discoidin domain of Dell protein contributes to its deposition in the extracellular matrix' CELL TISSUE RES vol. 330, no. 1, 2007, pages 83 - 95;;HIDAI, C. ET AL.: 'The Dell deposition domain can immobilize 3alpha-hydroxysteroid dehydrogenase in the extracellular matrix without interfering with enzymatic activity' BIOPROCESS BIOSYST ENG vol. 32, no. 5, 2009, pages 569 - 73"
39,US,A1,US 2004/0220098 A1,144-970-100-387-724,2004-11-04,2004,US 75520304 A,2004-01-09,US 75520304 A 20040109;;US 48163395 A 19950607;;US 39555495 A 19950228;;US 43920403 P 20030110,Inhibin Compositions And Methods Of Enhancing Fertility And Growth,SATTERLEE DANIEL G.;;FIORETTI WILLIAM C.;;CADD GARY G.,SATTERLEE DANIEL G;;FIORETTI WILLIAM C;;CADD GARY G,https://lens.org/144-970-100-387-724,Patent Application,yes,3,1,45,4,C07K14/575;;A01K2207/10;;A01K2227/30;;A01K2267/02;;A61K38/00;;A61K39/0005;;A61K2039/6068;;C07K2319/24,A61K38/00;;A61K39/00;;C07K14/575;;C12N15/85,514/12;;X1193,,,
40,WO,A2,WO 2014/161884 A2,128-496-586-027-351,2014-10-09,2014,EP 2014056594 W,2014-04-02,EP 13162198 A 20130403,Artificial Transcription Factors Regulating Nuclear Receptors And Their Therapeutic Use,ALIOPHTHA AG,NEUTZNER ALBERT;;FLAMMER JOSEF;;HUXLEY ALICE,https://lens.org/128-496-586-027-351,Patent Application,yes,0,7,7,103,C07K14/4702;;C07K2319/81;;C12N15/62,C07K14/47,,11821858;;14770178;;16199884;;17526515;;20130105;;2668735;;9159105;;9843940;;20192761;;19394375;;11292573;;8486625;;20148354;;22622808;;21905187;;20599772,10.1038/NRD1087;;10.1073/PNAS.94.11.5525;;10.1016/S0958-1669(01)00272-5;;10.1038/NBT0202-135;;10.1073/PNAS.95.25.14628;;10.1146/annurev-biochem-010909-095056;;10.1038/nprot.2010.34;;10.1016/s0928-0987(00)00212-8;;10.1007/s11010-010-0388-7;;10.1007/s10549-012-2090-9;;10.1002/anie.201103307;;10.1128/mcb.9.6.2487,"SERA T. ADV DRUG DELIV REV vol. 61, 2009, pages 513 - 526;;KLUG A. ANNU REV BIOCHEM vol. 79, 2010, pages 213 - 231;;GONZALEZ B. NAT PROTOC vol. 5, 2010, pages 791 - 810;;BEERLI R.R. ET AL. PROC NATL ACAD SCI USA vol. 95, 1998, pages 14628 - 14633;;LUND C.V. ET AL. MOL CELL BIOL vol. 25, 2005, pages 9082 - 9091;;WADIA J.S. ET AL. NAT MED vol. 10, 2004, pages 310 - 315;;MCEWAN I.J. METHODS IN MOLECULAR BIOLOGY: THE NUCLEAR RECEPTOR SUPERFAMILY vol. 505, pages 3 - 17;;SANDER J.D. NUCLEIC ACIDS RESEARCH vol. 35, pages 599 - 605;;CHELSKY D. ET AL. MOL CELL BIOL vol. 9, 1989, pages 2487 - 2492;;BENATUIL L. ET AL. PROTEIN ENG DES SEL vol. 23, 2010, pages 155 - 159"
41,US,A1,US 2016/0046681 A1,083-778-795-818-373,2016-02-18,2016,US 201414781688 A,2014-04-02,EP 13162198 A 20130403,Artificial Transcription Factors Regulating Nuclear Receptors And Their Therapeutic Use,ALIOPHTHA AG,NEUTZNER ALBERT;;FLAMMER JOSEF;;HUXLEY ALICE,https://lens.org/083-778-795-818-373,Patent Application,yes,0,7,7,103,C07K14/4702;;C07K2319/81;;C12N15/62,C07K14/47,,,,"IPRP (including the Written Opinion) of parent PCT/EP2014/056594, publshed 10/6/2015"
42,US,A1,US 2010/0130375 A1,025-033-707-044-460,2010-05-27,2010,US 45203708 A,2008-07-10,FR 0705210 A 20070719,Apolipoprotein Aii Assay Method For The In Vitro Diagnosis Of Colorectal Cancer,BIOMERIEUX SA,ATAMAN-ONAL YASEMIN;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;POIRIER FLORENCE,https://lens.org/025-033-707-044-460,Patent Application,yes,2,15,15,41,G01N33/57419;;G01N2333/775,C40B30/04;;G01N33/00;;G01N33/53;;G01N33/573;;G01N33/574,506/9;;435/7.23;;435/7.92;;435/7.4;;436/86,1563002;;16581821;;2872262,,"Tockman et al (Cancer Res., 1992, 52:2711s-2718s);;Freeman et al (Alcohol Alcohol, 2006, 41(3): 300-3005);;Hachem et al (J Clin Chem Clin Biochem, 1986, 24(3): Abstract)"
43,US,A1,US 2010/0129844 A1,002-125-984-443-658,2010-05-27,2010,US 45204808 A,2008-07-10,FR 0705201 A 20070719,Aminoacylase 1 Assay Method For The In Vitro Diagnosis Of Colorectal Cancer,BIOMERIEUX SA,CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;ROLLAND DOMINIQUE,https://lens.org/002-125-984-443-658,Patent Application,yes,2,16,16,41,G01N33/57419;;G01N2333/98,C12Q1/37;;C12N9/48,435/24;;435/212,16465618,10.1086/500563,"Sass J. et al. Mutations in ACY1, the Gene Encoding Aminoacylase1... The Anerican J of Human Genetics 78:401-409, March 2006."
44,US,A1,US 2010/0136571 A1,128-868-555-911-579,2010-06-03,2010,US 45204208 A,2008-07-10,FR 0705198 A 20070719,I-plastin Assay Method For The In Vitro Diagnosis Of Colorectal Cancer,BIOMERIEUX SA;;CENTRE NAT RECH SCIENT;;INST CURIE,ARPIN MONIQUE;;BATTAIL-POIROT NICOLE;;BEAULIEU CORINNE;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE,https://lens.org/128-868-555-911-579,Patent Application,yes,4,16,16,41,G01N33/57419;;G01N33/57488,G01N33/53;;C07K16/18,435/7.1;;530/388.8,,,
45,US,A1,US 2010/0129828 A1,030-611-319-387-800,2010-05-27,2010,US 45203508 A,2008-07-10,FR 0705202 A 20070719,Method Of Assaying Leukocyte Elastase Inhibitor For The In Vitro Diagnosis Of Colorectal Cancer,BIOMERIEUX SA,BEAULIEU CORINNE;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;MEJAN-LETOURNEUR ODILE;;ROLLAND DOMINIQUE,https://lens.org/030-611-319-387-800,Patent Application,yes,3,15,15,41,G01N33/57419;;G01N2333/811,G01N33/53,435/7.1,14997500;;15490093;;12661896,,"Friedman et al., Proteomics 2004, 4, 793-811.;;Guo et al., J Mol. Med., 2004, 82:768-774.;;Kim et al., Annals Clin. Lab. Sci. 2003, 33(1): 32-38."
46,US,A1,US 2012/0121602 A1,157-048-216-949-175,2012-05-17,2012,US 201013387392 A,2010-08-02,IL 20020209 A 20090802,Novel Proteins,SANDLER TAMARA;;DEVARY ORLY;;TWO TO BIOTECH LTD,SANDLER TAMARA;;DEVARY ORLY,https://lens.org/157-048-216-949-175,Patent Application,yes,0,29,39,20,C07K14/521;;A61K38/00;;C07K14/47;;C07K2319/02;;C07K2319/21;;C07K2319/23,A61K38/17;;A61K39/395;;A61P3/00;;A61P3/04;;A61P3/10;;A61P5/00;;A61P5/26;;A61P21/00;;A61P29/00;;A61P31/00;;A61P35/00;;A61P37/00;;C07K14/435;;C07K16/18;;G01N33/566,424/139.1;;530/324;;514/19.3;;514/6.9;;514/4.8;;514/9.7;;530/387.9;;514/21.3;;514/10.2;;435/331;;435/7.92,10631780;;10779480;;19765975;;2271534;;9635409;;20955963,10.1101/GR.10.4.398;;10.1016/S0168-9525(98)01486-3;;10.1016/S0167-7799(99)01398-0;;10.1021/BI00489A001;;10.1016/j.sbi.2009.08.003;;10.1016/j.bpg.2010.07.012,"Wells, 1990, Biochemistry 29:8509-8517.;;Bork, Genome Research , 2000, Vol. 10, pages 398-400.;;Skolnick et al., 2000, Trends in Biotech. 18(1):34-39.;;Doerks et al., 1998, Trends in Genetics 14:248-250.;;Tokuriki and Tawflik, (Current Opinion in Structural Biology 2009, 19: 596-604.;;Mayatepek et al, Best Practice & Research Clinical Gastroenterology, 2010, Vol. 24, pages 607-618.;;Emily Loghmani, Stang J, Story M (eds) Guidelines for Adolescent Nutrition Services, 2005, pages 167-182."
47,US,B2,US 8278032 B2,029-545-452-449-398,2012-10-02,2012,US 81757610 A,2010-06-17,JP 2005300851 A 20051014;;JP 2006156458 A 20060605,Transporter Protein In Mammal And Utilization Of The Same,MORIYAMA YOSHINORI;;OMOTE HIROSHI;;OTSUKA MASATO;;MATSUMOTO TAKUYA;;HIASA MIKI;;GENOMEMBRANE INC,MORIYAMA YOSHINORI;;OMOTE HIROSHI;;OTSUKA MASATO;;MATSUMOTO TAKUYA;;HIASA MIKI,https://lens.org/029-545-452-449-398,Granted Patent,yes,0,6,12,22,C07K14/705;;G01N33/5432,C12Q1/00;;C07K14/435,435/4;;530/350,12477932;;12603313;;16330770;;9661020,10.1046/J.1432-1033.2003.03418.X;;10.1073/PNAS.0506483102,"Strausberg et al., Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA 99:16899-16903, 2002.;;Database SwissProt[online], Accession No. Q8KOH1, > Jun. 1, 20O3. Definition: 130013J15Rik protein.;;Database SwissProt[online], Accession No. Q86VL8 > Oct. 1, 2003, Definition: Hypothetical protein FLJ31196.;;Database SwissProt[online], Accession No. Q8IV44 http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?74728032:CAGE-DDBJ:5750 17>> Jun. 1, 2003, Definition: FLJ31196 protein.;;Database SwissProt[online], Accession No. Q96FL8 > Jun. 1, 2003, Definition: Hypothetical protein FLJ10847.;;Database SwissProt[online], Accession No. Q9NVA3 http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?74734474:CAGE-DDBJ:5815 02>> Jun. 1, 2003, Definition: Hypothetical protein FLJ10847.;;Hvorup RN et al., ""The Multidrug/oligosaccharidyl-lipid/polysaccharide (MOP) Exporter Superfamily"", Eur. J. Biochem., vol. 270, No. 5, pp. 799-813, 2003.;;International Preliminary Report on Patentability for PCT/JP2006/320409 dated Jun. 19, 2008.;;Otsuka et al., ""A Human Transporter Protein That Mediates the Final Excretion Step for Toxic Organic Cations,"" Proc. Natl. Acad. Sci. USA, vol. 102, No. 50, pp. 17923-17928, Dec. 2005.;;Morita et al., ""NorM, a Putative Multidrug Efflux Protein, of Vibrio Parahaemolyticus and Its Homolog in Escherichia coli,"" Antimircrob Agents Chemother., vol. 42, No. 7, pp. 1778-1782, 1998."
48,WO,A2,WO 2009/073544 A2,139-988-549-355-639,2009-06-11,2009,US 2008/0084943 W,2008-11-26,US 99118807 P 20071129,Methods For Treating A Disorder By Regulating Gprc6a,UNIV KANSAS;;QUARLES L DARRYL;;PI MIN,QUARLES L DARRYL;;PI MIN,https://lens.org/139-988-549-355-639,Patent Application,yes,3,3,3,36,C12Q1/6886;;A01K67/0276;;A01K2217/075;;A01K2227/105;;A01K2267/03;;A61K31/56;;A61K31/7105;;C07K14/705;;C12N15/8509;;C12Q2600/106;;C12Q2600/136;;C12Q2600/158,A61K38/22;;A61P5/24;;A61P35/00,,15194188;;15816861;;16455645;;16491104;;19050760;;9457168,10.1111/J.1471-4159.2005.03025.X;;10.1038/SJ.BJP.0706682;;10.1371/JOURNAL.PONE.0003858;;10.1016/J.GENE.2004.03.003;;10.1074/JBC.M512865200,"KUANG D ET AL.: 'Cloning and characterization of a family C orphan G-protein coupled receptor.' J. NEUROCHEM. vol. 93, no. 2, April 2005, pages 383 - 391;;ROHRER D.K. ET AL.: 'G protein-coupled receptors: functional and mechanistic insights through altered gene expression.' PHYSIOL REV. vol. 78, no. 1, January 1998, pages 35 - 52;;CHRISTIANSEN B ET AL.: 'Known regulators of nitric oxide synthase and arginase are agonists at the human G-protein-coupled receptor GPRC6A.' BR J PHARMACOL. vol. 147, no. 8, April 2006, pages 855 - 863;;WELLENDORPH P ET AL.: 'Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor.' GENE vol. 335, 23 June 2004, pages 37 - 46;;WANG M ET AL.: 'Activation of family C G-protein-coupled receptors by the tripeptide glutathione.' J. BIOL. CHEM. vol. 281, no. 13, 31 March 2006, pages 8864 - 8870;;PI M ET AL.: 'GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome.' PLOS ONE. vol. 3, no. 12, 2008, page E3858"
49,US,B2,US 7135550 B2,159-842-584-386-389,2006-11-14,2006,US 23498502 A,2002-09-03,US 23498502 A 20020903;;US 27293201 P 20010302;;US 27823301 P 20010323;;US 32943701 P 20011015,Three Hybrid Assay System,GPC BIOTECH AG,COME JON H;;BECKER FRANK;;KLEY NIKOLAI A;;REICHEL CHRISTOPH,https://lens.org/159-842-584-386-389,Granted Patent,yes,72,2,67,41,C40B30/04;;C07D231/54;;C07D487/04;;C07F9/65583;;C07F9/6561;;G01N33/6845;;G01N2500/10,C07D231/54;;C07D487/04;;C07F9/6558;;C07F9/6561;;C40B30/04;;G01N33/68,530/350;;435/6;;536/23.4;;514/712,10976071;;11075340;;11095729;;12007565;;12482929;;1317266;;1429680;;1651502;;17920;;2050695;;2123553;;2209542;;2547163;;3018930;;3038523;;7694365;;7739893;;7744855;;7937952;;8031710;;8242750;;8650188;;8917502;;9380684;;9560251;;9608841;;9653112;;9784872,10.1016/S0006-2952(02)00884-5;;10.1016/S0076-6879(00)28392-4;;10.1126/SCIENCE.7694365;;10.1073/PNAS.93.23.12817;;10.1073/PNAS.262420099;;10.1021/JO00013A053;;10.1016/S0968-0896(98)00125-4;;10.1073/PNAS.95.14.7898;;10.1073/PNAS.93.12.5888;;10.1074/JBC.270.20.12065;;10.1021/AC9713666;;10.1073/PNAS.88.16.7351;;10.1073/PNAS.94.20.10618;;10.1073/PNAS.250400997;;10.1021/JA9941532;;10.1126/SCIENCE.17920;;10.1016/0960-0760(94)90004-3;;10.1073/PNAS.95.9.5187;;10.1038/340245A0;;10.1073/PNAS.87.23.9231;;10.1126/SCIENCE.3018930;;10.1073/PNAS.91.22.10340;;10.1016/0092-8674(92)90285-K;;10.1093/NAR/23.7.1152;;10.1016/0092-8674(93)90498-F,"The Merck Index, Seventh Edition, 1960, Stecher et al. eds., pp. 180, 430 and 677.;;Bachmair, A. et al. In Vivo Half-Life of a Protein is a Function of its Amino-Terminal Residue. Science 234, 179-186 (1986).;;Baker, R.T. et al. Ubiquitin-specific Proteases of Saccharomyces cerevisiae. J. Biol. Chem. 267, 23364-23375 (1992).;;Baker, R.T. & Varshavsky, A. Yeast N-terminal Amidase. J. Biol. Chem. 270, 12065-12074 (1995).;;Bartel, B. et al. The recognition component of the N-end rule pathway. EMBO J. 9, 3179-3189 (1990).;;Bartel, P.L. & Fields, S., eds. The yeast-two-hybrid system. Oxford University Press, New York, NY (1997).;;Bergmann, K.E. et al. Bivalent Ligands as Probes of Estrogen Receptor Action. J. Steroid Biochem. Molec. Biol. 49, 139-152 (1994).;;Dohmen, R.J. et al. The N-end rule is mediated by the UBC2(RAD6) ubiquitin-conjugating enzyme, PNAS 88, 7351-7355 (Aug. 1991).;;Fields, S. & Song, O. A novel genetic system to detect protein-protein interactions. Nature 340, 245-246 (1989).;;Gyrius, J. et al. cdl1, a Human G1 and S Phase Protein Phosphatase that Associates with Cdk2. Cell 75, 791-803 (1993).;;Johnsson, N. & Varshavsky, A. Split ubiquitin as a sensor of protein interactions in vivo. PNAS 91, 10340-10344 (Oct. 1994).;;Kwon, Y.T, et al. The mouse and human genes encoding the recognition component of the N-end rule pathway. PNAS 95, 7898-7903 (Jul. 1998).;;Laser, H. et al. A new screen for protein interactions reveals that the Saccharomyces cerevisiae high mobility group proteins Nhp6A/B are involved in the regulation of the GAL 1 promoter. PNAS 97, 13732-13737 (Dec. 5, 2000).;;Licitra, et al. A three-hybrid system for detecting small ligand-protein receptor interactions. PNAS 93, 12817-12821 (Nov. 1996).;;Lin et al. J. Am. Chem. Soc. 122, 4247-4248 (2000).;;Ozkaynak, E. et al. The yeast ubiquitin genes: a family of natural gene fusions. EMBO J. 6, 1429 (1987).;;Reichel, C. et al. Enhanced green fluorescence by the expression of an Aequorea victoria green fluorescent protein mutant in mono- and dicotyledonous plant cells. PNAS 93. 5888-5893 (Jun. 1996).;;Stagljar, I. et al. A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins In vivo. PNAS 95, 5187-5192 (Apr. 1998).;;Tobias, J.W. & Varshavsky, A. Cloning and Functional Analysis of the Ubiquitin-specific Protease Gene UBP1 of Saccharomyces cerevisiae. J. Biol. Chem. 266, 12021-12028 (1991).;;Varshavsky, A. The N-End Rule. Cell 725-735 (1992).;;Yang, M. et al. Protein-peptide interactions analyzed with the yeast two-hybrid system. Nucleic Acid Res. 23, 1152-1156 (1995).;;Zhu, L. & Hannon, G.J., eds. Yeast hybrid technologies. Biotechniques Press, Westborough, Ma (2000).;;Amara, J.F., et al., ""A versatile synthetic dimerizer for the regulation of protein-protein interactions."" PNAS 94: 10618-10623 (1997).;;Baker, K., et al., ""Chemical complementation: A reaction-independent genetic assay for enzyme catalysis."" PNAS 99(26): 16537-16543 (2002).;;Bertozzi, C.R., et al., ""The Synthesis of Heterobifunctional Linkers for the Conjugation of Ligands to Molecular Probes."" J. Org. Chem. 56: 4326-4329 (1991).;;Griffith, E.C., et al., ""Yeast Three-Hybrid System for Detecting Ligand-Receptor Interactions."" Methods in Enzymology 328: 89-103 (2000).;;Henthorn, D.C., et al., ""A GAL4-based yeast three-hybrid system for the identification of small molecule-target protein interactions."" Biochemical Pharmacology 63: 1619-1628 (2002).;;MacBeath, G., et al., ""Printing Proteins as Microassays for High-Throughput Function Determination."" Science 289: 1760-1763 (2000).;;Spencer, D.M., et al., ""Controlling Signal Transduction with Synthetic Ligands."" Science 262: 1019-1024 (1993).;;Bierer et al., ""Two district signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin"". Proc. Natl. Acad. Sci., vol. 87 pp. 9231-9235 (1990).;;Keenan et al., ""Synthesis and Activity of Bivalent FKBP12 Ligands for the Regulated Dimerization of Proteins"", Bioorganic & Medicinal Chemistry vol. 6 pp. 1309-1335 (1998).;;Lin et al., ""Dexamethasone-Methotrexate: An Efficient Chemical Inducer of Protein Dimerization In Vivo"", J. Am. Chem. Soc. vol. 122, pp. 4247-4248 (2000).;;Matthews et al., ""Dihydrofolate Reductase: X-ray Structure of the Binary complex with Methotrexate"", Science, vol. 197 pp. 452-455 (1977).;;Sota et al., ""Detection of Conformational Changes in an Immobilized Protein Using Surface Plasmon Resonance"", Analytical Chemistry, vol. 70, pp. 2019-2024 (1998).;;ExPASy entry for Enzyme: EC 1.5.1.3., Dihydrofolate reductase, pp. 1-2, printed on Dec. 21, 2005."
50,US,B2,US 7892728 B2,131-296-743-261-371,2011-02-22,2011,US 8964606 A,2006-10-12,JP 2005300851 A 20051014;;JP 2006156458 A 20060605,Transporter Protein In Mammal And Utilization Of The Same,GENOMEMBRANE INC,MORIYAMA YOSHINORI;;OMOTE HIROSHI;;OTSUKA MASATO;;MATSUMOTO TAKUYA;;HIASA MIKI,https://lens.org/131-296-743-261-371,Granted Patent,yes,3,6,12,22,C07K14/705;;G01N33/5432,C12Q1/00;;C07K14/435,435/4;;530/350,12603313;;16330770;;9661020,10.1046/J.1432-1033.2003.03418.X;;10.1073/PNAS.0506483102,"Otsuka et al., ""A Human Transporter Protein That Mediates the Final Excretion Step for Toxic Organic Cations,"" Proc. Natl. Acad. Sci. USA, vol. 102, No. 50, pp. 17923-17928, Dec. 2005.;;Morita et al., ""NorM, a Putative Multidrug Efflux Protein, of Vibrio Parahaemolyticus and Its Homolog in Escherichia coli,"" Antimicrob Agents Chemother, vol. 42, No. 7, pp. 1778-1782, 1998.;;Database SwissProt[online], Accession No. Q8KOH1, > Jun. 1, 2003, Definition: 130013J15Rik protein.;;Database SwissProt[online], Accession No. Q86VL8 > Oct. 1, 2003, Definition: Hypothetical protein FLJ31196.;;Database SwissProt[online], Accession No. Q8IV44 > Jun. 1, 2003, Definition: FLJ31196 protein.;;Database SwissProt[online], Accession No. Q96FL8 > Jun. 1, 2003, Definition: Hypothetical protein FLJ10847.;;Database SwissProt[online], Accession No. Q9NVA3 > Jun. 1, 2003, Definition: Hypothetical protein FLJ10847.;;Hvorup RN et al., ""The Multidrug/oligosaccharidyl-lipid/polysaccharide (MOP) Exporter Superfamily"", Eur. J. Biochem., vol. 270, No. 5, pp. 799-813, 2003.;;International Preliminary Report on Patentability for PCT/JP2006/320409 dated Jun. 19, 2008."
51,US,B2,US 8735078 B2,095-239-126-897-476,2014-05-27,2014,US 45203708 A,2008-07-10,FR 0705210 A 20070719,Apolipoprotein Aii Assay Method For The In Vitro Diagnosis Of Colorectal Cancer,ATAMAN-ONAL YASEMIN;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;POIRIER FLORENCE;;BIOMERIEUX SA,ATAMAN-ONAL YASEMIN;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;POIRIER FLORENCE,https://lens.org/095-239-126-897-476,Granted Patent,yes,0,15,15,41,G01N33/57419;;G01N2333/775,G01N33/53,435/7.1,,,"Freeman et al (Alcohol Alcohol, 2006, 41(3): 300-3005).;;Hachem et al (J Clin Chem Clin Biochem, 1986, 24(3): Abstract).;;Tockman et al (Cancer Res., 1992, 52:2711s-2718s).;;Oct. 31, 2011 Office Action issued in U.S. Appl. No. 12/452,035.;;May 13, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,038.;;Sep. 1, 2011 Office Action issued in U.S. Appl. No. 12/452,038.;;Sep. 15, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,042.;;Oct. 28, 2011 Office Action issued in U.S. Appl. No. 12/452,042.;;Aug. 1, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,034.;;Oct. 27, 2011 Office Action issued in U.S. Appl. No. 12/452,034.;;Oct. 28, 2011 Restriction Requirement issued in U.S. Appl. No. 12/452,047.;;SCORE sequence search result #1, Geneseq Database, ""20110423-191537-us-12-452-038-2.rag"" Apr. 23, 2011.;;Bruce et al., ""Cancer-Wide Tissue Microarray Survey of Ezrin and Merlin Expression,""Proc Amer Assoc Cancer Res, vol. 46, Abstract #424, 2005.;;Gould et al., ""cDNA Cloning and Sequencing of the Protein-Tyrosine Kinase Substrate, Ezrin, Reveals Homology to Band 4.1,"" The EMBO Journal, vol. 8, No. 13, pp. 4133-4142, 1989.;;Etzioni et al., ""The Case for Early Detection,"" Nature Review, vol. 3, Internet pp. 1-10, Apr. 2003.;;Mercer, ""Use of Multiple Markers to Enhance Clinical Utility,"" Immunol Ser., vol. 53, pp. 39-54, 1990.;;Delanote et al., ""Plastins: Versatile Modulators of Actin Organization in (patho)physiological Cellular Processes,"" Acta Pharmacologica Sinica, vol. 26, No. 7, pp. 769-779, Jul. 2005.;;Hasselblatt et al., ""Identification of Novel Diagnostic Markers for Choroid Plexus Tumors,"" Am. J. Surg Pathol, vol. 30, No. 1, pp. 66-74, Jan. 2006.;;Lin et al., ""Identification of I-Plastin, a Human Fimbrin Isoform Expressed in Intestine and Kidney,"" Molecular and Cellular Biology, vol. 14, No. 4, pp. 2457-2467, Apr. 1994.;;Carroll et al., ""Liver Fatty Acid-Binding Protein: A Marker for Studying Cellular Differentiation in Gut Epithelial Neoplasms,"" Gastroenterology, vol. 99, pp. 1727-1735, 1999.;;Kayser et al., ""Primary Colorectal Carcinomas and their Intrapulmonary Metastases: Clinical, Glyco-, Immuno- and Lectin Histochemical, Nuclear and Syntactic Structure Analysis with Emphasis on Correlation with Period of Occurrence of Metastases and Survival,"" APMIS, vol. 110, pp. 435-446, 2002.;;Kuusela et al., ""Comparison of CA 19-9 and Carcinoembryonic Antigen (CEA) Levels in the Serum of Patients with Colorectal Diseases,"" Br. J. Cancer, vol. 49, pp. 135-139, 1984.;;Pelsers et al., ""Fatty Acid-Binding Proteins as Plasma Markers of Tissue Injury,"" Clinica Chimica Acta, vol. 352, pp. 15-35, 2005.;;Iurisci et al., ""Concentrations of Galectin-3 in the Sera of Normal Controls and Cancer Patients,"" Clinical Cancer Research, vol. 6, pp. 1389-1393, Apr. 2000.;;Niederkofler et al., ""Novel Mass Spectrometric Immunoassays for the Rapid Structural Characterization of Plasma Apolipoproteins,"" Journal of Lipid Research, vol. 44, pp. 630-639, 2003.;;Hortin, ""The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Pepetidome,"" Clinical Chemistry, vol. 52, No. 7, pp. 1223-1237, 2006.;;Hachem, ""Serum Apolipoproteins A-I, A-II and B in Hepatic Metastases Comparison with other Liver Diseases: Hepatomas and Cirrhosis,"" J. Clin. Chem. Clin. Biochem., vol. 24, pp. 161-166, 1986.;;Remold-O'Donnell et al., ""Sequence and Molecular Characterization of Human Monocyte/Neutrophil Elastase Inhibitor,"" Proc. Natl. Acad. Sci., vol. 89, pp. 5635-5639, Jun. 1992.;;Cooley et al., ""The Serpin MNEI Inhibits Elastase-Like and Chymotrypsin-Like Serine Proteases through Efficient Reactions at Two Active Sites,"" Biochemistry, vol. 40, pp. 15762-15770, 2001.;;Algrain et al, ""Ezrin Contains Cytoskeleton and Membrane Binding Domains Accounting for its Proposed Role as a Membrane-Cytoskeletal Linker,"" The Journal of Cell Biology, vol. 120, No. 1, pp. 129-139, Jan. 1993.;;Jiang et al., ""Cytokine Regulation of Ezrin Expression in the Human Colon Cancer Cell Line HT29,"" Anticancer Research, vol. 16, pp. 861-866, 1996.;;Hiscox et al, ""Ezrin Regulates Cell-Cell and Cell-Matrix Adhesion, A Possible Role with E-Cadherin/beta-Catenin,"" Journal of Cell Science, vol. 112, pp. 3081-3090, 1999.;;Xiao et al., ""An Approach to Studying Lung Cancer-Related Proteins in Human Blood,"" Molecular & Cellular Proteomics, vol. 4, pp. 1480-1486, 2005.;;Anders et al., ""Aminoacyclases,"" Advances in Pharmacology, vol. 27, pp. 431-448, 1994.;;Lorentz et al., ""A New Method for the Assay of Aminoacylase: Elaboration of a Fixed-Incubation Method for Routine Measurements,"" Clinica Chimica Acta, vol. 63, pp. 263-269, 1975.;;Lorentz et al, ""Clinical Application of a New Method for the Determination of Aminoacylase in Human Serum,"" Clinica Chimica Acta, vol. 63, pp. 271-274, 1975.;;Cook et al, ""Human Aminoacylase-1,"" The Journal of Biological Chemistry, vol. 268, No. 23, pp. 17010-17017, 1993.;;Miller et al., ""Lack of Expression of Aminoacylae-1 in Small Cell Lang Cancer,"" The Journal of Clinical Investigation, Inc., vol. 83, pp. 2120-2124, Jun. 1989.;;Balabanov et al., ""Tumour-Related Enzyme Alterations in the Clear Cell Type of Human Renal Cell Carcinoma Identified by Two-dimensional Gel Electrophoresis,"" Eur. J. Biochem., vol. 268, pp. 5977-5980, 2001.;;Chan et al, ""Human Liver Fatty Acid Binding Protein cDNA and Amino Acid Sequence,"" The Journal of Biological Chemistry, vol. 260, No. 5, pp. 2629-2632, 1985.;;Das et al., ""Expression Pattern of Fatty Acid-Binding Proteins in Human Normal and Cancer Prostate Cells and Tissues,"" Clinical Cancer Research, vol. 7, 1706-1715, Jun. 2001.;;Stulik et al., ""Proteome Study of Colorectal Carcinogenesis,"" Electrophoresis, vol. 22, pp. 3019-3025, 2001.;;Yamazaki et al., ""Liver Fatty Acid-Binding Protein is a New Prognostic Factor for Hepatic Resection of Colorectal Cancer Metastases,"" Journal of Surgical Oncology, vol. 72, pp. 83-87, 1999.;;Sweetser et al., ""The Human and Rodent Intestinal Fatty Acid Binding Protein Genes,"" The Journal of Biological Chemistry, vol. 262, No. 33, pp. 16060-16071, 1987.;;Pelsers et al, ""Intestinal-Type and Liver-Type Fatty Acid-Binding Protein in the Intestine. Tissue Distribution and Clinical Utility"", Clinical Biochemistry, vol. 36, pp. 529-535, 2003.;;Xiao et al, ""Dietary Exposure to Soy or Whey Proteins Alters Colonic Global Gene Expression Profiles During Rat Colon Tumorigenesis,"" Molecular Cancer, vol. 4, No. 1, pp. 1-17, Jan. 11, 2005.;;Engwegen et al., ""Identification of Serum Proteins Discriminating Colorectal Cancer Patients and Healthy Controls Using Surface-Enhanced Laser Desorption Ionisation-Time of Flight Mass Spectrometry,"" World J. Gastrenterol, vol. 12, No. 10, pp. 1536-1544, Mar. 14, 2006.;;Zhang et al., ""Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer,"" Cancer Research, vol. 64, pp. 5882-5890, Aug. 15, 2004.;;Lin et al., ""Human Plastin Genes,"" The Journal of Biological Chemistry, vol. 268, No. 4, pp. 2781-2792, 1993.;;Lavabre-Bertrand et al., ""Plasma Proteasome Level is a Potential Marker in Patients with Solid Tumors and Hemopoietic Malignancies,"" Cancer, vol. 92, No. 10, pp. 2493-2500, Nov. 15, 2001.;;Schwartz, ""Enzymes as Prognostic Markers and Therapeutic Indicators in Patients with Cancer,"" Clinica Chimica Acta, vol. 206, pp. 77-82, 1992.;;McCool et al., ""Roles of Calreticulin and Calnexin During Mucin Synthesis in LS180 and HT29/A1 Human Colonic Adenocarcinoma Cells,"" Biochem. J., vol. 341, pp. 593-600, 1999.;;Motoo et al., ""Serum Levels of Pancreatitis-Associated Protein in Digestive Diseases with Special Reference to Gastrointestinal Cancer,"" Digestive Diseases and Sciences, vol. 44, No. 6, pp. 1142-1147, Jun. 1999.;;Abe et al., ""Preparation of Recombinant MK-1/EP-CAM and Establishment of an ELISA System for Determining Soluble MK-1/EP-CAM Levels in Sera of Cancer Patients,"" Journal of Immunological Methods, vol. 270, pp. 227-233, 2002.;;Katayama et al., ""Soluble E-Cadherin Fragments Increased in Circulation of Cancer Patients,"" Br. J. Cancer, vol. 69, pp. 580-585, 1994.;;Wilmanns et al., ""Soluble Serum E-Cadherin as a Marker of Tumour Progression in Colorectal Cancer Patients,"" Clinical & Experimental Metastasis, vol. 21, pp. 75-78, 2004.;;Gold et al., ""Specific Carcinoembryonic Antigens of the Human Digestive System,"" J. Exp. Med., pp. 467-481, 1965.;;Kim et al., ""Gastrointestinal Tract Cancer Screening Using Fecal Carcinoembryonic Antigen,"" Annals of Clinical & Laboratory Science, vol. 33, No. 1, pp. 32-38, 2003.;;Holmgren et al., ""Detection by Monoclonal Antibody of Carbohydrate Antigen CA 50 in Serum of Patients with Carcinoma,"" British Medical Journal, vol. 288, pp. 1479-1482, May 19, 1984.;;Klug et al., Monoclonal Anitbody Immunoradiometric Assay for An Antigenic Determinant (CA 72) on a Novel Pancarcinoma Antigen (TAG-72), Int. J. Cancer, vol. 38, pp. 661-669, 1986.;;Holland et al., ""Testosterona Serica: Posible Marcador En El Cancer Colorrectal,"" Medicina (Buenos Aires), vol. 53, pp. 117-123, 1993.;;Model et al., Detection of Methylated DNA in Plasma from Colorectal Cancer Patients and Controls by Real-Time PCR Analysis of Septin 9, World Congress on Gastrointestinal Cancer, Jul. 2006.;;Ebert et al., ""Aristaless-like Homeobox-4 Gene Methylation is a Potential Marker for Colorectal Adenocarcinomas,"" Gastroenterology, vol. 131, pp. 1418-1430, 2006.;;Bianco et al., ""Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon Cancer,"" Clin. Cancer Res., vol. 12, No. 17, pp. 5158-5164, Sep. 1, 2006.;;Mori et al., ""Two-Dimensional Electrophoresis Database of Fluorescence-Labeled Proteins of Colon Cancer Cells,"" Journal of Chromatography B, vol. 823, pp. 82-97, 2005.;;Duffy et al., ""Tumour Markers in Colorectal Cancer: European Group on Tumour Markers (EGTM) Guidelines for Clinical Use,"" European Journal of Cancer, vol. 43, pp. 1348-1360, 2007.;;Rouzier et al., ""Immunocytochemical Detection of Bone Marrow Micrometastases in Colorectal Carcinoma Patients, Using A Monoclonal Antibody to Villin,"" Cytometry (Communications in Clinical Cytometry), vol. 46, pp. 281-289, 2001.;;Nishizuka et al., ""Diagnostic Markers that Distinguish Colon and Ovarian Adenocarcinomas: Identification by Genomic, Proteomic, and Tissue Array Profiling,"" Cancer Research, vol. 63, pp. 5243-5250, Sep. 1, 2003.;;Wang et al., Proteomic Dissection of the Molecular Mechanisms Underlying Hepatic Metastasis in Colorectal Cancer, XP009093529, Database Accession No. PREV200600505326, AGA Abstracts, p. A-676, W1533, Apr. 2006.;;Mori et al., A Genome-Wide Search Identifies Epigenetic Silencing of Somatostatin, Tachykinin-1, and 5 other Genes in Colon Cancer, Gastroenterology, vol. 131, pp. 797-808, 2006.;;Database WPI Week 200777, Thomson Scientific, London, GB; AN 2007-817830, XP002464797 & CN 1 967 246 (Proteome Analysis Research Center) May 23, 2007, Abstract.;;Fujiwara et al., Global Gene Expression Analysis of Rat Colon Cancers Induced by a Food-Borne Carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, Carcinogenesis, vol. 25, No. 8, pp. 1495-1505, 2004.;;Dorudi et al., ""E-Cadherin Expression in Colorectal Cancer,"" American Journal of Pathology, vol. 142, No. 4, pp. 981-986, Apr. 1993.;;Lawrie et al., ""Liver Fatty Acid Binding Protein Expression in Colorectal Neoplasia,"" British Journal of Cancer, vol. 90, pp. 1955-1960, 2004.;;Mar. 18, 2009 International Search Report Issued in International Application No. PCT/FR2008/051291.;;Feb. 23, 2009 International Search Report Issued in International Application No. PCT/FR2008/051289.;;Feb. 18, 2009 International Search Report Issued in International Application No. PCT/FR2008/051295.;;Jan. 16, 2009 International Search Report Issued in International Application No. PCT/FR2008/051298.;;Mar. 27, 2009 International Search Report Issued in International Application No. PCT/FR2008/051290.;;Mar. 6, 2009 International Search Report Issued in International Application No. PCT/FR2008/051293.;;Mar. 5, 2009 International Search Report Issued in International Application No. PCT/FR2008/051292.;;U.S. Appl. No. 12/452,035, filed Dec. 14, 2009, in the name of Corinne Beaulieu et al.;;U.S. Appl. No. 12/452,038 filed Dec. 14, 2009, in the name of Yasemin Ataman-Onal et al.;;U.S. Appl. No. 12/452,042, filed Dec. 14, 2009, in the name of Monique Arpin et al.;;U.S. Appl. No. 12/452,048, filed Dec. 14, 2009, in the name of Jean-Philippe Charrier et al.;;U.S. Appl. No. 12/452,034, filed Dec. 14, 2009, in the name of Yasemin Ataman-Onal et al.;;U.S. Appl. No. 12/452,037, filed Dec. 14, 2009, in the name of Yasemin Ataman-Onal et al.;;Jan. 3, 2012 Office Action issued in U.S. Appl. No. 12/452,035.;;Jul. 24, 2012 Restriction Requirement issued in U.S. Appl. No. 12/999,242.;;Jul. 31, 2012 Office Action issued in U.S. Appl. No. 12/452,048.;;Jun. 21, 2012 Office Action issued in U.S. Appl. No. 12/452,035.;;Apr. 17, 2012 Office Action issued in U.S. Appl. No. 12/452,038.;;May 18, 2012 Office Action issued in U.S. Appl. No. 12/452,034.;;Jun. 12, 2012 Office Action issued in U.S. Appl. No. 12/452,042.;;Jun. 18, 2012 Office Action issued in U.S. Appl. No. 12/452,047.;;Davies et al., ""Loss of Cellular Distribution of Ezrin in Human Colon Cancer"", ASCO 2006, Gastrointestinal Cancers Symposium, 2006 Abstract 322.;;Mahipal et al., ""Epidermal Growth Factor Receptor Overexpression in Resected Pancreatic Cancer"", J Clinical Oncology, 2011, 29: suppl 4; Abstract 317.;;Brattstrom et al., ""HER-2 overexpression in patients with esophageal carcinoma correlates with poorer survival"", ASCO 2005 Gastrointestinal Cancers Symposium, 2005, Abstract 63.;;Kavanagh et al., ""Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?"" BMC Cancer, Jan. 1, 2009, 9:1-6.;;Sep. 30, 2013 Office Action issued in U.S. Appl. No. 12/452,034.;;Feb. 12, 2009 International Search Report Issued in International Application No. PCT/FR2008/051294.;;Nov. 25, 2009 International Search Report Issued in International Application No. PCT/FR2009/051361 (w/ translation)."
52,US,A1,US 2009/0035754 A1,176-949-616-335-591,2009-02-05,2009,US 63172505 A,2005-08-04,US 59892604 P 20040804,Methods And Compositions For Detecting Steroids,UNIV UTAH,MEIKLE A WAYNE;;STILLMAN DAVID J;;TERRY ALAN H;;ORROCK JARED M;;SANDROCK TANYA M,https://lens.org/176-949-616-335-591,Patent Application,yes,0,5,37,14,G01N33/743;;C12N15/81;;Y10S435/81,C12Q1/68;;C12N1/19;;C12N15/00,435/6;;435/320.1;;435/254.2,,,
53,US,B2,US 8097431 B2,150-038-103-734-975,2012-01-17,2012,US 63172505 A,2005-08-04,US 59892604 P 20040804,Methods And Compositions For Detecting Steroids,MEIKLE A WAYNE;;STILLMAN DAVID J;;ORROCK JARED M;;TERRY ALAN H;;SANDROCK TANYA M;;UNIV UTAH RES FOUND,MEIKLE A WAYNE;;STILLMAN DAVID J;;ORROCK JARED M;;TERRY ALAN H;;SANDROCK TANYA M,https://lens.org/150-038-103-734-975,Granted Patent,yes,0,5,37,14,G01N33/743;;C12N15/81;;Y10S435/81,G01N33/53;;C07H21/04;;C12N5/00;;C12N15/00;;C12P21/06;;C12Q1/42;;C12Q1/48;;C12Q1/66,435/7.8;;435/8;;435/15;;435/21;;435/69.1;;435/320.1;;435/325;;435/810;;536/23.4;;536/23.5,10082565;;10368774;;10392442;;10529899;;10902781;;11126125;;11228060;;11297580;;11836323;;12017555;;12650678;;12711012;;12729685;;12948882;;3283939;;7673408;;7737504;;7838736;;7989605;;8058776;;8370533;;8593856;;8825559;;9073609;;9108040;;9213220;;9251029;;9661615,10.1073/PNAS.91.17.8180;;10.1210/ME.10.2.196;;10.1210/ER.20.5.689;;10.1172/JCI117616;;10.1016/0378-1119(95)00037-7;;10.1093/NAR/22.25.5767;;10.1016/S0076-6879(97)83025-X;;10.1006/TAAP.1996.8069;;10.1210/JC.85.7.2370;;10.1073/PNAS.94.8.3697;;10.1016/0378-1119(93)90681-R;;10.1210/ER.20.3.321;;10.1210/JC.86.4.1539;;10.1126/SCIENCE.3283939;;10.2307/3432519;;10.1210/rp.57.1.411;;10.1016/s0960-0760(03)00034-7;;10.1002/(sici)1097-4644(19970801)66:2<184::aid-jcb6>3.0.co;2-m;;10.1289/ehp.6139;;10.1210/jcem.83.7.4929;;10.1210/jc.80.9.2658;;10.1016/s0022-3476(99)70414-2;;10.3109/09513590009167711;;10.1016/s0887-2333(03)00009-2;;10.1210/jc.87.2.791;;10.1016/s0045-6535(03)00261-3;;10.1289/ehp.95103s7113;;10.1002/(sici)1097-0061(19990615)15:8<639::aid-yea408>3.0.co;2-3,"Giguere. 1999. Endocrine Rev. 20:689-725.;;http://chemistry.about.com/od/chemicalstructures/ig/Steroids/, downloaded Nov. 10, 2010.;;http://www.chm.bris.ac.uk/webprojects2002/schnepp/vitamind.html downloaded Nov. 10, 2010.;;http://www.colorado.edu/intphys/Class/IPHY3430-200/image/23-8 downloaded Nov. 10, 2010.;;Balasubramanian, B., et al., 1999, Binding of Gal4p and biocoid to nucleosomal sites in yeast in the absence of replication. Mol. Cell Biol. 19(4): 2977-2985.;;Beck, V., E. et al., 2003, Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy. J. Steroid Biochem. Mol. Biol. 84: 259-268.;;Berghofer-Hochheiner, Y., et al., 1997, Expression of the vitamin D and the retinoid X receptors in Saccharomyces cerevisiae: alternative in vivo models for ligand-induced transactivation. J. Cell Biochem. 66: 184-196.;;Evans, R. M., 1988, The steroid and thyroid hormone receptor superfamily. Science 240: 889-895.;;Gaido, K. W., et al., 1997, Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143: 205-212.;;Gao, C. Y. et al., 2000, Tightly regulated, beta-estradiol does-dependent expression system for yeast. Biotechniques 29(6): 1226-1231.;;Gong, Y., et al., 2003, Clustering of sex hormone disruptors in Singapore's marine environment. Environ. Health Perspect. 111: 1448-1453.;;Jin, C. H. et al., 1996, Human vitamin D receptor-dependent transactivation in Saccharomyces cerevisiae requires retinoid X receptor. Mol. Endocrinol. 10: 196-205.;;Klein, K. O. et al., 1998, Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girls with precocious puberty treated with a luteinizing hormone-releasing hormone agonist. J. Clin. Endocrinol. Metab. 83(7): 2387-2389.;;Klein, K. O., et al., 1994, Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J. Clin. Invest. 94: 2475-2480.;;Klein, K. O. et al., 1995, Use of ultrasensitive recombinant cell bioassay to measure estrogen levels in women with breast cancer receiving the aromatase inhibitor, letrozole. J. Clin. Endocrinol. Metab. 80(9): 2658-2660.;;Klein, K. O. et al., 1999, Estrogen levels in girls with premature thelarche compared with normal prepubertal girls as determined by an ultrasensitive recombinant cell bioassay. J. Pediatr. 134: 190-192.;;Kuhn, C. M., 2002, Anabolic steroids. Recent Prog. Horm. Res. 57: 411-434.;;Larmore K. A. et al., 2000, Estradiol suppression and recovery during leuprolide acetate treatment in women as determined weekly by an ultrasensitive recombinant cell bioassay. Gynecol. Endocrinol. 14: 405-410.;;Lee, H. J., et al., 2003, Novel yeast bioassay system for detection of androgenic and antiandrogenic compounds. Toxicol. In Vitro 17: 237-244.;;Louvion, J. F., et al., 1993, Fusion of GAL4-VP16 to a steroid-binding domain provides a tool for gratuitous induction of galactose-responsive genes in yeast. Gene 131: 129-134.;;Mauras, N., et al., 2000, Estrogen suppression in males: metabolic effects. J. Clin. Endocrinol. Metab. 85(7): 2370-2377.;;McKenna, N. J., et al., 1999, Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20(3): 321-344.;;Mumberg, D., R. et al., 1994, Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression. Nucleic Acids Res. 22: 5767-5768.;;Mumberg, D., et al., 1995, Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene 156: 119-122.;;Pajic, T., et al., 1999, Biotransformation of steroids by the fission yeast Schizosaccharomyces pombe. Yeast 15: 639-645.;;Paris, F. N. et al., 2002, A new Recombinant cell bioassay for ultrasensitive determination of serum estrogenic bioactivity in children. J. Clin. Endocrinol. Metab. 87: 791-797.;;Raivio et. al., J. Clin. Endocrinol. Metab. 86 (3): 1539-1544 (2001).;;Ronicke, V., et al.,1997, Use of conditional promoters for expression of heterologous proteins in Saccharomyces cerevisiae. Methods Enzymol. 283: 313-322.;;Shiraishi, F., et al., 2003, Estrogenic and thyroid hormone activity of a series of hydroxyl-polychlorinated biphenyls. Chemosphere 52: 33-42.;;Soto, A. M., et al., 1995M The E-Screen assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ. Health Perspect. 103 Suppl 7: 113-122.;;Walfish, P. G., et al., 1997, Yeast hormone response element assays detect and characterize GRIP1 coactivator-dependent activation of transcription by thyroid and retinoid nuclear receptors. Proc. Natl. Acad. Sci. USA 94: 3697-3702.;;Wang, Y., et al., 1994, A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA 91: 8180-8184.;;International Search Report and Written Opinion for International Application No. PCT/US2005/028071 dated Jun. 20, 2008."
54,US,B2,US 8361731 B2,142-176-805-399-644,2013-01-29,2013,US 45203808 A,2008-07-10,FR 0705197 A 20070719,Ezrin Assay Method For The In Vitro Diagnosis Of Colorectal Cancer,BIOMERIEUX SA;;CENTRE NAT RECH SCIENT;;INST CURIE;;ARPIN MONIQUE;;ATAMAN-ONAL YASMIN;;BEAULIEU CORINNE;;BUSSERET SANDRINE;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;ROLLAND DOMINIQUE,ARPIN MONIQUE;;ATAMAN-ONAL YASMIN;;BEAULIEU CORINNE;;BUSSERET SANDRINE;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;ROLLAND DOMINIQUE,https://lens.org/142-176-805-399-644,Granted Patent,yes,0,20,20,23,C07K7/08;;C07K7/06;;G01N33/57419;;G01N2333/705,G01N33/53;;G01N33/574,435/7.1;;435/7.23,10389686;;10462524;;10518104;;10778968;;11410510;;11722587;;11735128;;11745181;;11746103;;11747453;;12379327;;12493773;;12562854;;12922171;;1376927;;14500354;;14563446;;15041719;;15059925;;15065605;;15138477;;15313933;;1563002;;15653098;;15970581;;16011914;;16330944;;16465618;;16570345;;16581821;;16644871;;16952549;;1699834;;17101318;;17512720;;2100569;;2429934;;2591371;;2824476;;2872262;;3566712;;3838309;;4953873;;6426610;;7682766;;8050492;;8123491;;8139549;;8394326;;8416983;;8428952;;15960882;;8068563;;8687142;;11565796;;240519;;1175300;;1572080;;10417322;;8295527;;16951234;;12661896;;15644144;;12193204;;6582896;;17188166,10.1002/IJC.2910380508;;10.1006/BBRC.2001.6047;;10.1158/1078-0432.CCR-03-0321;;10.1136/BMJ.288.6429.1479;;10.1128/MCB.14.4.2457;;10.1002/CYTO.1169;;10.1073/PNAS.89.12.5635;;10.1002/(SICI)1096-9098(199910)72:2<83::AID-JSO8>3.0.CO;2-C;;10.1023/B:CLIN.0000017204.38807.22;;10.1016/J.JCHROMB.2005.05.024;;10.1086/500563;;10.1084/JEM.122.3.467;;10.1016/J.EJCA.2007.03.021;;10.1158/0008-5472.CAN-04-0746;;10.1373/CLINCHEM.2006.069252;;10.1046/J.0014-2956.2001.02546.X;;10.1074/MCP.M500055-MCP200;;10.1016/S1570-9639(03)00204-8;;10.1194/JLR.D200034-JLR200;;10.1074/JBC.M210455200;;10.1515/CCLM.1986.24.3.161;;10.1016/J.CCCN.2004.09.001;;10.1021/BI0113925;;10.1006/EXCR.1994.1209;;10.1083/JCB.120.1.129;;10.1053/J.GASTRO.2006.08.034;;10.1093/CARCIN/BGH155;;10.1053/J.GASTRO.2006.06.006;;10.1016/S0009-9120(03)00096-1;;10.1016/S0022-1759(02)00332-0;;10.1016/0009-8981(75)90046-7;;10.1016/0009-8981(75)90047-9;;10.1002/1522-2683(200108)22:14<3019::aid-elps3019>3.0.co;2-t;;10.1002/(sici)1096-9098(199910)72:2<83::aid-jso8>3.3.co;2-3;;10.1002/1097-0142(20011115)92:10<2493::aid-cncr1599>3.0.co;2-f;;10.1016/0009-8981(92)90008-e;;10.1042/0264-6021:3410593;;10.1158/1078-0432.ccr-06-0274;;10.1111/j.1745-7254.2005.00145.x;;10.1034/j.1600-0463.2002.100601.x;;10.1016/j.surg.2006.05.009;;10.1093/alcalc/agl021,"SCORE sequence search result #1, Geneseq database, ""20110423-191537-us-12-452-038-2.rag"" Apr. 23, 2011.;;Bruce et al (Proc Amer Assoc Cancer Res, 2005, 46, abstract #424).;;Gould et al (The EMBO Journal, 1989, 8:4133-4142).;;Davies et al (ASCO, 2006 gastrointestinal Cancers Symposium, Abstract 322).;;Lawrie et al (British J of Cancer, 2004, 90:1955-1960).;;Etzioni et al (Nature Reviews, Apr. 2003, 3: internet pp. 1-10).;;Mercer (Immunol Ser, 1990, 53:39-54).;;Mahipal et al (ASCO, J Clinical Oncology, 2001, 29:suppl 4; abstract 317).;;Brattstrom et al (ASCO, 2005 Gastrointestinal Cancers Symposium, 2005, abstract 63).;;Kavanagh et al (BMC Cancer, 2009, 9:1-6).;;Niederkofler et al., ""Novel Mass Spectrometric Immunoassays for the Rapid Structural Characterization of Plasma Apolipoproteins,"" Journal of Lipid Research, vol. 44, pp. 630-639, 2003.;;Hortin, ""The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Pepetidome,"" Clinical Chemistry, vol. 52, No. 7, pp. 1223-1237, 2006.;;Hachem, ""Serum Apolipoproteins A-I, A-II and B in Hepatic Metastases Comparison with other Liver Diseases: Hepatomas and Cirrhosis,"" J. Clin. Chem. Clin. Biochem., vol. 24, pp. 161-166, 1986.;;Remold-O'Donnell et al., ""Sequence and Molecular Characterization of Human Monocytc/Neutrophil Elastase Inhibitor,"" Proc. Natl. Acad. Sci., vol. 89, pp. 5635-5639, Jun. 1992.;;Cooley et al., ""The Serpin MNEI Inhibits Elastase-Like and Chymotrypsin-Like Serine Proteases through Efficient Reactions at Two Active Sites,"" Biochemistry, vol. 40, pp. 15762-15770, 2001.;;Algrain et al, ""Ezrin Contains Cytoskeleton and Membrane Binding Domains Accounting for its Proposed Role as a Membrane-Cytoskeletal Linker,"" The Journal of Cell Biology, vol. 120, No. 1, pp. 129-139, Jan. 1993.;;Jiang et al., ""Cytokine Regulation of Ezrin Expression in the Human Colon Cancer Cell Line HT29,"" Anticancer Research, vol. 16, pp. 861-866, 1996.;;Hiscox et al, ""Ezrin Regulates Cell-Cell and Cell-Matrix Adhesion, A Possible Role with E-Cadherin/beta-Catenin,"" Journal of Cell Science, vol. 112, pp. 3081-3090, 1999.;;Xiao et al., ""An Approach to Studying Lung Cancer-Related Proteins in Human Blood,"" Molecular & Cellular Proteomics, vol. 4, pp. 1480-1486, 2005.;;Anders et al., ""Aminoacyclases,"" Advances in Pharmacology, vol. 27, pp. 431-448, 1994.;;Lorentz et al., ""A New Method for the Assay of Aminoacylase: Elaboration of a Fixed-Incubation Method for Routine Measurements,"" Clinica Chimica Acta, vol. 63, pp. 263-269, 1975.;;Lorentz et al, ""Clinical Application of a New Method for the Determination of Aminoacylase in Human Serum,"" Clinics Chimica Acta, vol. 63, pp. 271-274, 1975.;;Cook et al, ""Human Aminoacylase-1,"" The Journal of Biological Chemistry, vol. 268, No. 23, pp. 17010-17017, 1993.;;Miller et al., ""Lack of Expression of Aminoacylae-1 in Small Cell Lang Cancer,"" The Journal of Clinical Investigation, Inc., vol. 83, pp. 2120-2124, Jun. 1989.;;Balabanov et al., ""Tumour-Related Enzyme Alterations in the Clear Cell Type of Human Renal Cell Carcinoma Identified by Two-dimensional Gel Electrophoresis,"" Eur. J. Biochem., vol. 268, pp. 5977-5980, 2001.;;Chan et al, ""Human Liver Fatty Acid Binding Protein cDNA and Amino Acid Sequence,"" The Journal of Biological Chemistry, vol. 260, No. 5, pp. 2629-2632, 1985.;;Das et al., ""Expression Pattern of Fatty Acid-Binding Proteins in Human Normal and Cancer Prostate Cells and Tissues,"" Clinical Cancer Research, vol. 7, 1706-1715, Jun. 2001.;;Stulik et al., ""Proteome Study of Colorectal Carcinogenesis,"" Electrophoresis, vol. 22, pp. 3019-3025, 2001.;;Yamazaki et al., ""Liver Fatty Acid-Binding Protein is a New Prognostic Factor for Hepatic Resection of Colorectal Cancer Metastases,"" Journal of Surgical Oncology, vol. 72, pp. 83-87, 1999.;;Sweetser et al., ""The Human and Rodent Intestinal Fatty Acid Binding Protein Genes,"" The Journal of Biological Chemistry, vol. 262, No. 33, pp. 16060-16071, 1987.;;Pelsers et al, ""Intestinal-Type and Liver-Type Fatty Acid-Binding Protein in the Intestine. Tissue Distribution and Clinical Utility"", Clinical Biochemistry, vol. 36, pp. 529-535, 2003.;;Xiao et al, ""Dietary Exposure to Soy or Whey Proteins Alters Colonic Global Gene Expression Profiles During Rat Colon Tumorigenesis,"" Molecular Cancer, vol. 4, No. 1, pp. 1-17, Jan. 11, 2005.;;Engwegen et al., ""Identification of Serum Proteins Discriminating Colorectal Cancer Patients and Healthy Controls Using Surface-Enhanced Laser Desorption Ionisation-Time of Flight Mass Spectrometry,"" World J. Gastrenterol, vol. 12, No. 10, pp. 1536-1544, Mar. 14, 2006.;;Zhang et al., ""Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer,"" Cancer Research, vol. 64, pp. 5882-5890, Aug. 15, 2004.;;Lin et al., ""Human Plastin Genes,"" The Journal of Biological Chemistry, vol. 268, No. 4, pp. 2781-2792, 1993.;;Lavabre-Bertrand et al., ""Plasma Proteasome Level is a Potential Marker in Patients with Solid Tumors and Hemopoietic Malignancies,"" Cancer, vol. 92, No. 10, pp. 2493-2500, Nov. 15, 2001.;;Schwartz, ""Enzymes as Prognostic Markers and Therapeutic Indicators in Patients with Cancer,"" Clinica Chimica Acta, vol. 206, pp. 77-82, 1992.;;McCool et al., ""Roles of Calreticulin and Calnexin During Mucin Synthesis in LS180 and HT29/A1 Human Colonic Adenocarcinoma Cells,"" Biochem. J., vol. 341, pp. 593-600, 1999.;;Motoo et al., ""Serum Levels of Pancreatitis-Associated Protein in Digestive Diseases with Special Reference to Gastrointestinal Cancer,"" Digestive Diseases and Sciences, vol. 44, No. 6, pp. 1142-1147, Jun. 1999.;;Abe et al., ""Preparation of Recombinant MK-1/EP-CAM and Establishment of an ELISA System for Determining Soluble MK-1/EP-CAM Levels in Sera of Cancer Patients,"" Journal of Immunological Methods, vol. 270, pp. 227-233, 2002.;;Katayama et al., ""Soluble E-Cadherin Fragments Increased in Circulation of Cancer Patients,"" Br. J. Cancer, vol. 69, pp. 580-585, 1994.;;Wilmanns et al., ""Soluble Serum E-Cadherin as a Marker of Tumour Progression in Colorectal Cancer Patients,"" Clinical & Experimental Metastasis, vol. 21, pp. 75-78, 2004.;;Gold et al., ""Specific Carcinoembryonic Antigens of the Human Digestive System,"" J. Exp. Med., pp. 467-481, 1965.;;Kim et al., ""Gastrointestinal Tract Cancer Screening Using Fecal Carcinoembryonic Antigen,"" Annals of Clinical & Laboratory Science, vol. 33, No. 1, pp. 32-38, 2003.;;Holmgren et al., ""Detection by Monoclonal Antibody of Carbohydrate Antigen CA 50 in Serum of Patients with Carcinoma,"" British Medical Journal, vol. 288, pp. 1479-1482, May 19, 1984.;;Klug et al., Monoclonal Anitbody Immunoradiometric Assay for An Antigenic Determinant (CA 72) on a Novel Pancarcinoma Antigen (TAG-72), Int. J. Cancer, vol. 38, pp. 661-669, 1986.;;Holland et al., ""Testosterona Serica: Posible Marcador En El Cancer Colorrectal,"" Medicina (Buenos Aires), vol. 53, pp. 117-123, 1993.;;Model et al., ""Detection of Methylated DNA in Plasma from Colorectal Cancer Patients and Controls by Real-Time PCR Analysis of Septin 9,"" World Congress on Gastrointestinal Cancer, Jul. 2006.;;Ebert et al., ""Aristaless-like Homeobox-4 Gene Methylation is a Potential Marker for Colorectal Adenocarcinomas,"" Gastroenterology, vol. 131, pp. 1418-1430, 2006.;;Bianco et al., ""Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon Cancer,"" Clin. Cancer Res., vol. 12, No. 17, pp. 5158-5164, Sep. 1, 2006.;;Mori et al., ""Two-Dimensional Electrophoresis Database of Fluorescence-Labeled Proteins of Colon Cancer Cells,"" Journal of Chromatography B, vol. 823, pp. 82-97, 2005.;;Duffy et al., ""Tumour Markers in Colorectal Cancer: European Group on Tumour Markers (EGTM) Guidelines for Clinical Use,"" European Journal of Cancer, vol. 43, pp. 1348-1360, 2007.;;Rouzier et al., ""Immunocytochemical Detection of Bone Marrow Micrometastases in Colorectal Carcinoma Patients, Using A Monoclonal Antibody to Villin,"" Cytometry (Communications in Clinical Cytometry), vol. 46, pp. 281-289, 2001.;;Nishizuka et al., ""Diagnostic Markers that Distinguish Colon and Ovarian Adenocarcinomas: Identification by Genomic, Proteomic, and Tissue Array Profiling,"" Cancer Research, vol. 63, pp, 5243-5250, Sep. 1, 2003.;;Wang et al., Proteomic Dissection of the Molecular Mechanisms Underlying Hepatic Metastasis in Colorectal Cancer, XP009093529, Database Accession No. PREV200600505326, AGA Abstracts, p. A-676, W1533, Apr. 2006.;;Mori et al., A Genome-Wide Search Identifies Epigenetic Silencing of Somatostatin, Tachykinin-1, and 5 other Genes in Colon Cancer, Gastroenterology, vol. 131, pp. 797-808, 2006.;;Database WPI Week 200777, Thomson Scientific, London, GB; AN 2007-817830, XP002464797 & CN 1 967 246 (Proteome Analysis Research Center) May 23, 2007, Abstract.;;Fujiwara et al., Global Gene Expression Analysis of Rat Colon Cancers Induced by a Food-Borne Carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, Carcinogenesis, vol. 25, No. 8, pp. 1495-1505, 2004.;;Dorudi et al., ""E-Cadherin Expression in Colorectal Cancer,"" American Journal of Pathology, vol. 142, No. 4, pp. 981-986, Apr. 1993.;;Lawrie et al., ""Liver Fatty Acid Binding Protein Expression in Colorectal Neoplasia,"" British Journal of Cancer, vol. 90, pp. 1955-1960, 2004.;;Mar. 18, 2009 International Search Report Issued in International Application No. PCT/FR2008/051291.;;Feb. 23, 2009 International Search Report Issued in International Application No. PCT/FR2008/051289.;;Feb. 18, 2009 International Search Report Issued in International Application No. PCT/FR2008/051295.;;Jan. 16, 2009 International Search Report Issued in International Application No. PCT/FR2008/051298.;;Mar. 27, 2009 International Search Report Issued in International Application No. PCT/FR2008/051290.;;Mar. 6, 2009 International Search Report Issued in International Application No. PCT/FR2008/051293.;;Mar. 5, 2009 International Search Report Issued in International Application No. PCT/FR2008/051292.;;U.S. Appl. No. 12/452,035, filed Dec. 14, 2009, in the name of Corinne Beaulieu et al.;;U.S. Appl. No. 12/452,037, filed Dec. 14, 2009, in the name of Yasemin Ataman-Onal et al.;;U.S. Appl. No. 12/452,042, filed Dec. 14, 2009, in the name of Monique Arpin et al.;;U.S. Appl. No. 12/452,048, filed Dec. 14, 2009, in the name of Jean-Philippe Charrier et al.;;U.S. Appl. No. 12/452,034, filed Dec. 14, 2009, in the name of Yasemin Ataman-Onal et al.;;U.S. Appl. No. 12/452,047, filed Dec. 14, 2009, in the name of Yasemin Ataman-Onal et al.;;Oct. 31, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,035.;;Nov. 16, 2011 Election of Species Requirement issued in U.S. Appl. No. 12/452,037.;;Sep. 15, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,042.;;Oct. 28, 2011 Office Action issued in U.S. Appl. No. 12/452,042.;;Oct. 28, 2011 Restriction Requirement issued in U.S. Appl. No. 12/452,047.;;Delanote et al., ""Plastins: Versatile Modulators of Actin Organization in (patho)physiological Cellular Processes,"" Acta Pharmacologica Sinica, vol. 26, No. 7, pp. 769-779, Jul. 2005.;;Hasselblatt et al., ""Identification of Novel Diagnostic Markers for Choroid Plexus Tumors,"" Am. J. Surg Pathol, vol. 30, No. 1, pp. 66-74, Jan. 2006.;;Lin et al., ""Identification of I-Plastin, a Human Fimbrin Isoform Expressed in Intestine and Kidney,"" Molecular and Cellular Biology, vol. 14, No. 4, pp. 2457-2467, Apr. 1994.;;Carroll et al., ""Liver Fatty Acid-Binding Protein: A Marker for Studying Cellular Differentiation in Gut Epithelial Neoplasms,"" Gastroenterology, vol. 99, pp. 1727-1735, 1999.;;Kayser et al., ""Primary Colorectal Carcinomas and their Intrapulmonary Metastases: Clinical, Glyco-, Immuno- and Lectin Histochemical, Nuclear and Syntactic Structure Analysis with Emphasis on Correlation with Period of Occurrence of Metastases and Survival,"" APMIS, vol. 110, pp. 435-446, 2002.;;Kuusela et al., ""Comparison of CA 19-9 and Carcinoembryonic Antigen (CEA) Levels in the Serum of Patients with Colorectal Diseases,"" Br. J. Cancer, vol. 49, pp. 135-139, 1984.;;Pelsers et al., ""Fatty Acid-Binding Proteins as Plasma Markers of Tissue Injury,"" Clinica Chimica Acta, vol. 352, pp. 15-35, 2005.;;Iurisci et al., ""Concentrations of Galectin-3 in the Sera of Normal Controls and Cancer Patients,"" Clinical Cancer Research, vol. 6, pp. 1389-1393, Apr. 2000.;;Jan. 3, 2012 Office Action issued in U.S. Appl. No. 12/452,035.;;Feb. 12, 2009 International Search Report Issued in International Application No. PCT/FR2008/051294.;;Nov. 25, 2009 International Search Report Issued in International Application No. PCT/FR2009/051361 (w/ translation).;;Aug. 1, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,034.;;Oct. 27, 2011 Office Action issued in U.S. Appl. No. 12/452,034.;;Jan. 9, 2012 Office Action issued in U.S. Appl. No. 12/452,047.;;Feb. 3, 2012 Office Action issued in U.S. Appl. No. 12/452,048.;;Feb. 1, 2012 Office Action issued in U.S. Appl. No. 12/452,037.;;Bruce et al., ""Cancer-Wide Tissue Microarray Survey of Ezrin and Merlin Expression,""Proc Amer Assoc Cancer Res, vol. 46, Abstract #424, 2005.;;Gould et al., ""cDNA Cloning and Sequencing of the Protein-Tyrosine Kinase Substrate, Ezrin, Reveals Homology to Band 4.1,"" The EMBO Journal, vol. 8, No. 13, pp. 4133-4142, 1989.;;Etzioni et al., ""The Case for Early Detection,"" Nature Review, vol. 3, Internet pp. 1-10, Apr. 2003.;;Mercer, ""Use of Multiple Markers to Enhance Clinical Utility,"" Immunol Ser., vol. 53, pp. 39-54, 1990.;;Otsuka et al. ""Differential Expression of L-Plastin Gene in Human Colorectal Cancer Progression and Metastasis,"" Biochemical and Biophysical Research Communications, vol. 289, No. 4, pp. 876-881, 2001.;;Shin et al., ""Global Profiling of the Cell Surface Proteome of Cancer Cells Uncovers an Abundance of Proteins with Chaperone Function,"" The Journal of Biological Chemistry, Feb. 28, 2003, pp. 7607-7616, vol. 278, No. 9, The American Society for Biochemistry and Molecular Biology, Inc., U.S.A.;;Tomonaga et al., ""Identification of Altered Protein Expression and Post-Translational Modifications in Primary Colorectal Cancer by Using Agarose Two-Dimensional Gel Electrophoresis,"" Clinical Cancer Research, vol. 10, Mar. 15, 2004, pp. 2007-2014.;;Stierum et al., ""Proteome Analysis Reveals Novel Proteins Associated with Proliferation and Differentiation of Colorectal Cancer Cell Line Caco-2,"" Biochemica et Biophysica Acta, 2003, pp. 73-91, vol. 1650, No. 1-2.;;Kaetzel et al., ""Protein Disulphide-Isomerase from Human Placenta and Rat Liver-Purification and Immunological Characterization with Monoclonal Antibodies,"" Biochem. J., 1987, pp. 39-47, vol. 241, No. 1, Great Britain.;;Kozaki et al, ""Tissue Distribution of ERp61 and Association of Its Increased Expression with IgG Production in Hybridoma Cells,"" Experimental Cell Research, 1994, pp. 348-358, vol. 213, No. 2, Academic Press, Inc.;;Leys et al., ""Expression and Prognostic Significance of Prothymosin-alpha and ERp57 in Human Gastric Cancer,"" Surgery, 2007, pp. 41-50, vol. 141, No. 1, Mosby Co., St. Louis, MO, U.S.A.;;Sass et al., ""Mutations in ACY1, the Gene Encoding Aminoacylase 1, Cause a Novel Inborn Error of Metabolism"", The American Journal of Human Genetics, Mar. 2006, vol. 78, pp. 401-409.;;Tockman et al., ""Considerations in Bringing a Cancer Biomarker to Clinical Application"", Cancer Research, May 1, 1992, vol. 52, pp. 2711s-2718s.;;Freeman et al., ""APO-AII is an Elevated Biomarker of Chronic Non-Human Primate Ethanol Self-Administration"", Alcohol & Alcoholism, Mar. 2006, vol. 41, No. 3, pp. 300-305.;;Elsevier Publishing, ""Human PDIA1 Tryptic Peptide-SEQ ID 33,"" Retrieved from EBI Accession No. GSP:ASS06881, Database Accession No. ASS06881, 2008."
55,US,B2,US 8445211 B2,066-566-380-772-35X,2013-05-21,2013,US 45204208 A,2008-07-10,FR 0705198 A 20070719,I-plastin Assay Method For The In Vitro Diagnosis Of Colorectal Cancer,ARPIN MONIQUE;;BATTAIL-POIROT NICOLE;;BEAULIEU CORINNE;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;BIOMERIEUX SA;;CENTRE NAT RECH SCIENT;;INST CURIE,ARPIN MONIQUE;;BATTAIL-POIROT NICOLE;;BEAULIEU CORINNE;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE,https://lens.org/066-566-380-772-35X,Granted Patent,yes,1,16,16,41,G01N33/57419;;G01N33/57488,G01N33/53,435/7.1;;530/350;;530/387.7;;530/388.1;;530/388.8;;435/7.23;;436/64,10389686;;10462524;;10518104;;10778968;;11410510;;11722587;;11735128;;11745181;;11746103;;11747453;;12379327;;12493773;;12562854;;12922171;;1376927;;14500354;;14563446;;15041719;;15059925;;15065605;;15138477;;15313933;;1563002;;15653098;;15970581;;16011914;;16330944;;16465618;;16570345;;16581821;;16644871;;16952549;;1699834;;17101318;;17512720;;2100569;;2429934;;2542383;;2591371;;2824476;;2872262;;3566712;;3838309;;4953873;;6426610;;7682766;;8050492;;8123491;;8139549;;8394326;;8416983;;8428952;;15960882;;8068563;;8687142;;11565796;;240519;;1175300;;1572080;;10417322;;8295527;;16951234;;12661896;;15644144;;12193204;;6582896;;17188166;;19118499,10.1002/IJC.2910380508;;10.1006/BBRC.2001.6047;;10.1158/1078-0432.CCR-03-0321;;10.1136/BMJ.288.6429.1479;;10.1002/CYTO.1169;;10.1073/PNAS.89.12.5635;;10.1002/(SICI)1096-9098(199910)72:2<83::AID-JSO8>3.0.CO;2-C;;10.1023/B:CLIN.0000017204.38807.22;;10.1016/J.JCHROMB.2005.05.024;;10.1086/500563;;10.1084/JEM.122.3.467;;10.1016/J.EJCA.2007.03.021;;10.1158/0008-5472.CAN-04-0746;;10.1373/CLINCHEM.2006.069252;;10.1046/J.0014-2956.2001.02546.X;;10.1074/MCP.M500055-MCP200;;10.1016/S1570-9639(03)00204-8;;10.1194/JLR.D200034-JLR200;;10.1074/JBC.M210455200;;10.1515/CCLM.1986.24.3.161;;10.1016/J.CCCN.2004.09.001;;10.1021/BI0113925;;10.1006/EXCR.1994.1209;;10.1083/JCB.120.1.129;;10.1053/J.GASTRO.2006.08.034;;10.1093/CARCIN/BGH155;;10.1053/J.GASTRO.2006.06.006;;10.1016/S0009-9120(03)00096-1;;10.1016/S0022-1759(02)00332-0;;10.1016/0009-8981(75)90046-7;;10.1016/0009-8981(75)90047-9;;10.1002/1522-2683(200108)22:14<3019::aid-elps3019>3.0.co;2-t;;10.1002/(sici)1096-9098(199910)72:2<83::aid-jso8>3.3.co;2-3;;10.1002/1097-0142(20011115)92:10<2493::aid-cncr1599>3.0.co;2-f;;10.1016/0009-8981(92)90008-e;;10.1042/0264-6021:3410593;;10.1158/1078-0432.ccr-06-0274;;10.1034/j.1600-0463.2002.100601.x;;10.1016/j.surg.2006.05.009;;10.1093/alcalc/agl021;;10.1186/1471-2407-9-1,"Delanote et al. (Acta Pharmacol. Sin. Jul. 2005; 26 (7): 769-79).;;Hasselblatt et al. (Am. J. Surg. Pathol. Jan. 2006; 30 (1): 66-74).;;Lawrie et al. (Br. J. Cancer. 2004; 90: 1955-60).;;Lin et al. (Mol. Cell. Biol. Apr. 1994; 14 (4): 2457-67).;;Carroll et al. (Gastroenterology. Dec. 1990; 99 (6): 1727-35).;;Niederkofler et al., ""Novel Mass Spectrometric Immunoassays for the Rapid Structural Characterization of Plasma Apolipoproteins,"" Journal of Lipid Research, vol. 44, pp. 630-639, 2003.;;Hortin, ""The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Pepetidome,"" Clinical Chemistry, vol. 52, No. 7, pp. 1223-1237, 2006.;;Hachem, ""Serum Apolipoproteins A-I, A-II and B in Hepatic Metastases Comparison with other Liver Diseases: Hepatomas and Cirrhosis,"" J. Clin. Chem. Clin. Biochem., vol. 24, pp. 161-166, 1986.;;Remold-O'Donnell et al., ""Sequence and Molecular Characterization of Human Monocyte/Neutrophil Elastase Inhibitor,"" Proc. Natl. Acad. Sci., vol. 89, pp. 5635-5639, Jun. 1992.;;Cooley et al., ""The Serpin MNEI Inhibits Elastase-Like and Chymotrypsin-Like Serine Proteases through Efficient Reactions at Two Active Sites,"" Biochemistry, vol. 40, pp. 15762-15770, 2001.;;Algrain et al, ""Ezrin Contains Cytoskeleton and Membrane Binding Domains Accounting for its Proposed Role as a Membrane-Cytoskeletal Linker,"" The Journal of Cell Biology, vol. 120, No. 1, pp. 129-139, Jan. 1993.;;Jiang et al., ""Cytokine Regulation of Ezrin Expression in the Human Colon Cancer Cell Line HT29,"" Anticancer Research, vol. 16, pp. 861-866, 1996.;;Hiscox et al, ""Ezrin Regulates Cell-Cell and Cell-Matrix Adhesion, A Possible Role with E-Cadherin/beta-Catenin,"" Journal of Cell Science, vol. 112, pp. 3081-3090, 1999.;;Xiao et al., ""An Approach to Studying Lung Cancer-Related Proteins in Human Blood,"" Molecular & Cellular Proteomics, vol. 4, pp. 1480-1486, 2005.;;Anders et al., ""Aminoacyclases,"" Advances in Pharmacology, vol. 27, pp. 431-448, 1994.;;Lorentz et al., ""A New Method for the Assay of Aminoacylase: Elaboration of a Fixed-Incubation Method for Routine Measurements,"" Clinica Chimica, Acta, vol. 63, pp. 263-269, 1975.;;Lorentz et al, ""Clinical Application of a New Method for the Determination of Aminoacylase in Human Serum,"" Clinica Chimica Acta, vol. 63, pp. 271-274, 1975.;;Cook et al, ""Human Aminoacylase-1,"" The Journal of Biological Chemistry, vol. 268, No. 23, pp. 17010-17017, 1993.;;Miller et al., ""Lack of Expression of Aminoacylae-1 in Small Cell Lung Cancer,"" The Journal of Clinical Investigation, Inc., vol. 83, pp. 2120-2124, Jun. 1989.;;Balabanov et al., ""Tumour-Related Enzyme Alterations in the Clear Cell Type of Human Renal Cell Carcinoma Identified by Two-dimensional Gel Electrophoresis,"" Eur. J. Biochem., vol. 268, pp. 5977-5980, 2001.;;Chan et al, ""Human Liver Fatty Acid Binding Protein eDNA and Amino Acid Sequence,"" The Journal of Biological Chemistry, vol. 260, No. 5, pp. 2629-2632, 1985.;;Das et al., ""Expression Pattern of Fatty Acid-Binding Proteins in Human Normal and Cancer Prostate Cells and Tissues,"" Clinical Cancer Research, vol. 7, 1706-1715, Jun. 2001.;;Stulik et al., ""Proteome Study of Colorectal Carcinogenesis,"" Electrophoresis, vol. 22, pp. 3019-3025, 2001.;;Yamazaki et al., ""Liver Fatty Acid-Binding Protein is a New Prognostic Factor for Hepatic Resection of Colorectal Cancer Metastases,"" Journal of Surgical Oncology, vol. 72, pp. 83-87, 1999.;;Sweetser et al., ""The Human and Rodent Intestinal Fatty Acid Binding Protein Genes,"" The Journal of Biological Chemistry, vol. 262, No. 33, pp. 16060-16071, 1987.;;Pelsers et al, ""Intestinal-Type and Liver-Type Fatty Acid-Binding Protein in the Intestine. Tissue Distribution and Clinical Utility"", Clinical Biochemistry, vol. 36, pp. 529-535, 2003.;;Xiao et al, ""Dietary Exposure to Soy or Whey Proteins Alters Colonic Global Gene Expression Profiles During Rat Colon Tumorigenesis,"" Molecular Cancer, vol. 4, No. 1, pp. 1-17, Jan. 11, 2005.;;Engwegen et al., ""Identification of Serum Proteins Discriminating Colorectal Cancer Patients and Healthy Controls Using Surface-Enhanced Laser Desorption Ionisation-Time of Flight Mass Spectrometry,"" World J. Gastrenterol, vol. 12, No. 10, pp. 1536-1544, Mar. 14, 2006.;;Zhang et al., ""Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer,"" Cancer Research, vol. 64, pp. 5882-5890, Aug. 15, 2004.;;Lin et al., ""Human Plastin Genes,"" The Journal of Biological Chemistry, vol. 268, No. 4, pp. 2781-2792, 1993.;;Lavabre-Bertrand et al., ""Plasma Proteasome Level is a Potential Marker in Patients with Solid Tumors and Hemopoietic Malignancies,"" Cancer, vol. 92, No. 10, pp. 2493-2500, Nov. 15, 2001.;;Schwartz, ""Enzymes as Prognostic Markers and Therapeutic Indicators in Patients with Cancer,"" Clinica Chimica Acta, vol. 206, pp. 77-82, 1992.;;McCool et al., ""Roles of Calreticulin and Calnexin During Mucin Synthesis in LS180 and HT29/A1 Human Colonic Adenocarcinoma Cells,"" Biochem. J., vol. 341, pp. 593-600, 1999.;;Motoo et al., ""Serum Levels of Pancreatitis-Associated Protein in Digestive Diseases with Special Reference to Gastrointestinal Cancer,"" Digestive Diseases and Sciences, vol. 44, No. 6, pp. 1142-1147, Jun. 1999.;;Abe et al., ""Preparation of Recombinant MK-1/EP-CAM and Establishment of an ELISA System for Determining Soluble MK-1/EP-CAM Levels in Sera of Cancer Patients,"" Journal of Immunological Methods, vol. 270, pp. 227-233, 2002.;;Katayama et al., ""Soluble E-Cadherin Fragments Increased in Circulation of Cancer Patients,"" Br. J. Cancer, vol. 69, pp. 580-585, 1994.;;Wilmanns et al., ""Soluble Serum E-Cadherin as a Marker of Tumour Progression in Colorectal Cancer Patients,"" Clinical & Experimental Metastasis, vol. 21, pp. 75-78, 2004.;;Gold et al., ""Specific Carcinoembryonic Antigens of the Human Digestive System,"" J. Exp. Med., pp. 467-481, 1965.;;Kim et al., ""Gastrointestinal Tract Cancer Screening Using Fecal Carcinoembryonic Antigen,"" Annals of Clinical & Laboratory Science, vol. 33, No. 1, pp. 32-38, 2003.;;Holmgren et al., ""Detection by Monoclonal Antibody of Carbohydrate Antigen CA 50 in Serum of Patients with Carcinoma,"" British Medical Journal, vol. 288, pp. 1479-1482, May 19, 1984.;;Klug et al., Monoclonal Anitbody Immunoradiometric Assay for an Antigenic Determinant (CA 72) on a Novel Pancarcinoma Antigen (TAG-72), Int. J. Cancer, vol. 38, pp. 661-669, 1986.;;Holland et al., ""Testosterona Serica: Posible Marcador En El Cancer Colorrectal,"" Medicina (Buenos Aires), vol. 53, pp. 117-123, 1993.;;Model et al., Detection of Methylated DNA in Plasma from Colorectal Cancer Patients and Controls by Real-Time PCR Analysis of Septin 9, World Congress on Gastrointestinal Cancer, Jul. 2006.;;Ebert et al., ""Aristaless-like Homeobox-4 Gene Methylation is a Potential Marker for Colorectal Adenocarcinomas,"" Gastroenterology, vol. 131, pp. 1418-1430, 2006.;;Bianco et al., ""Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon Cancer,"" Clin. Cancer Res., vol. 12, No. 17, pp. 5158-5164, Sep. 1, 2006.;;Mori et al., ""Two-Dimensional Electrophoresis Database of Fluorescence-Labeled Proteins of Colon Cancer Cells,"" Journal of Chromatography B, vol. 823, pp. 82-97, 2005.;;Duffy et al., ""Tumour Markers in Colorectal Cancer: European Group on Tumour Markers (EGTM) Guidelines for Clinical Use,"" European Journal of Cancer, vol. 43, pp. 1348-1360, 2007.;;Rouzier et al., ""Immunocytochemical Detection of Bone Marrow Micrometastases in Colorectal Carcinoma Patients, Using a Monoclonal Antibody to Villin,"" Cytometry (Communication in Clinical Cytometry), vol. 46, pp. 281-289, 2001.;;Nishizuka et al., ""Diagnostic Markers that Distinguish Colon and Ovarian Adenocarcinomas: Identification by Genomic, Proteomic, and Tissue Array Profiling,"" Cancer Research, vol. 63, pp. 5243-5250, Sep. 1, 2003.;;Wang et al., Proteomic Dissection of the Molecular Mechanisms Underlying Hepatic Metastasis in Colorectal Cancer, XP009093529, Database Accession No. PREV200600505326, AGA Abstracts, p. A-676, W1533, Apr. 2006.;;Mori et al., A Genome-Wide Search Identifies Epigenetic Silencing of Somatostatin, Tachykinin-1, and 5 other Genes in Colon Cancer, Gastroenterology, vol. 131, pp. 797-808, 2006.;;Database WPI Week 200777, Thomson Scientific, London, GB; AN 2007-817830, XP002464797 & CN 1 967 246 (Proteome Analysis Research Center) May 23, 2007, Abstract.;;Fujiwara et al., Global Gene Expression Analysis of Rat Colon Cancers Induced by a Food-Borne Carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, Carcinogenesis, vol. 25, No. 8, pp. 1495-1505, 2004.;;Dorudi et al., ""E-Cadherin Expression in Colorectal Cancer,"" American Journal of Pathology, vol. 142, No. 4, pp. 981-986, Apr. 1993.;;Lawrie et al., ""Liver Fatty Acid Binding Protein Expression in Colorectal Neoplasia,"" British Journal of Cancer, vol. 90, pp. 1955-1960, 2004.;;U.S. Appl. No. 12/452,035, filed Dec. 14, 2009, in the name of Corinne Beaulieu et al.;;U.S. Appl. No. 12/452,038, filed Dec. 14, 2009, in the name of Monique Arpin et al.;;U.S. Appl. No. 12/452,037, filed Dec. 14, 2009, in the name of Yasemin Ataman-Onal et al.;;U.S. Appl. No. 12/452,048, filed Dec. 14, 2009, in the name of Jean-Philippe Charrier et al.;;U.S. Appl. No. 12/452,034, filed Dec. 14, 2009, in the name of Yasemin Ataman-Onal et al.;;U.S. Appl. No. 12/452,047, filed Dec. 14, 2009, in the name of Yasemin Ataman-Onal et al.;;Oct. 31, 2011Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,035.;;May 13, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,038.;;Sep. 1, 2011 Office Action issued in U.S. Appl. No. 12/452,038.;;Nov. 16, 2011 Election of Species Requirement issued in U.S. Appl. No. 12/452,037.;;Aug. 1, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,034.;;Oct. 27, 2011 Office Action issued in U.S. Appl. No. 12/452,034.;;Oct. 28, 2011 Restriction Requirement issued in U.S. Appl. No. 12/452,047.;;Score sequence search result #1, Geneseq Database, ""20110423-191537-us-12-452-038-2.rag"" Apr. 23, 2011.;;Bruce et al., ""Cancer-Wide Tissue Microarray Survey of Ezrin and Merlin Expression,""Proc Amer Assoc Cancer Res, vol. 46, Abstract #424, 2005.;;Gould et al., ""cDNA Cloning and Sequencing of the Protein-Tyrosine Kinase Substrate, Ezrin, Reveals Homology to Band 4.1,"" The EMBO Journal, vol. 8, No. 13, pp. 4133-4142, 1989.;;Etzioni et al., ""The Case for Early Detection,"" Nature Review, vol. 3, Internet pp. 1-10, Apr. 2003.;;Mercer, ""Use of Multiple Markers to Enhance Clinical Utility,"" Immunol Ser., vol. 53, pp. 39-54, 1990.;;Kayser et al., ""Primary Colorectal Carcinomas and their Intrapulmonary Metastases: Clinical, Glyco-, Immuno- and Lectin Histochemical, Nuclear and Syntactic Structure Analysis with Emphasis on Correlation with Period of Occurrence of Metastases and Survival,"" APMIS, vol. 110, pp. 435-446, 2002.;;Kuusela et al., ""Comparison of CA 19-9 and Carcinoembryonic Antigen (CEA) Levels in the Serum of Patients with Colorectal Diseases,"" Br. J. Cancer, vol. 49, pp. 135-139, 1984.;;Pelsers et al., ""Fatty Acid-Binding Proteins as Plasma Markers of Tissue Injury,"" Clinica Chimica Acta, vol. 352, pp. 15-35, 2005.;;Iurisci et al., ""Concentrations of Galectin-3 in the Sera of Normal Controls and Cancer Patients,"" Clinical Cancer Research, vol. 6, pp. 1389-1393, Apr. 2000.;;Jan. 3, 2012 Office Action issued in U.S. Appl. No. 12/452,035.;;Jan. 9, 2012 Office Action issued in U.S. Appl. No. 12/452,047.;;Feb. 3, 2012 Office Action issued in U.S. Appl. No. 12/452,048.;;Feb. 1, 2012 Office Action issued in U.S. Appl. No. 12/452,037.;;Otsuka et al. ""Differential Expression of L-Plastin Gene in Human Colorectal Cancer Progression and Metastasis,"" Biochemical and Biophysical Research Communications, vol. 289, No. 4, pp. 876-881, 2001.;;Shin et al.; ""Global Profiling of the Cell Surface Proteome of Cancer Cells Uncovers an Abundance of Proteins with Chaperone Function;"" The Journal of Biological Chemistry; Feb. 28, 2003; pp. 7607-7616; vol. 278, No. 9; The American Society for Biochemistry and Molecular Biology, Inc.; U.S.A.;;Tomonaga et al.; ""Identification of Altered Protein Expression and Post-Translational Modifications in Primary Colorectal Cancer by Using Agarose Two-Dimensional Gel Electrophoresis;"" Clinical Cancer Research; vol. 10, Mar. 15, 2004; pp. 2007-2014.;;Stierum et al.; ""Proteome Analysis Reveals Novel Proteins Associated with Proliferation and Differentiation of Colorectal Cancer Cell Line Caco-2;"" Biochemica et Biophysica Acta; 2003; pp. 73-91; vol. 1650, No. 1-2.;;Kaetzel et al.; ""Protein Disulphide-isomerase from Human Placenta and Rat Liver-Purification and Immunological Characterization with Monoclonal Antibodies;"" Biochem. J.; 1987; pp. 39-47; vol. 241, No. 1; Great Britain.;;Kozaki et al.; ""Tissue Distribution of ERp61 and Association of Its Increased Expression with IgG Production in Hybridoma Cells;"" Experimental Cell Research; 1994; pp. 348-358; vol. 213, No. 2; Academic Press, Inc.;;Leys et al.; ""Expression and Prognostic Significance of Prothymosin-alpha and ERp57 in Human Gastric Cancer;"" Surgery; 2007; pp. 41-50; vol. 141, No. 1; Mosby Co.; St. Louis, MO, U.S.A.;;Sass et al., ""Mutations in ACY1, the Gene Encoding Aminoacylase 1, Cause a Novel Inborn Error of Metabolism"", The American Journal of Human Genetics, Mar. 2006, vol. 78, pp. 401-409.;;Tockman et al., ""Considerations in Bringing a Cancer Biomarker to Clinical Application"", Cancer Research, May 1, 1992, vol. 52, pp. 2711s-2718s.;;Freeman et al., ""APO-AII is an Elevated Biomarker of Chronic Non-Human Primate Ethanol Self-Administration"", Alcohol & Alcoholism, Mar. 2006, vol. 41, No. 3, pp. 300-305.;;Elsevier Publishing, ""Human PDIA1 Tryptic Peptide-SEQ ID 33;"" Retrieved from EBI Accession No. GSP:ASS06881; Database Accession No. ASS06881, 2008.;;Aug. 3, 2012 Office Action issued in U.S. Appl. No. 12/452,037.;;Jul. 24, 2012 Restriction Requirement issued in U.S. Appl. No. 12/999,242.;;Jul. 31, 2012 Office Action issued in U.S. Appl. No. 12/452,048.;;Apr. 17, 2012 Office Action issued in U.S. Appl. No. 12/452,038.;;May 18, 2012 Office Action issued in U.S. Appl. No. 12/452,034.;;Jun. 18, 2012 Office Action issued in U.S. Appl. No. 12/452,047.;;Davies et al., ""Loss of Cellular Distribution of Ezrin in Human Colon Cancer"", ASCO 2006, Gastrointestinal Cancers Symposium, 2006 Abstract 322.;;Mahipal et al., ""Epidermal Growth Factor Receptor Overexpression in Resected Pancreatic Cancer"", J Clinical Oncology, 2011, 29: suppl 4; Abstract 317.;;Brattstrom et al., ""HER-2 overexpression in patients with esophageal carcinoma correlates with poorer survival"", ASCO 2005 Gastrointestinal Cancers Symposium, 2005, Abstract 63.;;Kavanagh et al., ""Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?"" BMC Cancer, Jan. 1, 2009, 9:1-6.;;Office Action issued Jun. 21, 2012 in U.S. Appl. No. 12/452,035.;;Dec. 28, 2012 Office Action issued in U.S. Appl. No. 12/452,037."
56,US,A,US 5747659 A,089-900-799-044-04X,1998-05-05,1998,US 48049395 A,1995-06-07,US 48163395 A 19950607,"Fusion Gene Products Encoding Avian Alpha Subunit Inhibin Protein, Or An Immunogenic Fragment Thereof, And A Carrier Protein",AGRITECH TECHNOLOGIES LTD;;UNIV LOUISIANA STATE,FIORETTI WILLIAM C;;KOUSOULAS KONSTANTIN;;SATTERLEE DANIEL G,https://lens.org/089-900-799-044-04X,Granted Patent,yes,10,16,45,4,C12N15/8509;;A01K2217/05;;A01K2227/30;;A01K2267/02;;A61K38/00;;A61K39/00;;A61K39/0005;;A61K2039/6068;;C07K14/575;;C07K2319/00,A01K67/00;;A01K67/02;;A61K31/00;;A61K38/00;;A61K38/22;;A61K39/00;;A61P15/00;;C07K14/465;;C07K14/575;;C07K19/00;;C12N1/21;;C12N15/09;;C12N15/85;;C12P21/02,536/23.4;;536/23.51;;435/69.7;;435/69.4;;435/172.3;;435/252.3;;435/320.1;;435/325,1320308;;1500838;;1518004;;1625233;;16726904;;1707868;;2115710;;2315699;;2752983;;3082696;;3127517;;3133192;;3136065;;3148911;;3458167;;3655607;;7542343;;7990647;;8286568;;8399835;;8405890;;8418903;;8439615;;8464014;;8464018;;8502617;;8504921,10.1095/BIOLREPROD49.5.1026;;10.1530/JRF.0.1030285;;10.1210/ENDO-123-1-120;;10.3382/PS.0671625;;10.1095/BIOLREPROD48.2.262;;10.1677/JOE.0.1160293;;10.1016/0093-691X(91)90284-K;;10.1095/BIOLREPROD49.3.453;;10.1677/JOE.0.1340011;;10.3382/PS.0720955;;10.1016/0303-7207(86)90133-4;;10.1006/GCEN.1993.1058;;10.1006/GCEN.1993.1103;;10.1126/SCIENCE.2315699;;10.1677/JOE.0.114R001;;10.1530/JRF.0.0970213;;10.1530/JRF.0.0970255;;10.1073/PNAS.83.10.3091;;10.1159/000180934;;10.1210/ENDO-125-2-898;;10.1095/BIOLREPROD48.1.15;;10.1016/0024-3205(94)00519-2;;10.1016/0264-410X(92)90356-O;;10.1530/JRF.0.0950489;;10.1530/JRF.0.0950175,"Synthetic Peptide Segments of Inhibin and Subunits: Preparation and Characterization of Polyclonal Antibodies , Saito et al., Endocrinology , 1989, vol. 125, No.2, pp. 898 905.;;Murdoch, W.J., Immunoregulation of mammalian fertility, Life Sci. , vol. 55 (24), pp. 1871 1886 (1994).;;Forage, R.G. et al., Immunization against an inhibin subunit produced by recombinant DNA techniques results in increased ovulation rate in sheep, J. Endocrinol. , vol. 114(2), p. R1 4 (Aug. 1987).;;Morris, D.G. et al., Effect of immunization against synthetic peptide sequences of the alpha N subunit of bovine inhibin on ovulation rate, gonadotrophin concentrations and fertility in heifers, J. Reprod. Fertil. , vol. 103 (2), pp. 285 291 (Mar. 1995).;;Bowie et al. 1990. Science 247:1306 1310.;;Wang et al. 1993. Biol. Reprod. 49:453 458.;;Forage et al. 1986. PNAS USA 83:3091 3095.;;Forage et al. 1987. J. Endocrinol. 114:R1 R4.;;Johnson et al. 1993. Gen. and Compar. Endocrinol. 90:43 50.;;Fraser et al., Does inhibin have an endocrine role during the luteal phase of the primate menstrual cycle , Journal of Reproduction and Fertility , No. 11, Abstract No. 78 (Jul. 1993).;;Webley et al., Inverse relationship between progesterone and inhibin subunit production by marmoset luteal cells in vitro , Journal of Reproduction and Fertility , No. 11, Abstract No. 155 (Jul. 1993).;;Morris et al., Effect of immunization against bovine inhibin peptides on FSH and LH in heifers , Journal of Reproduction and Fertility , No. 11, Abstract No. 156 (Jul. 1993).;;Rivier et al., Studies of the Inhibin Family of Hormones: A Review , Hormone Res. , vol. 28, pp. 104 118 (1987).;;Akashiba et al., Secretion of Inhibin by Chicken Granulosa Cells in Vitro , Poultry Science , vol. 67, pp. 1625 1631 (1988).;;Findlay, An Update on the Roles of Inhibin, Activin, and Follistatin as Local Regulators of Folliculogenesis , Biology of Reproduction , vol. 48, pp. 15 23 (1993).;;Johnson et al., The molecular biology and endocrinology of inhibin in the domestic hen , Journal of Endocrinology , pp. 297 308, (1993).;;Johnson et al., Characterization of a Source and Levels of Plasma Immunoreactive Inhibin during the Ovulatory Cycle of the Domestic Hen , Biology of Reproduction , vol. 48, pp. 262 267 (1993).;;Johnson et al., Characterization and Quantitation of mRNA for the Inhibin Subunit in the Granulosa Layer of the Domestic Hen , General and Comparative Endocrinology , vol. 90, pp. 43 50 (1993).;;Johnson et al., Plasma Concentrations of Immunoeractive Inhibin and Gonadotropins following Removal of Ovarian Follicles in the Domestic Hen , Biology of Reproduction , vol. 49, pp. 1 6 (1993).;;McNatty et al., Contrations of immunoreactive inhibin in ovarian and peripheral venous plasma and follicular fluid of Booroola ewes that are homozygous carriers or non carriers of the Fec B gene , J. Reprod. Fert. , vol. 95, pp. 489 502 (1992).;;Rivier et al., Age Dependent Changes in Physiological Action, Content, and Immunostaining of Inhibin in Male Rates , Endocrinology , vol. 123, pp. 120 126 (1988).;;Robertson et al., Isolation of a 31 kDa form of inhibin from bovine follicular fluid , Molecular and Cellular Endocrinology , vol. 44, pp. 271 277 (1986).;;Scanlong et al., et al., Active immunization of heifers against a synthetic fragment of bovinc inhibin , Journal of Reproduction and Fertility , vol. 97, pp. 213 222 (1993).;;Tsonis et al., Inhibin bioactivity and pituitary cell mitogenic activity from cultured chicken ovarian granulosea and thecal/stromal cells , Journal of Endocrinology , vol. 116, pp. 293 299 (1988).;;Glencross et al., Effect of active immunization of heifers against inhibin on plasma FSH concentrations, ovarian follicular development and ovulation , Journal of Endocrinology , vol. 135, pp. 11 18 (1992).;;Johnson, Inhibin in the Hen , Poultry Sciences , vol. 72, pp. 955 958 (1993).;;Meyer et al., Antiserum to an inhibin alpha chain peptide neutralizes inhibin bioactivity and increases ovulation rate in sheep , J. Anim. Science , vol. 69, pp. 747 754 (1991).;;Morris et al., Effect of immunizing prepuberal lambs of low and high ovulation rate genotypes with inhibin partially purified from bovine follicular fluid , Theriogeneology , vol. 35, No. 2, pp. 339 350 (Feb. 1991).;;Morris et al., Effect of immunization against synthetic peptide sequences of bovine inhibin subunit on ovulation rate and twin calving rate in heifers , Journal of Reproduction and Fertility , vol. 97, pp. 255 261 (1993).;;Risridger et al., Current perspectives of inhibin biology , Acta Endocrinologica (Copenh) , vol. 122 pp. 673 682 (1990).;;Wang et al., Increase in Ovarian Inhibin Gene Expression and Plasma Immunoeractive Inhibin Level Is Correlated with a Decrease in Ovulation Rate in the Domestic Hen , General and Comparative Endocrinology , vol. 91, pp. 52 58 (1993).;;Wang et al., Complementary Deoxyribonucleic Acid Cloning and Sequence Analysis of the Subunit of Inhibin from Chicken Ovarian Granulosa Cells , Biology of Reproduction , vol. 49, pp. 1 6 (1993).;;Wrathall et al., Effects of active immunization against a synthetic peptide sequence of the inhibin subunit on plasma gonadotrophin concentrations, ovulation rate and lambing rate in ewes , J. Reprod. Fert. , vol. 95, pp. 175 182 (1992).;;North et al., Flock Recycling , Commercial Chicken Production Manual , Van Nostrand Reinhold, New york, pp. 431 439 (date unknown).;;Chinnah et al., Antigen dependent adjuncant activity of a polydispersed (1 4) linked acetylated mannan (acemannan), vaccine , vol. 10 (8), pp. 551 557 (1992).;;Chouljenko et al., Expression and Purification of Chicken and Inhibition as a Fusion Protein with the E.coli Maltose Binding Protein, Poultry Science , vol. 73 (Supp. 1), p. 84 (1994)."
57,US,A,US 6124115 A,046-375-875-707-325,2000-09-26,2000,US 53289695 A,1995-09-22,US 53289695 A 19950922,Production And Use Of Isolated Type 5 17 Beta -hydroxysteroid Dehydrogenase,ENDORECHERCHE INC,LABRIE FERNAND;;LUU-THE VAN,https://lens.org/046-375-875-707-325,Granted Patent,yes,1,11,11,51,C12N9/0006,C12N15/09;;C12N5/10;;C12N9/04;;C12N15/12,435/69.1;;435/320.1;;435/325;;536/23.2,1314081;;1327779;;1741954;;2243100;;2483219;;271968;;2779584;;2846351;;7626483;;7737980;;7961757;;8075637;;8099587;;8274401;;8547185,10.1089/DNA.1991.10.701;;10.1016/0022-4731(89)90082-4;;10.1038/NG0594-34;;10.1016/0960-0760(93)90308-J;;10.1016/0960-0760(95)00039-3;;10.1073/PNAS.74.12.5463;;10.1016/0960-0760(92)90391-U;;10.1074/JBC.270.18.10461;;10.1111/J.1432-1033.1992.TB17310.X;;10.1016/0960-0760(95)00209-X;;10.1210/MEND-3-8-1301;;10.1016/0014-5793(88)80548-9,"Luu The, V. et al., Mol. Endocrinol. , 3:1301 1309 (1989).;;Peltoketo, H. et al., FEBS Lett , 239:73 77 (1988).;;Wu, L. et al., J. Biol Chem , 268:12964 12969 (1993).;;Geissler, WM, Nature Genetics , 7:34 39 (1994).;;H e l e ne et al., Biochimica et Biophysica Acta , 1049:99 125 (1990).;;Maniatis in Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Press 1982); pp. 1.21 1.41.;;Sanger F. et al., Proc. Natl. Acad. Sci. , 74:5463 5467 (1977).;;Kingston, R.E., In: Current Protocols in Molecular Biology, Ausubel et al. eds., pp. 9.1.1 9.1.9, John Wiley & Sons, N.Y. (1987).;;Lachance et al., J. Biol. Chem. , 265:20469 20475 (1990).;;Lachance et al., DNA and Cell Biol. 10:701 711 (1991).;;Bernier et al., J. Biol. Chem , 269, 28200 28205, (1994).;;Deyashiki, et al. J. Biol. Chem , 270, 10461 10467, (1995).;;Zhang, et al., Clinical and Investigative Medicine , 18(4):b40 XP000196659 (1995).;;Miyajima, EMBL Sequence Data , Human m RNA (HA1753), Abs. XP002020808 (1993).;;Qin, et al., J. Steroid Biochem. and Molecular Biology , 46:673 679 (1993).;;Luu The, et al., J. Steroid Biochem. and Molecular Biology , 55(5 6):581 587 (1995).;;Labrie, et al., J. Steroid Biochem. , 34(1 6):189 197 (1989).;;Dumont, et al., J. Steroid Biochem. and Molecular Biology , 41(3 8):605 608 (1992).;;Peltoketo, et al., European Journal of Biochemistry , 209(1):459 466 (1992).;;Andersson, et al., J. Steroid Biochem. and Molecular Biology , 53(1 6):37 39 (1995).;;Rothenberg, et al., J. National Cancer Institute , 81(20):39 44 (1989).;;Ciaccio, et al., EMBL Sequence Database , Human dihydrodiol dehydrogenase gene, 5 flanking region, Abs. XP002020809 (1996)."
58,US,A,US 5726058 A,162-026-823-388-684,1998-03-10,1998,US 47221795 A,1995-06-07,US 47221795 A 19950607;;US 20618694 A 19940307;;US 98842792 A 19921201,"Dna Molecules, Vectors And Host Cells Comprising A Syndecan Enhancer Element And A Syndecan Suppressor Element",JALKANEN; MARKKU;;ALANEN-KURKI; LEENA;;AUVINEN; PETRI;;JAAKKOLA; PANU;;LEPPAE; SIRPA;;MALI; MARKKU;;VIHINEN; TAPANI;;WAERRI; ANNI,JALKANEN MARKKU;;ALANEN-KURKI LEENA;;AUVINEN PETRI;;JAAKKOLA PANU;;LEPPAE SIRPA;;MALI MARKKU;;VIHINEN TAPANI;;WAERRI ANNI,https://lens.org/162-026-823-388-684,Granted Patent,yes,3,1,28,4,C07K14/705;;A61K31/135;;A61K38/1825;;A61K38/1841;;A61K2300/00,A61K31/135;;A61K38/18;;C07K14/705,435/354;;435/320.1;;536/24.1,1025365;;1369684;;1538586;;1556147;;1646484;;1698781;;1708391;;1726565;;1736308;;1750507;;1794464;;1847668;;1860887;;2001586;;2007184;;2144898;;2324102;;2469682;;2494194;;2519615;;2521461;;2663574;;2680421;;2824563;;2956468;;2963012;;2964452;;2998604;;3025223;;3144000;;3156852;;3159726;;3161889;;3161899;;3320062;;3417053;;3548769;;7192599;;7448765,10.1083/JCB.106.2.423;;10.1083/JCB.114.3.585;;10.1016/0092-8674(89)90902-1;;10.1083/JCB.103.6.2683;;10.1016/0092-8674(91)90308-L;;10.1073/PNAS.89.3.932;;10.1172/JCI113236;;10.1073/PNAS.87.18.6985;;10.1146/ANNUREV.CB.02.110186.000331;;10.1016/0012-1606(91)90290-J;;10.1016/0022-4731(76)90004-2;;10.1083/JCB.106.3.953;;10.1016/0012-1606(88)90401-0;;10.1126/SCIENCE.1646484;;10.1083/JCB.108.5.1945;;10.1016/0014-4827(92)90194-D;;10.1083/JCB.105.6.3087;;10.1083/JCB.108.4.1547;;10.1083/JCB.101.3.976;;10.1016/0092-8674(91)90512-W;;10.1073/PNAS.85.24.9562;;10.1016/0012-1606(89)90110-3,"Couchman, J., et al., Changes in Microfilament And Focal Adhesion Distribution with Loss of Androgen Responsiveness in Cultured Mammary Tumor Cells, Cancer Res. 41 :263 269 (1981).;;Ekblom, P., et al., Cell Matrix Interactions and Cell Adhesion During Development, Ann. Rev. Cell Biol. 2 :27 47 (1986).;;Elenius, K., et al., Binding of Human Syndecan to Extracellular Matrix Proteins, J. Biol. Chem. 265 ( 29 ):17837 17843 (1990).;;Elenius, K., et al., Growth Factors Induce 3T3 Cells to Express bFGF binding Syndecan, J. Biol. Chem. 267 ( 9 ):6435 6441 (Mar. 25, 1992).;;Elenius, K., et al., Induced Expression of Syndecan in Healing Wounds, J. Cell Biol. 114 ( 3 ):585 595 (Aug. 1991).;;Inki, P., et al., Immunohistochemical Localization of Syndecan in Mouse Skin Tumors Induced by UV Irradiation, Amer. J. Pathology 139 ( 6 ):1333 1340 (Dec. 1991).;;Inki, P., et al., Syndecan in Carcinomas Produced from Transformed Epithelial Cells in Nude Mice, Lab. Invest. 66 (3):314 323 (1992).;;Jalkanen, M., et al., Binding of Extracellular Effector Molecules by Cell Surface Proteoglycans, in: Receptors for Extracellular Matrix, McDonald and Mecham, eds., New York: Harcourt Brace Jovanovich Publishers, pp. 1 37 (Nov. 1991).;;Jalkanen, M., Biology of Cell Surface Heparan Sulfate Proteoglycans, Medical Biology 65 :41 47 (1987).;;Jalkanen, M., et al., Cell Surface Proteoglycan of Mouse Mammary Epithelial Cells Is Shed by Cleavage of Its Matrix binding Ectodomain from Its Membrane associated Domain, J. Cell Biol. 105 ( 6,Pt.2 ):3087 3096 (1987).;;Jalkanen, M., et al., Heparan Sulfate Proteoglycans from Mouse Mammary Epithelial Cells: Localization on the Cell Surface with a Monoclonal Antibody, J. Cell Biol. 101 :976 984 (1985).;;Jalkanen, M., et al., Loss of Syndecan Expression in Mouse Mammary Epithelial Cells After Transformation With A Point Mutated c Ha ras Proto Oncogene, J. Cell. Biochem. Suppl. 13F :52, Abstract D317, (1989).;;Jalkanen, M., et al., Mouse Mammary Epithelial Cells Produce Basement Membrane And Cell Surface Heparan Sulfate Proteoglycans Containing Distinct Core Proteins, J. Cell Biol. 106 :953 962 (1988).;;Jalkanen, M., et al., Simultaneous Loss of Syndecan Expression and Epithelial Phenotype in S115 Carcinoma Cells Exposed to Steroids, J. Cell Biochem. Suppl. 14F :153, Abstract A113 (1990).;;Jalkanen, M., et al., Stimulation of syndecan gene expression in mesenchymal cells by bFGF and TGF , J. Cell Biochem. Suppl.15F :223, Abstract CF115 (Oct. 1991).;;Jalkanen, M., et al., Syndecan, a regulator of cell behaviour, is lost in malignant transformation, Biochem. Soc. Transactions 19 :1069 1072 (Nov. 1991).;;Jalkanen, M., et al., Syndecan Expression Is Suppressed In Steroid Induced Transformation of Mouse Mammary Tumor Cell Line (S 115), J. Cell Biol. 109 :320a, Abstract No. 1758 (1989).;;Kiefer, M., et al., Ligand affinity cloning and structure of a cell surface heparan sulfate proteoglycan that binds basic fibroblast growth factor, Proc. Natl. Acad. Sci. USA 87 :6985 6989 (1990).;;King, R., et al., The Role of Receptors in the Steroidal Regulation of Tumour Cell Proliferation, J. Steroid Biochem. 7 :869 873 (1976).;;Koda, J., et al., Heparan Sulfate Proteoglycans from Mouse Mammary Epithelial Cells, J. Biol. Chem. 260 ( 13 ):8157 8162 (1985).;;Lepp a , S., et al. Steroid induced epithelial fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells, Cell Regulation 2 :1 11 (Jan. 1991).;;Lepp a , S., et al., Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells, Proc. Natl. Acad. Sci. USA 89 :932 936 (Feb. 1992).;;Liotta, L.A., Tumor Invasion and Metastases Role of the Extracellular Matrix: Rhoads Memorial Award Lecture, Cancer Res. 46 :1 7 (1986).;;Mali, M., et al., Sequence of Human Syndecan Indicates a Novel Gene Family of Integral Membrane Proteoglycans, J. Biol. Chem. 265 ( 12 ):6884 6889 (1990).;;Martindale, The Extra Pharmacopoeia, 29th Ed., Reynolds, J.E.F., Ed., London: The Pharmaceutical Press, pp. 650 651 and 16525 (1989).;;Plantefaber, L., et al., Changes in Integrin Receptors on Oncogenically Transformed Cells, Cell 56 :281 290 (1989).;;Rapraeger, A., et al., Requirement of Heparan Sulfate for bFGF Mediated Fibroblast Growth and Myoblast Differentiation, Science 252 :1705 1708 (Jun. 21, 1991).;;Rapraeger, A., et al., The Cell Surface Proteoglycan from Mouse Mammary Epithelial Cells Bears Chondroitin Sulfate and Heparan Sulfate Glycosaminoglycans, J. Biol. Chem. 260 ( 20 ):11046 11052 (1985).;;Rapraeger, A., et al., Cell Surface Proteoglycan of Mammary Epithelial Cells, J. Biol. Chem. 260 ( 7 ):4103 4109 (1985).;;Rapraeger, A., et al., Cell Surface Proteoglycan Associates with the Cytoskeleton at the Basolateral Cells Surface of Mouse Mammary Epithelial Cells, J. Cell Biol. 103 ( 6,pt.2 ):2683 2696 (1986).;;Ruoslahti, E., et al., Proteoglycans as Modulators of Growth Factor Activities, Cell 64 :867 869 (Mar. 8, 1991).;;Salmivirta, M., et al., Syndecan from Embryonic Tooth Mesenchyme Binds Tenascin, J. Biol. Chem. 266 ( 12 ):7733 7739 (Apr. 25, 1991).;;Salmivirta, M., et al., Neurite Growth Promoting Protein (Amphoterin, p30) Binds Syndecan, Exp. Cell Res. 200 :444 451 (1992).;;Sanderson, R., et al., B Lymphocytes express and lose syndecan at specific stages of differentiation, Cell Reg. 1 :27 35 (1989).;;Saunders, S., et al., Cell Surface Proteoglycan Binds Mouse Mammary Epithelial Cells to Fibronectin and Behaves as a Receptor for Interstitial Matrix, J. Cell Biol. 106 :423 430 (1988).;;Saunders, S., et al., Mammary Epithelial Cells Transfected with Antisense cDNA Reduce Cell Surface Syndecan and Become Fibroblastic in Morphology, J. Cell Biol. 109 :5a, Abstract No. 7 (1989).;;Saunders, S., et al., Molecular Cloning of Syndecan, an Integral Membrane Proteoglycan, J. Cell Biol. 108 :1547 1556 (1989).;;Sanderson, R., et al., Molecular polymorphism of a cell surface proteoglycan: Distinct structures on simple and stratified epithelia, Proc. Natl. Acad. Sci. USA 85 :9562 9566 (1988).;;Schweigerer, L., et al., Basic Fibroblast Growth Factor as a Growth Inhibitor for cultured Human Tumor Cells, J. Clin. Invest. 80 ( 5 ):1516 1520 (1987).;;Thesleff, I., et al., Cell Surface Proteoglycan Expression Correlates with Epithelial Mesenchymal Interaction during Tooth Morphogenesis, Developmental Biol. 129 :565 572 (1988).;;Vaahtokari, A., et al., Associations between transforming growth factor 1 RNA expression and epithelial mesenchymal interactions during tooth morphogenesis, Development 113 :985 994 (Nov. 1991).;;Vainio, S., et al., Epithelial Mesenchymal Interactions Regulate the Stage Specific Expression of a Cell Surface Proteoglycan, Syndecan, in the Developing Kidney, Developmental Biology 134 :382 391 (1989).;;Vainio, S., et al., Expression of Syndecan Gene is Induced Early, Is Transient, and Correlates with Changes in Mesenchymal Cell Proliferation during Tooth Organogenesis, Developmental Biology 147 :322 333 (Oct. 1991).;;Vainio, S., et al., Syndecan and Tenascin Expression Is Induced by Epithelial Mesenchymal Interactions in Embryonic Tooth Mesenchyme, J. Cell Biol. 108 :1945 1954 (1989).;;Wilkinson, D., et al., Expression pattern of the FGF related proto oncogene int 2 suggests multiple roles in fetal development, Development 105 :131 136 (1989).;;Yates, J., et al., Correlation of Growth Properties and Morphology with Hormone Responsiveness of Mammary Tumor Cells in Culture, Cancer Res. 41 :258 262 (1981).;;Yayon, A., et al., Cell Surface, Heparin like Molecules Are Required for Binding of Basic Fibroblast Growth Factor to Its High Affinity Receptor, Cell 64 :841 848 (Feb. 22, 1991)."
59,US,B2,US 8367362 B2,188-524-124-855-349,2013-02-05,2013,US 45204808 A,2008-07-10,FR 0705201 A 20070719,Aminoacylase 1 Assay Method For The In Vitro Diagnosis Of Colorectal Cancer,BIOMERIEUX SA;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;ROLLAND DOMINIQUE,CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;ROLLAND DOMINIQUE,https://lens.org/188-524-124-855-349,Granted Patent,yes,0,16,16,41,G01N33/57419;;G01N2333/98,C12Q1/34,435/18;;435/6;;435/14,10389686;;10462524;;10518104;;10778968;;11410510;;11722587;;11735128;;11745181;;11746103;;11747453;;12379327;;12493773;;12562854;;12922171;;1376927;;14500354;;14563446;;15041719;;15059925;;15138477;;15313933;;1563002;;15653098;;15970581;;16330944;;16465618;;16570345;;16581821;;16644871;;16952549;;1699834;;2100569;;2542383;;2591371;;2824476;;2872262;;3566712;;3838309;;7682766;;8050492;;8139549;;8394326;;8416983;;8428952;;15960882;;8068563;;8687142;;11565796;;240519;;1175300;;1572080;;10417322;;15644144;;12193204;;6582896;;17188166;;19118499,10.1006/BBRC.2001.6047;;10.1158/1078-0432.CCR-03-0321;;10.1128/MCB.14.4.2457;;10.1002/CYTO.1169;;10.1073/PNAS.89.12.5635;;10.1002/(SICI)1096-9098(199910)72:2<83::AID-JSO8>3.0.CO;2-C;;10.1158/0008-5472.CAN-04-0746;;10.1373/CLINCHEM.2006.069252;;10.1046/J.0014-2956.2001.02546.X;;10.1074/MCP.M500055-MCP200;;10.1016/S1570-9639(03)00204-8;;10.1194/JLR.D200034-JLR200;;10.1074/JBC.M210455200;;10.1016/J.CCCN.2004.09.001;;10.1021/BI0113925;;10.1006/EXCR.1994.1209;;10.1083/JCB.120.1.129;;10.1093/CARCIN/BGH155;;10.1053/J.GASTRO.2006.06.006;;10.1016/S0009-9120(03)00096-1;;10.1016/S0022-1759(02)00332-0;;10.1016/0009-8981(75)90046-7;;10.1016/0009-8981(75)90047-9;;10.1002/1522-2683(200108)22:14<3019::aid-elps3019>3.0.co;2-t;;10.1002/(sici)1096-9098(199910)72:2<83::aid-jso8>3.3.co;2-3;;10.1002/1097-0142(20011115)92:10<2493::aid-cncr1599>3.0.co;2-f;;10.1016/0009-8981(92)90008-e;;10.1042/0264-6021:3410593;;10.1111/j.1745-7254.2005.00145.x;;10.1034/j.1600-0463.2002.100601.x;;10.1016/j.surg.2006.05.009;;10.1093/alcalc/agl021;;10.1186/1471-2407-9-1,"Sass J. et al. Mutations in ACY1, the Gene Encoding Aminoacylase1 . . . The Anerican J of Human Genetics 78:401-409, Mar. 2006.;;Feb. 12, 2009 International Search Report Issued in International Application No. PCT/FR2008/051294.;;Nov. 25, 2009 International Search Report Issued in International Application No. PCT/FR2009/051361 (w/ translation).;;Jan. 9, 2012 Office Action issued in U.S. Appl. No. 12/452,047.;;Feb. 1, 2012 Office Action issued in U.S. Appl. No. 12/452,037.;;Otsuka et al. ""Differential Expression of L-Plastin Gene in Human Colorectal Cancer Progression and Metastasis,"" Biochemical and Biophysical Research Communications, vol. 289, No. 4, pp. 876-881, 2001.;;Shin et al., ""Global Profiling of the Cell Surface Proteome of Cancer Cells Uncovers an Abundance of Proteins with Chaperone Function,"" The Journal of Biological Chemistry, Feb. 28, 2003, pp. 7607-7616, vol. 278, No. 9, The American Society for Biochemistry and Molecular Biology, Inc., U.S.A.;;Tomonaga et al., ""Identification of Altered Protein Expression and Post-Translational Modifications in Primary Colorectal Cancer by Using Agarose Two-Dimensional Gel Electrophoresis,"" Clinical Cancer Research, vol. 10, Mar. 15, 2004, pp. 2007-2014.;;Stierum et al., ""Proteome Analysis Reveals Novel Proteins Associated with Proliferation and Differentiation of Colorectal Cancer Cell Line Caco-2,"" Biochemica et Biophysica Acta, 2003, pp. 73-91, vol. 1650, No. 1-2.;;Kaetzel et al., ""Protein Disulphide-Isomerase from Human Placenta and Rat Liver-Purification and Immunological Characterization with Monoclonal Antibodies,"" Biochem. J., 1987, pp. 39-47, vol. 241, No. 1, Great Britain.;;Kozaki et al., ""Tissue Distribution of ERp61 and Association of its Increased Expression with IgG Production in Hybridoma Cells,"" Experimental Cell Research, 1994, pp. 348-358, vol. 213, No. 2, Academic Press, Inc.;;Leys et al., ""Expression and Prognostic Significance of Prothymosin-alpha and ERp57 in Human Gastric Cancer,"" Surgery, 2007, pp. 41-50, vol. 141, No. 1, Mosby Co., St. Louis, MO, U.S.A.;;Tockman et al., ""Considerations in Bringing a Cancer Biomarker to Clinical Application,"" Cancer Research, May 1, 1992, vol. 52, pp. 2711s-2718s.;;Freeman et al., ""APO-AII is an Elevated Biomarker of Chronic Non-Human Primate Ethanol Self-Administration,"" Alcohol & Alcoholism, Mar. 2006, vol. 41, No. 3, pp. 300-305.;;Elsevier Publishing, ""Human PDIA1 Tryptic Peptide-SEQ ID 33,"" Retrieved from EBI Accession No. GSP:ASS06881, Database Accession No. ASS06881, 2008.;;Apr. 17, 2012 Office Action issued in U.S. Appl. No. 12/452,038.;;May 18, 2012 Office Action issued in U.S. Appl. No. 12/452,034.;;Jun. 12, 2012 Office Action issued in U.S. Appl. No. 12/452,042.;;Jun. 18, 2012 Office Action issued in U.S. Appl. No. 12/452,047.;;Davies et al., ""Loss of Cellular Distribution of Ezrin in Human Colon Cancer"", ASCO 2006, Gastrointestinal Cancers Symposium, 2006 Abstract 322.;;Mahipal et al., ""Epidermal Growth Factor Receptor Overexpression in Resected Pancreatic Cancer"", J Clinical Oncology, 2011, 29: suppl 4; Abstract 317.;;Brattstrom et al., ""HER-2 overexpression in patients with esophageal carcinoma correlates with poorer survival"", ASCO 2005 Gastrointestinal Cancers Symposium, 2005, Abstract 63.;;Kavanagh et al., ""Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?"" BMC Cancer, Jan. 1, 2009, 9:1-6.;;Restriction Requirement issued Jul. 24, 2012 in U.S. Appl. No. 12/999,242.;;Office Action issued Aug. 3, 2012 in U.S. Appl. No. 12/452,037.;;Mar. 27, 2009 International Search Report Issued in International Application No, PCT/FR2008/051290.;;Mar. 6, 2009 International Search Report Issued in International Application No. PCT/FR2008/051293.;;Mar. 5, 2009 International Search Report Issued in International Application No. PCT/FR2008/051292.;;U.S. Appl. No. 12/452,935, filed Dec. 14, 2009, in the name of Corinne Beaulieu et al.;;U.S. Appl. No. 12/452,038, filed Dec. 14, 2009, in the name of Monique Arpin at al.;;U.S. Appl. No. 12/452,037, filed Dec. 14, 2009, in the name of Yasemin Ataman-Onal et al.;;U.S. Appl. No. 12/452,042, filed Dec. 14, 2009, in the name of Monique Arpin et al.;;U.S. Appl. No. 12/452,034, filed Dec. 14, 2009, in the name of Yasemin Ataman-Onal et al.;;U.S. Appl. No. 12/452,047, filed Dec. 14, 2009, in the name of Yasemin Ataman-Onal et al.;;Oct. 31, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,035.;;May 13, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,038.;;Sep. 1, 2011 Office Action issued in U.S. Appl. No. 12/452,038.;;Nov. 16, 2011 Election of Species Requirement issued in U.S. Appl. No. 12/452,037.;;Sep. 15, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,042.;;Oct. 28, 2011 Office Action issued in U.S. Appl. No. 12/452,042.;;Aug. 1, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,034.;;Oct. 27, 2011 Office Action issued in U.S. Appl. No. 12/452,034.;;Oct. 28, 2011 Restriction Requirement issued in U.S. Appl. No. 12/452,047.;;SCORE sequence search result #1, Geneseq Database, ""20110423-191537-us-12-452-038-2.rag"" Apr. 23, 2011.;;Bruce et al., ""Cancer-Wide Tissue Microarray Survey of Ezrin and Merlin Expression, ""Proc Amer Assoc Cancer Res, vol. 46, Abstract #424, 2005.;;Gould et al., ""cDNA Cloning and Sequencing of the Protein-Tyrosine Kinase Substrate, Ezrin, Reveals Homology to Band 4.1,"" The EMBO Journal, vol. 8, No. 13, pp. 4133-4142, 1989.;;Etzioni et al., ""The Case for Early Detection,"" Nature Review, vol. 3, Internet pp. 1-10, Apr. 2003.;;Mercer, ""Use of Multiple Markers to Enhance Clinical Utility,"" Immunol Ser., vol. 53, pp. 39-54, 1990.;;Delanote et al., ""Plastins: Versatile Modulators of Actin Organization in (patho)physiological Cellular Processes,"" Acta Pharmacologica Sinica, vol. 26, No. 7, pp. 769-779, Jul. 2005.;;Hasselblatt et al., ""Identification of Novel Diagnostic Markers for Choroid Plexus Tumors,"" Am. J. Surg Pathol, vol. 30, No. 1, pp. 66-74, Jan. 2006.;;Lin et al., ""Identification of 1-Plastin, a Human Fimbrin Isoform Expressed in Intestine and Kidney,"" Molecular and Cellular Biology, vol. 14, No. 4, pp. 2457-2467, Apr. 1994.;;Carroll et al., ""Liver Fatty Acid-Binding Protein: A Marker for Studying Cellular Differentiation in Gut Epithelial Neoplasms,"" Gastroenterology, vol. 99, pp. 1727-1735, 1999.;;Kayser et al., ""Primary Colorectal Carcinomas and their Intrapulmonary Metastases: Clinical, Glyco-, Immuno- and Lectin Histochemical, Nuclear and Syntactic Structure Analysis with Emphasis on Correlation with Period of Occurrence of Metastases and Survival,"" APMIS, vol. 110, pp. 435-446, 2002.;;Kuusela et al., ""Comparison of CA 19-9 and Carcinoembryonic Antigen (CEA) Levels in the Serum of Patients with Colorectal Diseases,"" Br. J. Cancer, vol. 49, pp. 135-139, 1984.;;Pelsers et al., ""Fatty Acid-Binding Proteins as Plasma Markers of Tissue Injury,"" Clinics Chimica Acta, vol. 352, pp. 15-35, 2005.;;Jan. 3, 2012 Office Action issued in U.S. Appl. No. 12/452,035.;;Jun. 21, 2012 Office Action issued in U.S. Appl. No. 12/452,035.;;Niederkofler et al., ""Novel Mass Spectrometric Immunoassays for the Rapid Structural Characterization of Plasma Apolipoproteins,"" Journal of Lipid Research, vol. 44, pp. 630-639, 2003.;;Hortin, ""The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Pepetidome,"" Clinical Chemistry, vol. 52, No. 7, pp. 1223-1237, 2006.;;Hachern, ""Serum Apolipoproteins A-I, A-II and B in Hepatic Metastases Comparison with other Liver Diseases: Hepatomas and Cirrhosis,"" J. Clin. Chem. Clin. Biochem., vol. 24, pp. 161-166, 1986.;;Remold-O'Donnell et al., ""Sequence and Molecular Characterization of Human Monocyte/Neutrophil Elastase Inhibitor,"" Proc. Natl. Acad. Sci., vol. 89, pp. 5635-5639, Jun. 1992.;;Cooley et al., ""The Serpin MNEI Inhibits Elastase-Like and Chymotrypsin-Like Serine Proteases through Efficient Reactions at Two Active Sites,"" Biochemistry, vol. 40, pp. 15762-15770, 2001.;;Algrain et al, ""Ezrin Contains Cytoskeleton and Membrane Binding Domains Accounting for its Proposed Role as a Membrane-Cytoskeletal Linker,"" The Journal of Cell Biology, vol. 120, No. 1, pp. 129-139, Jan. 1993.;;Jiang et al., ""Cytokine Regulation of Ezrin Expression in the Human Colon Cancer Cell Line HT29,"" Anticancer Research, vol. 16, pp. 861-866, 1996.;;Hiscox et al, ""Ezrin Regulates Cell-Cell and Cell-Matrix Adhesion, A Possible Role with E-Cadherin/beta-Catenin,"" Journal of Cell Science, vol. 112, pp. 3081-3090, 1999.;;Xiao et al., ""An Approach to Studying Lung Cancer-Related Proteins in Human Blood,"" Molecular & Cellular Proteomics, vol. 4, pp. 1480-1486, 2005.;;Anders et al., ""Aminoacyclases,"" Advances in Pharmacology, vol. 27, pp. 431-448, 1994.;;Lorentz et al., ""A New Method for the Assay of Aminoacylase: Elaboration of a Fixed-Incubation Method for Routine Measurements,"" Clinica Chimica Acta, vol. 63, pp. 263-269, 1975.;;Lorentz et al, ""Clinical Application of A New Method for the Determination of Aminoacylase in Human Serum,"" Clinica Chimica Acta, vol. 63, pp. 271-274, 1975.;;Cook et al, ""Human Aminoacylase-1,"" The Journal of Biological Chemistry, vol. 268, No. 23, pp. 17010-17017, 1993.;;Miller et al., ""Lack of Expression of Aminoacylae-1 in Small Cell Lung Cancer,"" The Journal of Clinical Investigation, Inc., vol. 83, pp. 2120-2124, Jun. 1989.;;Balabanov et al., ""Tumour-Related Enzyme Alterations in the Clear Cell Type of Human Renal Cell Carcinoma Identified by Two-dimensional Gel Electrophoresis,"" Eur. J. Biochem., vol. 268, pp. 5977-5980, 2001.;;Chan et al, ""Human Liver Fatty Acid Binding Protein cDNA and Amino Acid Sequence,"" The Journal of Biological Chemistry, vol. 260, No. 5, pp. 2629-2632, 1985.;;Das et al., ""Expression Pattern of Fatty Acid-Binding Proteins in Human Normal and Cancer Prostate Cells and Tissues,"" Clinical Cancer Research, vol. 7, 1706-1715, Jun. 2001.;;Stulik et al., ""Proteorne Study of Colorectal Carcinogenesis,"" Electrophoresis, vol. 22, pp. 3019-3025, 2001.;;Yamazaki et al., ""Liver Fatty Acid-Binding Protein is a New Prognostic Factor for Hepatic Resection of Colorectal Cancer Metastases,"" Journal of Surgical Oncology, vol. 72, pp. 83-87, 1999.;;Sweetser et al., ""The Human and Rodent Intestinal Fatty Acid Binding Protein Genes,"" The Journal of Biological Chemistry, vol. 262, No. 33, pp. 16060-16071, 1987.;;Pelsers et al, ""Intestinal-Type and Liver-Type Fatty Acid-Binding Protein in the Intestine. Tissue Distribution and Clinical Utility"", Clinical Biochemistry, vol. 36, pp. 529-535, 2003.;;Xiao et al, ""Dietary Exposure to Soy or Whey Proteins Alters Colonic Global Gene Expression Profiles During Rat Colon Tumorigenesis,"" Molecular Cancer, vol. 4, No. 1, pp. 1-17, Jan. 11, 2005.;;Engwegen et al., ""Identification of Scrum Proteins Discriminating Colorectal Cancer Patients and Healthy Controls Using Surface-Enhanced Laser Desorption Ionisation-Time of Flight Mass Spectrometry,"" World J. Gastrenterol, vol. 12, No. 10, pp. 1536-1544, Mar. 14, 2006.;;Zhang et al., ""Three Biomarkers Identified from Serum Proteornic Analysis for the Detection of Early Stage Ovarian Cancer,""Cancer Research, vol. 64, pp. 5882-5890, Aug. 15, 2004.;;Lin et al., ""Human Plastin Genes,"" The Journal of Biological Chemistry, vol. 268, No. 4, pp. 2781-2792, 1993.;;Lavabre-Bertrand et al., ""Plasma Proteasome Level is a Potential Marker in Patients with Solid Tumors and Hemopoietic Malignancies,"" Cancer, vol. 92, No. 10, pp. 2493-2500, Nov. 15, 2001.;;Iurisci et al., ""Concentrations of Galectin-3 in the Sera of Normal Controls and Cancer Patients,"" Clinical Cancer Research, vol. 6, pp. 1389-1393, Apr. 2000.;;Schwartz, ""Enzymes as Prognostic Markers and Therapeutic Indicators in Patients with Cancer,"" Clinics Chimica Acta, vol. 206, pp. 77-82, 1992.;;McCool et al., ""Roles of Calreticulin and Calnexin During Mucin Synthesis in LS180 and HT29/A1 Human Colonic Adenocarcinoma Cells,"" Biochem. J., vol. 341, pp. 593-600, 1999.;;Motoo et al., ""Serum Levels of Pancreatitis-Associated Protein in Digestive Diseases with Special Reference to Gastrointestinal Cancer,"" Digestive Diseases and Sciences, vol. 44, No. 6, pp. 1142-1147, Jun. 1999.;;Abe et al., ""Preparation of Recombinant MK-1/EP-CAM and Establishment of an ELISA System for Determining Soluble MK-1/EP-CAM Levels in Sera of Cancer Patients,"" Journal of Immunological Methods, Vol. 270, pp. 227-233, 2002.;;Rouzier et al., ""Immunocytochemical Detection of Bono Marrow Micrometastases in Colorectal Carcinoma Patients, Using A Monoclonal Antibody to Villin,"" Cytometry (Communication in Clinical Cytometry), vol. 46, pp. 281-289, 2001.;;Nishizuka et al., ""Diagnostic Markers that Distinguish Colon and Ovarian Adenocarcinomas: Identification by Genomic, Proteomic, and Tissue Array Profiling,"" Cancer Research, vol. 63, pp. 5243-5250, Sep. 1, 2003.;;Wang et al., Proteomic Dissection of the Molecular Mechanisms Underlying Hepatic Metastasis in Colorectal Cancer, XP009093529, Database Accession No. PREV200600505326, AGA Abstracts, p. A-676, W1533, Apr. 2006.;;Mori et al., A Genome-Wide Search Identifies Epigenetic Silencing of Somatostatin, Tachykinin-1, and 5 other Genes in Colon Cancer, Gastroenterology, vol. 131, pp. 797-808, 2006.;;Database WPI Week 200777, Thomson Scientific, London, GB; AN 2007-817830, XP002464797 & CN 1 967 246 (Proteome Analysis Research Center) May 23, 2007, Abstract.;;Fujiwara et al., Global Gene Expression Analysis of Rat Colon Cancers Induced by a Food-Borne Carcinogen, 2-amino-1-methy1-6-phenylimidazo[4,5-b]pyridine, Carcinogenesis, vol. 25, No. 8, pp. 1495-1505, 2004.;;Dorudi et al., ""E-Cadherin Expression in Colorectal Cancer,"" American Journal of Pathology, vol. 142, No. 4, pp. 981-986, Apr. 1993.;;Lawrie et al., ""Liver Fatty Acid Binding Protein Expression in Colorectal Neoplasia,"" British Journal of Cancer, vol. 90, pp. 1955-1960, 2004.;;Mar. 18, 2009 International Search Report Issued in International Application No. PCT/FR2008/051291.;;Feb. 23, 2009 International Search Report Issued in International Application No. PCT/FR2008/051289.;;Feb. 18, 2009 International Search Report Issued in International Application No. PCT/FR2008/051295.;;Jan. 16, 2009 International Search Report Issued in International Application No. PCT/FR2008/051298."
60,US,B2,US 7723046 B2,050-651-826-610-407,2010-05-25,2010,US 70454607 A,2007-02-08,JP 2000351741 A 20001117;;JP 2001038619 A 20010215;;JP 2001077000 A 20010316,"Method Of Screening For A Compound Using Guanosine Triphosphate (gtp)-binding Protein-coupled Receptor Protein, Bg37",BANYU PHARMA CO LTD,MARUYAMA TAKAHARU;;NAKAMURA TAKAO;;ITADANI HARAKU;;TANAKA KEN-ICHI,https://lens.org/050-651-826-610-407,Granted Patent,yes,1,15,15,38,C07K14/705,G01N33/53;;C07K14/00;;C07K14/705;;C12N1/21;;C12N15/12,435/7.1;;435/69.1;;536/23.5;;530/350,10556317;;11578098;;12419312;;12524422;;15721318;;16400329;;16541101;;2271534;;2315699;;7569037;;8889548;;8920964;;9847074,10.1211/0022357011776603;;10.1016/S0006-291X(02)02550-0;;10.1093/NAR/27.23.4609;;10.1074/JBC.M209706200;;10.1038/SJ.EMBOJ.7601049;;10.1071/RD9940585;;10.1126/SCIENCE.2315699;;10.1038/NATURE04330;;10.1101/GR.6.9.791;;10.1016/J.BBRC.2005.01.139;;10.1021/BI00489A001,"Weigel, Biochem. J., 319: 657-667, 1996.;;Supplementary Partial European Search Report from corresponding European Patent Application Serial No. 01 97 6875.;;Houten, S.M. (2006) ""New EMBO member's review: endocrine functions of bile acids"" The EMBO Journal 25:1419-1425.;;Katsuma, S. (2005) ""Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1"" Biochemical and Biophysical Research Communications 329:386-390.;;Kawamata, Y. et al. (2003) ""A G protein-coupled receptor responsive to bile acids"" The Journal of Biological Chemistry 278:9435-9440.;;Watanabe, M. et al. (2006) ""Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation"" Nature 439:484-489.;;The Sanger Center (1998) ""Toward a complete human genome sequence,"" Genome Research, 8:1097-1108.;;Bonaldo, et al. (1996) ""Normalization and subtract: two approaches to facilitate gene discovery"" Genome Research 6:791-806.;;Bowie et al. (1990) ""Deciphering the message in protein sequences: tolerance to amino acid substitutions"" Science 247:1306-1310.;;Wells, J.A. (1990) ""Additivity of mutation effects in proteins"" Biochemistry 29:8509-8517.;;Wang, A. et al. (1999) Rapid analysis of gene expression (RAGE) facilitates universal expression profiling Nucleic Acids Research 27:4609-4618.;;Campbell, K. et al. (1997) ""Totipotency or multipotentiality of cultured cells: applications and progress"" Theriogenology 47:63-72.;;Philipps, A. (2001) ""The challenge of gene therapy and DNA delivery"" Journal of Pharmacy and Pharmacology 53:1169-1174.;;Maruyama, T. et al. (2002) Identification of membrane-type receptor for bile acids (M-BAR) Biochemical and Biophysical Research Communications 298:714-719.;;Wigley, P. et al. (1994) ""Site-specific transgene insertion: an approach"" Reprod. Fertil. Dev. 6:585-588."
61,US,B2,US 9416348 B2,143-346-916-112-242,2016-08-16,2016,US 201113883748 A,2011-11-04,CN 201010531420 A 20101104,Hepatocyte-like Cells And Uses Thereof,HUI LIJIAN;;HUANG PENGYU;;WANG XIN;;SHANGHAI INST FOR BIOLOGICAL SCIENCES;;CHINESE ACAD OF SCIENCES,HUI LIJIAN;;HUANG PENGYU;;WANG XIN,https://lens.org/143-346-916-112-242,Granted Patent,yes,0,5,5,27,C12N5/067;;A61M37/00;;C12N2501/60;;C12N2506/1307;;C12N2510/00,C12N5/00;;A61M37/00;;C12N5/02;;C12N5/071,,11146651;;12850695;;14988562;;14999681;;15163413;;15475575;;15795107;;15942773;;16912278;;17086172;;17086173;;17724450;;17885076;;18035408;;18398419;;18424555;;18501604;;18754011;;18845712;;18931654;;19008347;;19026649;;19325077;;19398399;;19481515;;19668188;;19838014;;19877180;;19998274;;20107439;;20139967;;20691899;;20888316;;4844560;;7451453;;7545495;;8253378;;8581509;;8589717;;20621044;;20621045;;21057492;;12509444;;20952534;;21562492;;19697349;;18356246;;6220021;;12902545;;21716291;;17468757;;9556759;;11864602;;20801124;;20682439;;11870262;;15169930;;19028990;;19167399;;20166152,10.1016/0003-2697(74)90248-6;;10.1126/SCIENCE.1172482;;10.1038/NBT.1503;;10.1016/J.CELL.2007.11.019;;10.1016/J.STEM.2009.05.005;;10.1038/NG0895-453;;10.1016/S0092-8674(04)00419-2;;10.1126/SCIENCE.1164270;;10.1053/J.GASTRO.2008.10.047;;10.1101/GAD.7.12A.2298;;10.1126/SCIENCE.1089769;;10.2183/PJAB.85.348;;10.1016/J.BIOPHA.2004.11.006;;10.1038/NATURE07314;;10.1038/NBT1257;;10.1038/NBT1258;;10.1038/NBT1335;;10.1007/BF00198899;;10.1038/NG0396-266;;10.1002/HEP.20084;;10.1038/nrg2318;;10.1038/nature10116;;10.1128/mcb.23.2.437-449.2003;;10.1242/dev.016634;;10.1016/s1386-6346(03)00114-1;;10.1002/stem.201;;10.1016/j.cub.2008.05.010;;10.1038/nature08797;;10.1038/nmeth.1426;;10.1016/j.stem.2010.06.002;;10.1016/j.cell.2010.07.002;;10.1016/j.stem.2010.08.012;;10.1038/nature08290;;10.1101/gad.1963910;;10.1016/j.stem.2010.06.004;;10.1002/hep.23354;;10.1634/stemcells.2007-0291;;10.1002/hep.23335;;10.1101/gad.390906;;10.1038/ng2033;;10.1038/nature09591;;10.1634/stemcells.2008-0696;;10.1016/s1097-2765(02)00459-8;;10.1053/j.gastro.2010.08.042;;10.1163/156856298x00622;;10.1016/j.stem.2010.07.004;;10.1124/pr.54.1.129;;10.1124/pr.56.2.5;;10.1101/sqb.2008.73.040;;10.1053/j.gastro.2009.01.019;;10.1002/stem.322,"NM-008260, published Oct. 17, 2010http://www.ncbi.nlm.nih.gov/nuccore/118130865?sat=14&satkey=4178466 Accessed on Feb. 6, 2015.;;Genbank NM-008092 , published Nov. 1, 2009, http://www.ncbi.nlm.nih.gov/nuccore/110681730?sat=13&satkey=7538466 Accessed on Feb. 6, 2015.;;Genbank NM-010446, published Oct. 18, 2009, http://www.ncbi.nlm.nih.gov/nuccore/153945803?sat=13&satkey=5678070 Accessed Feb. 6, 2015.;;Genbank NM-009327 (published Nov. 1, 2009, http://www.ncbi.nlm.nih.gov/nuccore/166295201?sat=13&satkey=7555724 Accessed Feb. 6, 2015.;;Feng2008, PNAS, 4005:6057-662.;;Sekiya; Nature, Jul. 2011, 475:390-395.;;Takahashi 2007, Cell, 131:861-872.;;Meissner (Nature Biotechnology, 2007, 25:1177-1181).;;Heng et al, 2005a, Cell Tissue Res, 321:147-150.;;Heng, 2005b, Biomedicine and Pharmacotherapy, 59:132-134.;;Kim (2009, Cell Stem Cell, 4:472-476).;;Zhou (Cell Stem Cell, 2009, 4:381-384).;;Warren (2010, Cell Stem Cell, 7:618-630).;;Basma, et al., ""Differentiation and Transplantation of Human Embryonic Stem Cell-Derived Hepatocytes"", Gastroenterology 2009, vol. 136, No. 3, Mar. 2009, pp. 990-1004.;;Cirillo, et al., ""Opening of Compacted Chromatin by Early Developmental Transcription Factors HNF3 (FoxA) and GATA-4"", Molecular Cell, vol. 9, Feb. 2002, pp. 279-289.;;Cristiano, et al., ""Molecular Conjugates: A Targeted Gene Delivery Vector for Molecular Medicine"", Springer-Verlag, Jul. 1995, pp. 479-486.;;Duan, et al., ""Differentiation and Enrichment of Hepatocyte-Like Cells from Human Embryonic Stem Cells in Vitro and In Vivo"", Stem Cells Dec. 2007, pp. 3058-3069.;;Feng, et al., ""PU.1 and C/EBPx/B Convert Fibroblasts Into Macrophage-Like Cells"", PNAS, Apr. 22, 2008, vol. 105, No. 16, pp. 6057-6062.;;Gebhardt, et al. ""Biliary Secretion of Sodium Fluorescein in Primary Monolayer Cultures of Adult Rat Hepatocytes and its Stimulation by Nicotinamide"", J. Cell Science 56, Aug. 1982, pp. 233-244.;;Gouon-Evans, et al., ""BMP-4 is Required for Hepatic Specification of Mouse Embryonic Stem Cell-Derived Definitive Endoderm"", Nature Biotechnology, vol. 24, No. 11, Nov. 2006, pp. 1402-1411.;;Grompe, et al., ""Loss of Fumarylacetoacetate Hydrolase is Responsible for the Neonatal Hepatic Dysfunction Phenotype of Lethal Albino Mice"", Genese & Development, Dec. 1993, pp. 2297-2307.;;Grompe, et al., ""Pharmacological Correction of Neonatal Lethal Hepatic Dysfunction in a Murine Model of Hereditary Tyrosinaemia Type 1"", Nature Genetics, vol. 10, Aug. 1995, pp. 453-460.;;Huang, et al., ""Induction of Functional Hepatocyte-Like Cells From Mouse Fibroblasts by Defined Factors"", Nature, vol. 475, Jul. 21, 2011, pp. 386-391.;;Hui, et al., ""p38 Suppresses Normal and Cancer Cell Proliferation by Antagonizing the JNK-c-Jun Pathway"", Nature Genetics, vol. 39, No. 6, Mar. 2007, pp. 741-749.;;Ieda, et al., ""Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors"", Cell 142, Aug. 6, 2010, pp. 375-386.;;Kanda, et al., ""In Vitro Differentiation of Hepatocyte-Like Cells From Embryonic Stem Cells Promoted by Gene Transfer of Hepatocyte Nuclear Factor 3"", Hepatology Research 26, Feb. 2003, pp. 225-231.;;Kane, et al., ""Purification and Characterization of Human Coagulation Factor V"", The Journal of Biological Chemistry, vol. 256, No. 2, Jan. 25, 1981, pp. 1002-1007.;;Kyrmizi, et al., ""Plasticity and Expanding Complexity of the Hepatic Transcription Factor Network During Liver Development"", Genes & Development 20:2293-2305, Jun. 2006, 14 pages.;;Li, et al., ""Hepatoblast-Like Progenitor Cells Derived From Embryonic Stem Cells Can Repopulate Livers of Mice"", Gastroenterology, vol. 139, No. 6, Dec. 2010, pp. 2158-2178.;;Li, et al., ""The Ink4/Arf Locus is a Barrier for iPS Cell Reprogramming"", Nature, Letters, vol. 460, Aug. 27, 2009, pp. 1136-1141.;;Liu, ""Effects of the Lentivirus Mediated Constitutive Expression of Foxa2 and Hnf4a Upon the Heptic Differentiation of Embryonic Stem Cells"", Tao Liu Chinese Doctoral Dissertation, May 2011, 125 pgs.;;Mikula, et al., ""Immortalized p19ARF Null Hepatocytes Restore Liver Injury and Generate Hepatic Progenitors After Transplantation"", Hepatology, vol. 39, No. 3, Mar. 2004, pp. 628-634.;;Miyoshi, et al., ""Hepatocyte Culture Utilizing Porous Polyvinyl Formal Resin Maintains Long-term Stable Albumin Secretion Activity"", Journal Biomaterials Science, Polymer Edition, vol. 9 No. 3, Feb. 1998, pp. 227-237.;;Odom, et al., ""Control of Pancreas and Liver Gene Expression by HNF Transcription Factors"", www.sciencemag.org, Science, vol. 303, Feb. 27, 2004, 5 pages.;;Overturf, et al., ""Hepatocytes Corrected by Gene Therapy are Selected in Vivo in a Murine Model of Hereditary Tyrosinaemia Type I"", 1996 Nature Genetics, vol. 12, Mar. 1996, pp. 266-273.;;Passier, et al., ""Getting to the Heart of the Matter: Direct Reprogramming to Cardiomyocytes"", Cell Stem Cell, Aug. 6, 2010, pp. 139-141.;;Passonneau, et al., ""A Comparison of Three Methods of Glycogen Measurement in Tissues"", Analytical Biochemistry 60, Aug. 1974, pp. 405-412.;;Rausa, et al., ""Association Between Hepatocyte Nuclear Factor 6 (HNF-6) and FoxA2 DNA Binding Domains Stimulates FoxA2 Transcriptional Activity but Inhibits HNF-6 DNA Binding"", Molecular and Cellular Biology, vol. 23, No. 2, Jan. 2003, pp. 436-449.;;Schrem, et al., ""Liver-Enriched Transcription Factors in Liver Function and Development. Part I: The Hepatocyte Nuclear Factor Network and Liver-Specific Gene Expression"", Pharmacological Reviews, vol. 54, No. 1, Mar. 2002, pp. 129-158.;;Schrem, et al., ""Liver-Enriched Transcription Factors in Liver Function and Development. Part II: The C/EBPs and D Site-Binding Protein in Cell Cycle Control, Carcinogenesis, Circadian Gene Regulation, Liver Regeneration, Apoptosis, and Liver-Specific Gene Regulation"", Pharmacological Reviews, vol. 56, No. 2, Jun. 2004, pp. 291-330.;;Shen, et al., ""Molecular Basis of Transdifferentiation of Pancreas to Liver"", Nature Cell Biology, vol. 2, Dec. 2000, pp. 879-889.;;Si-Tayeb, et al., ""Highly Efficient Generation of Human Hepatocyte-Like Cells from Induced Pluripotent Stem Cells"", Hepatology, Jan. 2010, pp. 297-305.;;Soto-Gutierrez, ""Reversal of Mouse Hepatic Failure Using an Implanted Liver-Assist Device Containing ES Cell-Derived Hepatocytes"", Nature Biotechnology, vol. 24, No. 11, Nov. 2006, pp. 1412-1420.;;Sullivan, et al., ""Generation of Functional Human Hepatic Endoderm from Human Induced Pluripotent Stem Cells"", Hepatology, Jan. 2010, pp. 329-335.;;Suzuki, et al., ""Tbx3 Controls the Fate of Hepatic Progenitor Cells in Liver Development by Suppressing p19ARF Expression"", Research Report, Development 135, Feb. 25, 2008, pp. 1589-1595.;;Szabo, et al., ""Direct Conversion of Human Fibroblasts to Multilineage Blood Progenitors"", Nature, vol. 468, Nov. 25, 2010, pp. 521-528.;;Tachikawa, et al., ""Regulation of the Endogenous VEGF-A Gene by Exogenous Designed Regulatory Proteins"", Pharmacology PNAS, vol. 101, No. 42, Oct. 2004, 6 pages.;;Vierbuchen, et al., ""Direct Conversion of Fibroblasts to Functional Neurons by Defined Factors"", Nature, vol. 463, Feb. 25, 2010, pp. 1035-1042.;;Wang, et al., ""The Origin and Liver Repopulating Capacity of Murine Oval Cells"", PNAS, vol. 100, Suppl. 1, Sep. 30, 2003, 8 pages.;;Xie, et al., ""Stepwise Reprogramming of B Cells into Macrophages"", Cell, vol. 117, May 28, 2004, pp. 663-676.;;Zaret, Kenneth S., ""Genetic Programming of Liver and Pancreas Progenitors: Lessons for Stem-Cell Differentiation"", Nature Reviews, Genetics, vol. 9, May 2008, pp. 329-340.;;Zaret, et al., ""Pioneer Factors, Genetic Competence, and Inductive Signaling: Programming Liver and Pancreas Progenitors from the Endoderm"", Cold Spring Harbor Symp Quant Biol, Nov. 21, 2008, 9 pages.;;Zern, Mark A., ""Cell Transplantation to Replace Whole Liver Transplantation"", Gastroenterology 136, Editorials, Mar. 2009, pp. 767-769.;;Zhou, et al., ""In Vivo Reprogramming of Adult Pancreatic Exocrine Cells to B-Cells"", Nature, vol. 455, Oct. 2, 2008, pp. 627-633.;;Aasen, et al., ""Efficient and Rapid Generation of Induced Pluripotent Stem Cells from Human Keratinocytes"", Nat. Biotechnol., 2008, vol. 26 (11), pp. 1276-1284.;;Fusaki, et al., ""Efficient Induction of Transgene-Free Human Pluripotent Stem Cells Using a Vector Based on Sendai Virus, an RNA Virus That Does Not Integrate Into the Host Genome"", Proc. Jpn. Acad., 2009, vol. 85 (8), pp. 348-362.;;International Preliminary Report on Patentability dated May 7, 2013 in PCT Application No. PCT/CN2011/001857.;;Jia, et al., ""A Nonviral Minicircle Vector for Deriving Human iPS Cells"", Nature Methods, 2010, vol. 7 (3), pp. 197-199.;;Loh, et al., ""Reprogramming of T Cells from Human Peripheral Blood"", Cell Stem Cell, 2010, vol. 7 (1), pp. 15-19.;;Okita, et al., ""Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors"", Science, 2008, vol. 322, pp. 949-953.;;Search Report & Written Opinion dated Feb. 9, 2012 in PCT Application No. PCT/CN2011/001857.;;Stadtfeld, et al., ""Induced Pluripotency: History, Mechanisms, and Applications"", Genes Dev., 2010, vol. 24 (20), pp. 2239-2263.;;Stadtfeld, et al., ""Reprogramming of Pancreatic Beta Cells into Induced Pluripotent Stem Cells"", Curr. Biol., 2008, vol. 18 (12), pp. 890-894.;;Staerk, et al., ""Reprogramming of Peripheral Blood Cells to Induced Pluripotent Stem Cells"", Cell Stem Cell, 2010, vol. 7 (1), pp. 20-24.;;Varas, et al., ""Fibroblast-Derived Induced Pluripotent Stem Cells Show No Common Retroviral Vector Insertions"", Stem Cells, 2009, vol. 27, pp. 300-306.;;Winkler, et al., ""No Evidence for Clonal Selection Due to Lentiviral Integration Sites in Human Induced Pluripotent Stem Cells"", Stem Cells, 2010, vol. 28, pp. 687-694.;;Yu, et al., ""Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences"", Science, 2009, vol. 324, pp. 797-801.;;Zhou, et al., ""Adenoviral Gene Delivery Can Reprogram Human Fibroblasts to Induced Pluripotent Stem Cells"", Stem Cells, 2009, vol. 27, pp. 2667-2674."
62,CA,A1,CA 2914755 A1,081-989-351-670-029,2014-12-18,2014,CA 2914755 A,2014-05-21,US 201361834993 P 20130614;;US 201461953336 P 20140314,Therapeutics For The Induction Of Endogenous Steroidogenesis And Methods Associated With Their Identification,UNIV MCGILL,PAPADOPOULOS VASSILIOS;;AGHAZADEH YASAMAN;;FAN JINJIANG,https://lens.org/081-989-351-670-029,Patent Application,no,0,6,6,30,C07K7/08;;A61K31/713;;A61K38/00;;C07K7/06;;C07K14/47;;C07K14/705;;C07K2319/10;;C12N15/113;;C12N2310/14;;C12N2320/30;;C12P33/00;;G01N33/5023;;G01N33/5044;;G01N33/743,C07K14/47;;A61K31/713;;A61K38/17;;A61P5/26;;C07K7/06;;C07K7/08;;C07K19/00;;C12N5/071;;C12P33/00;;C12Q1/02,,,,
63,EP,A4,EP 3008080 A4,125-130-776-583-53X,2016-11-09,2016,EP 14810382 A,2014-05-21,US 201361834993 P 20130614;;US 201461953336 P 20140314,Therapeutics For The Induction Of Endogenous Steroidogenesis And Methods Associated With Their Identification,UNIV MCGILL,PAPADOPOULOS VASSILIOS;;AGHAZADEH YASAMAN;;FAN JINJIANG,https://lens.org/125-130-776-583-53X,Search report,no,0,6,6,30,C07K7/08;;A61K31/713;;A61K38/00;;C07K7/06;;C07K14/47;;C07K14/705;;C07K2319/10;;C12N15/113;;C12N2310/14;;C12N2320/30;;C12P33/00;;G01N33/5023;;G01N33/5044;;G01N33/743,C07K14/47;;A61K31/713;;A61K38/17;;A61P5/26;;C07K7/06;;C07K7/08;;C07K19/00;;C12N5/071;;C12P33/00;;C12Q1/02,,23483955,,"TZU-AN LIU ET AL: ""14-3-3[epsilon] Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma"", PLOS ONE, vol. 8, no. 3, 6 March 2013 (2013-03-06), pages e57968, XP055306238, DOI: 10.1371/journal.pone.0057968;;See also references of WO 2014197979A1"
64,EP,A1,EP 3008080 A1,084-943-188-904-993,2016-04-20,2016,EP 14810382 A,2014-05-21,US 201361834993 P 20130614;;US 201461953336 P 20140314,Therapeutics For The Induction Of Endogenous Steroidogenesis And Methods Associated With Their Identification,UNIV MCGILL,PAPADOPOULOS VASSILIOS;;AGHAZADEH YASAMAN;;FAN JINJIANG,https://lens.org/084-943-188-904-993,Patent Application,no,0,6,6,30,C07K7/08;;A61K31/713;;A61K38/00;;C07K7/06;;C07K14/47;;C07K14/705;;C07K2319/10;;C12N15/113;;C12N2310/14;;C12N2320/30;;C12P33/00;;G01N33/5023;;G01N33/5044;;G01N33/743,C07K14/47;;A61K31/713;;A61K38/17;;A61P5/26;;C07K7/06;;C07K7/08;;C07K19/00;;C12N5/071;;C12P33/00;;C12Q1/02,,,,
65,US,B1,US 6872811 B1,074-480-930-550-237,2005-03-29,2005,US 16375998 A,1998-09-30,US 16375998 A 19980930,Hrpca9 And Hrpca10 Nucleic Acids And Polypeptides,MILLENNIUM PHARM INC,MACBETH KYLE J;;SHYJAN ANDREW W,https://lens.org/074-480-930-550-237,Granted Patent,yes,12,6,13,6,C07K14/4748;;A61K38/00;;C12Q1/6809;;C12Q1/6886;;C12Q2600/136,G01N33/53;;A61K38/00;;C07K14/47;;C07K14/82;;C07K16/32;;C12N5/10;;C12N15/09;;C12P21/02;;C12Q1/02;;C12Q1/68,536/23.1;;435/320.1;;435/252.3,10048485;;10216947;;1699952;;21556536;;3022128;;3285178;;7906532;;8861966;;9307296;;9743287,10.1016/0959-8049(93)90215-2;;10.1016/S1357-2725(98)00135-6;;10.1016/S0092-8674(88)80001-1;;10.1002/PROS.2990260407;;10.1083/JCB.111.5.2129;;10.1038/BJC.1998.565;;10.1093/DNARES/5.6.355;;10.1126/SCIENCE.2315699;;10.1038/NBT0394-320;;10.3892/ijo.6.2.293,"Shantz and Pegg, ( Int. ;J. Biochem Cell Bio., 1999, 31:107-122).*;;McClean and Hill (Eur. J. Cancer, 1993, 29A:2243-2248).*;;Fu et al (EMBO J., 1996, 15:4392-4401).*;;Albert et al (Molecular Biology of the Cell., 3rd Ed., Garland Publishing Co., New York, 1994, p. 465.*;;Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Ince., NY, p. 4), 1983.*;;Dermer (Bio/Technology, 12:320), 1994.*;;Bowie et al (Science, 25:1306-1310), 1990.*;;Burgess et al (J. Cell Bio., 111:2129-2138), 1990.*;;Lazar et al (Mol. Cell. Bui., 8:1247-1252), 1988.*;;Reiger et al (Glossary of Genetic and Cytogenetics, Classical and Molecular, 4th Ed., Springer-Verlag, Berlin), 1976.*;;Hillier et al (G1126752), Genbank Sequence Database (Acession N21582), National Center for Biotechnology Invormation, National Library of Medicine, Bethesda, Maryland), 1995.*;;Marra et al (G2292255) Genbank Sequence Database (Acession AA543778) National Center for Biotechnoogy Information, National Library of Medicine, Bethesda, MD), 1997.*;;Nagase et al (DNA Res., 5:355-364), 1983.*;;Tsou et al., ""Structural Characterization of a Heterogenous Family of Rat brain mRNAs"" Mol. and Cell. Biol. 6(3):768-778, 1986.;;Bieche et al., ""Overexpression of the stathmin gene in a subset of human breast cancer"" British J. of Cancer 78(6):701, 1998.;;Blok et al., ""Isolation of CDNAS that are differentially expressed between androgen-dependent . . . "" Prostate (U.S.) Wiley-Liss, New York, 26(4):213, 1995.;;Chang et al., ""Differentially expressed genes in androgen-dependent and independent prostate carcinomas"" Cancer Research 57(18):4075, 1997.;;Delworth et al., ""Systemic administration of 4-amidinoindanon-1-(2'-amidino)-hydrazone, . . . "" Int. J. of Oncology 6(2):293, 1995."
66,US,B2,US 8916161 B2,028-827-637-700-429,2014-12-23,2014,US 92196406 A,2006-06-14,US 69026905 P 20050614,Method Of Treating Or Preventing Benign Prostatic Hyperplasia Using Modified Pore-forming Proteins,BUCKLEY JAMES THOMAS;;SOPHIRIS BIO INC,BUCKLEY JAMES THOMAS,https://lens.org/028-827-637-700-429,Granted Patent,yes,0,25,25,74,A61K38/164;;A61K9/0019;;A61K9/0034;;A61K38/00;;C07K14/195,A61K38/16;;A61K38/00;;A61K39/395;;A61P13/08;;C07K14/195;;C07K16/28,424/183.1;;424/130.1;;424/154.1;;424/735;;424/737;;424/750;;424/758;;514/19.5;;514/21.1;;514/21.6;;514/12.2;;514/284;;514/602;;514/604;;514/258.1;;514/252.13;;514/21.9;;530/350,10428840;;10508095;;10907418;;11016941;;11062377;;11119561;;11212264;;11335716;;12022262;;12837835;;1383574;;14532761;;15546182;;17341729;;2915928;;7806374;;8140099;;8200504;;8978087;;9218785;;9317018;;9354459;;9743387;;9830006;;12814680;;15291864;;12808443;;12137830,10.1093/JNCI/95.13.990;;10.1074/JBC.M008097200;;10.1097/01.JU.0000091655.77601.0C;;10.1093/JNCI/DJK065;;10.1093/EMBOJ/16.12.3426;;10.1093/NAR/17.2.723;;10.1074/JBC.274.32.22604;;10.1093/PROTEIN/7.1.91;;10.2174/1389201023378418;;10.1128/IAI.69.1.599-601.2001;;10.1074/JBC.273.49.32656;;10.1021/BC0499127;;10.1111/J.1574-6968.1994.TB06781.X;;10.1074/JBC.M100770200;;10.1016/s0378-1097(96)00428-4;;10.1038/sj.gt.3301972;;10.1139/w99-086;;10.3949/ccjm.74.suppl_3.s63,"Zlotta et al. (European Urology, vol. 44, Issue 1, pp. 89-93, Published 2003).;;Gerber et al. (BJU International, 94, pp. 338-344, Published 2004).;;Denmeade S. R. et al., Prostate-Specific Antigen-Activated Thapsigargin Prodrug as Targeted Therapy for Prostate Cancer, (2003) Journal of the National Cancer Institute, vol. 95, No. 13, pp. 990-1000.;;Imagawa T. et al., Cloning, nucleotide sequence and expression of a hemolysin gene of Clostridium septicum, FEMS Microbiology Letters (1994) 117, 287-292.;;Meza R. et al, Isolation of Cry1Ab protein mutants of Bacillus thuringiensis by a highly efficient PCR site-directed mutagenesis system, FEMS Microbiology Letters (1996) 145, 333-339.;;Presti J. C. et al., Multicenter, Randomized, Double-blind, Placebo controlled study to investigate the effect of Finasteride (MK-906) on stage D prostate cancer, The Journal of Urology (1992), vol. 148, 1201-1204.;;Williams S. A. et al., A Prostate-Specific Antigen-Activated Channel-Forming Toxin as Therapy for Prostatic Disease, J Natl Cancer Inst (2007); 99:376-385.;;Vallette F. et al., Construction of mutant and chimeric genes using the polymerase chain reaction, Nucleic Acids Research (1989), vol. 17, No. 2, 723-733.;;Patri A. K. et al., Synthesis and In Vitro Testing of J591 Antibody-Dendrimer Conjugates for Targeted Prostate Cancer Therapy, Bioconjugate Chem. (2004), 15, 1174-1181.;;Bander N. H. et al., Targeting Metastatic Prostate Cancer With Radiolabeled Monoclonal Antibody J591 to the Extracellular Domain of Prostate Specific Membrane Antigen, The Journal of Urology, (2003), vol. 170, 1717-1721.;;Park H. S. et al., In vivo characterization of a prostate-specific antigen promoter-based suicide gene therapy for the treatment of benign prostatic hyperplasia, Gene Therapy, (2003),10:1129-1134.;;Declaration of Dr. Samuel R. Denmeade in granted EP Patent Application No. 06761050.1, published as WO 2006/133553.;;Panchal R. G. et al., Pore-Forming Proteins and their Application in Biotechnology, Current Pharmaceutical Biotechnology, (2002), 3:99-115.;;Williams et al., ""Tumoricidal Effects of a PSA-Activated Pore-Forming Toxin,"" Proceedings of the American Association for Cancer Research 46:1446 (2005).;;Barry et al., ""The Channel-Forming Protein Proaerolysin Remains a Dimer at Low Concentrations in Solution,"" J Biol. Chem. 276:551-554, 2001.;;Audtho et al., ""Production of Chymotrypsin-Resistant Bacillus thuringiensis Cry2Aa1 delta-Endotoxin by Protein Engineering,"" Appl. Environ. Micriobiol. 65:4601-4605 (1999).;;Ballard et al., ""The Primary Structure of Clostridium septicum Alpha-Toxin Exhibits Similarity with That of Aeromonas hydrophila Aerolysin,"" Infect. Immun. 63:340-344 (1995).;;Chen et al., ""Glycophosphatidylinositol-Anchored Protein Deficiency as a Marker of Mutator Phenotypes in Cancer,"" Cancer Res. 61:654-658 (2001).;;Correale et al., ""Generation of Human Cytolytic T Lymphocyte Lines Directed Against Prostate-Specific Antigen (PSA) Employing a PSA Oligoepitope Peptide,"" J. Immunol. 161:3186-3194 (1998).;;Gong et al., ""Overview of Evolving Strategies Incorporating Prostate-Specific Membrane Antigen as Target for Therapy,"" Mol. Urol. 4:217-222 (2000).;;Gordon et al., ""Clostridium septicum Alpha-Toxin Is Proteolytically Activated by Furin,"" Infect. Immun. 65:4130-4134 (1997).;;Pang et al., ""Activation and Fragmentation of Bacillus thuringiensis delta-Endotoxin by High Concentrations of Proteolytic Enzymes,"" Can. J. Microbiol. 45:816-825 (1999).;;Rosen et al. ""Enzymatic Activation of a Modified Proaerolysin Toxin by Prostate-Specific Antigen (PSA) as Treatment for Prostate Cancer,"" Proceedings of the American Association for Cancer Research Annual Meeting 43:92 (2002).;;Rossjohn et al., ""Aerolysin and Pertussis Toxin Share a Common Receptor-Binding Domain,"" EMBO J. 16:3426-3434 (1997).;;Spyres et al., ""Cytosolic Delivery and Characterization of the TcdB Glucosylating Domain by Using a Heterologous Protein Fusion,"" Infection Immun. 69:599-601 (2001).;;Tanha et al., ""Optimal Design Features of Camelized Human Single-Domain Antibody Libraries,"" J. Biol. Chem. 276:24774-24780 (2001).;;Walker and Bayley, ""A Pore-Forming Protein with a Protease-Activated Trigger,"" Protein Eng. 7:91-97 (1994).;;Abrami et al. (1998) Journal of Biological Chemistry 273(49):32656-32661.;;Denmeade et al. (1997) Cancer Research 57:4924-4930.;;Mackenzie et al. (1999) Journal of Biological Chemistry 274(32):22604-22609.;;Leskinen MJ et al., (2002) Adult Urology 60 (2):300-304.;;Potts J et al., (2007) Cleveland Clinic Journal of Medicine, 74 (3) S63-S71.;;Rich et al., (2008) American Family Physician, pp. 1-3."
67,US,A1,US 2009/0142323 A1,108-252-998-779-369,2009-06-04,2009,US 32440608 A,2008-11-26,US 99118807 P 20071129,Methods For Treating A Disorder By Regulating Gprc6a,QUARLES L DARRYL;;PI MIN,QUARLES L DARRYL;;PI MIN,https://lens.org/108-252-998-779-369,Patent Application,yes,2,3,3,36,C12Q1/6886;;A01K67/0276;;A01K2217/075;;A01K2227/105;;A01K2267/03;;A61K31/56;;A61K31/7105;;C07K14/705;;C12N15/8509;;C12Q2600/106;;C12Q2600/136;;C12Q2600/158,A61K31/56;;A01K67/027;;A61K31/7105;;A61K38/43;;A61P3/00;;A61P35/00;;C12Q1/68;;C40B30/06,424/94.1;;514/44;;514/169;;800/18;;435/6;;506/10,,,
68,US,A,US 5977319 A,134-667-134-506-117,1999-11-02,1999,US 95820197 A,1997-10-21,US 95820197 A 19971021;;US 2889796 P 19961021,Specific Binding Members For Estradiol; Materials And Methods,CAMBRIDGE ANTIBODY TECH,POPE ANTHONY RICHARD;;PRITCHARD KEVIN;;WILLIAMS ANDREW JAMES;;JOHNSON KEVIN STUART,https://lens.org/134-667-134-506-117,Granted Patent,yes,12,1,1,23,C07K16/26;;C07K2317/34;;C07K2317/622,C07K16/26,530/388.24;;424/145.1,1367224;;1404388;;1565653;;1748994;;1834458;;1907718;;1987490;;2677748;;3045807;;3087629;;3140379;;7579667;;7763975;;7764208;;8341653;;8496956;;9373313;;9630883;;9630891,10.1016/0022-2836(92)90223-7;;10.1016/S1380-2933(96)00051-6;;10.1038/NBT0396-267;;10.1038/NBT0396-309;;10.1038/352624A0;;10.1126/SCIENCE.3140379;;10.1016/0022-2836(91)90498-U;;10.1016/0958-1669(93)90010-T;;10.1073/PNAS.85.16.5879;;10.1038/341544A0;;10.1038/NBT0691-545;;10.1038/349293A0;;10.1073/PNAS.90.14.6444;;10.1016/0958-1669(95)80092-1;;10.1073/PNAS.89.8.3576;;10.1006/JMBI.1993.1260;;10.1016/0092-8674(86)90746-4;;10.1016/0958-1669(93)90079-C;;10.1126/science.242.4885.1494-b,"Aravelo, J.H. et al., Three dimensional Structure of an Anti steroid Fab and Progesterone Fab Complex, J. Molecular Biology, 231:103 118 (1993).;;Bird, R.E. et al., Single Chain Antigen Binding Proteins, Science, 242:423 426 (Oct., 1988).;;Clackson, T. et al., Making antibody fragments using phage display libraries, Nature, 352:624 628 (Aug. 15, 1991).;;Cook, B. et al., Measurement of steroid hormone concentrations in blood, urine and tissues, In: Steroid Hormones: a practical approach, Practical Approach series, Chapter 1, Rickwood et al., (eds.), Oxford University Press, Oxford, pp. 1 65 (1989).;;Gram, H. et al., In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library, Proc. Natl. Acad. Sci., USA, 89:3576 3580 (Apr., 1992).;;Holliger, P. et al., Engineering bispecific antibodies, Current Opinion in Biotechnology, 4:446 449 (1993).;;Holliger, P. et al., Diabodies: Small bivalent and bispecific antibody fragments, Proc. Natl. Acad. Sci., USA, 90:6444 6448 (Jul., 1993).;;Huston, J.S. et al., Protein engineering of antibody binding sites: Recovery of specific activity in an anti digoxin single chain Fv analogue produced in Escherichia coli, Proc. Natl. Acad. Sci., USA, 85:5879 5883 (Aug., 1988).;;Marks, J.D. et al., By passing Immunization Human Antibodies from V gene Libraries Displayed on Phage, J. Molecular Biology, 222:581 597 (1991).;;Munro, S. et al., An Hsp70 like Protein in the ER: Identity with the 78 kd Glucose Regulated Protein and Immunoglobulin Heavy Chain Binding Protein, Cell, 46:291 300 (Jul., 1986).;;Pl u ckthun, A., Antibody Engineering: Advances from the Use of Escherichia coli Expression Systems, Bio/Technology, 9:545 551 (Jun., 1991).;;Pope, A. et al., In vitro selection of a high affinity antibody to oestradiol using a phage display human antibody library, Immunotechnology, 2:209 217 (1996).;;Reff, M.E., High level production of recombinant immunoglobulins in mammalian cells, Current Opinion in Biotechnology, 4:573 576 (1993).;;Tomlinson, I.M. et al., The Repertoire of Human Germline V H Sequences Reveals about Fifty Groups of V H Segments with Different Hypervariable Loops, J. Molecular Biology, 227:776 798 (1992).;;Traunecker, A. et al., Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells, EMBO J., 10(12):3655 3659 (1991).;;Trill, J.J. et al., Production of monoclonal antibodies in COS and CHO cells, Current Opinion in Biotechnology, 6:553 560 (1995).;;Ward, E.S. et al., Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli, Nature, 341:544 546 (Oct. 12, 1989).;;Winter, G. et al., Man made antibodies, Nature, 349:293 299 (Jan. 24, 1991).;;Gibson, Toby James, Studies in the Epstein Barr virus genome University of Cambridge: Ph.D. Dissertation, Date approved: Dec. 7, 1984, BLDSC No. D58257/85, University of Cambridge, MRC Laboratory of Molecular Biology.;;Vaughn, T.J. et al., Human Antibodies with Sub nanomolar Affinities Isolated from a Large Non immunozed Phage Display Library, Nature Biotechnology, 14(3):309 314 (Mar. 1996).;;Carter, P., Binders from the deepest vaults, Nature Biotechnology, 14(3):267 (Mar. 1996)."
69,US,A1,US 2016/0287565 A1,002-040-570-839-705,2016-10-06,2016,US 201615092266 A,2016-04-06,US 201562143713 P 20150406,Combination Therapy For Treating Disorders Associated With Excess Cortisol Production,MILLENDO THERAPEUTICS INC,MOHIDEEN PHARIS;;OWENS JULIA CHRISTINE,https://lens.org/002-040-570-839-705,Patent Application,yes,0,3,3,6,A61K31/444;;A61K31/17;;A61K31/4184;;A61K31/4188;;A61K45/06;;A61K2300/00,A61K31/444;;A61K31/17;;A61K31/4188;;A61K45/06,,,,"Ghataore et al. Effects of mitotane treatment on human steroid metabolism: implications for patient management. Endocrine Connections, 2012, 1, 37-47.;;Hunter et al. Evaluation and treatment of women with hirsutism. American Family Physician, 2003; 67: 2565-72.;;Cerny. Progress towards clinically useful aldosterone synthase inhibitors. Current Topics in Medicinal Chemistry, 2013, 13, 1385-1401."
70,US,A1,US 2013/0035255 A1,085-687-047-368-054,2013-02-07,2013,US 201113636024 A,2011-03-25,US 31819310 P 20100326,Controlled Release Hybrid Systems,INTEGRATECH PROTEOMICS LLC;;SANDROCK TANYA,SANDROCK TANYA,https://lens.org/085-687-047-368-054,Patent Application,yes,0,3,3,19,C12N15/1055,G01N33/53;;C40B30/04,506/9;;435/6.13,,,
71,US,A1,US 2005/0256051 A1,037-943-959-315-843,2005-11-17,2005,US 16761605 A,2005-06-27,US 28465801 P 20010413,Nuclear Receptor-mediated Introduction Of A Pna Into Cell Nuclei,POPULATION COUNCIL INC,MORRIS PATRICIA L,https://lens.org/037-943-959-315-843,Patent Application,yes,3,6,6,8,C12N15/87;;C07K14/82;;C12N15/88,C12N15/09;;A61K38/00;;A61K47/48;;A61K48/00;;A61P3/00;;A61P5/06;;A61P9/12;;A61P17/00;;A61P19/02;;A61P21/04;;A61P25/18;;A61P25/28;;A61P29/00;;A61P31/12;;A61P31/14;;A61P31/16;;A61P31/18;;A61P31/22;;A61P35/00;;A61P35/02;;A61P37/02;;A61P37/06;;A61P43/00;;C07K14/82;;C12N5/10;;C12N15/87;;C12N15/88,514/12.000;;530/359.000,,,
72,US,A1,US 2007/0141642 A1,018-983-034-367-630,2007-06-21,2007,US 70454607 A,2007-02-08,JP 2000351741 A 20001117;;JP 2001038619 A 20010215;;JP 2001077000 A 20010316,"Guanosine Triphosphate (gtp)-binding Protein-coupled Receptor Protein, Bg37",BANYU PHARMA CO LTD,MARUYAMA TAKAHARU;;NAKAMURA TAKAO;;ITADANI HIRAKU;;TANAKA KEN-ICHI,https://lens.org/018-983-034-367-630,Patent Application,yes,1,15,15,38,C07K14/705,G01N33/567;;C07K14/705;;C07K14/72;;C12N1/21;;C12N15/12,435/7.200;;530/350.000,,,
73,US,A1,US 2010/0184236 A1,018-691-421-958-778,2010-07-22,2010,US 71690610 A,2010-03-03,JP 2000351741 A 20001117;;JP 2001038619 A 20010215;;JP 2001077000 A 20010316,"Guanosine Triphosphate (gtp)-binding Protein-coupled Receptor Protein, Bg37",BANYU PHARMA CO LTD,MARUYAMA TAKAHARU;;NAKAMURA TAKAO;;ITADANI HIRAKU;;TANAKA KEN-ICHI,https://lens.org/018-691-421-958-778,Patent Application,yes,1,15,15,38,C07K14/705,G01N33/566;;C07K14/435;;C07K14/705;;C12N1/21;;C12N15/12,436/501;;530/350,,,
74,US,A1,US 2011/0104701 A1,107-032-811-850-874,2011-05-05,2011,US 99924209 A,2009-07-09,FR 0854683 A 20080710,Protein Disulfide Isomerase Assay Method For The In Vitro Diagnosis Of Colorectal Cancer,BIOMERIEUX SA,ATAMAN-ONAL YASEMIN;;BEAULIEU CORINNE;;BUSSERET SANDRINE;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;ROLLAND DOMINIQUE,https://lens.org/107-032-811-850-874,Patent Application,yes,11,19,19,18,C12N9/90;;G01N33/57419;;G01N2333/99,C12Q1/68;;C07K7/06;;C07K7/08;;C07K16/00;;G01N33/53,435/6;;435/7.1;;530/327;;530/328;;530/387.9,,,
75,WO,A1,WO 2011/119956 A1,193-785-712-128-881,2011-09-29,2011,US 2011/0029992 W,2011-03-25,US 31819310 P 20100326,Controlled Release Hybrid Systems,INTEGRATECH PROTEOMICS LLC;;SANDROCK TANYA,SANDROCK TANYA,https://lens.org/193-785-712-128-881,Patent Application,yes,1,3,3,19,C12N15/1055,C12N15/10,,10101157;;10838414;;2547163;;7565735;;8242750;;9251017;;9295326,10.1074/JBC.272.38.23799;;10.1016/S0076-6879(97)83013-3;;10.1093/NAR/26.2.623;;10.1038/340245A0;;10.1016/0092-8674(93)90498-F,"KAKIZAWA TOMOKO ET AL: ""Ligand-dependent heterodimerization of thyroid hormone receptor and retinoid X receptor"", JOURNAL OF BIOLOGICAL CHEMISTRY, THE AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, INC., BALTIMORE, MD, US, vol. 272, no. 38, 19 September 1997 (1997-09-19), pages 23799-23804, XP002200320, ISSN: 0021-9258, DOI: DOI:10.1074/JBC.272.38.23799;;FIELDS, SONG NATURE vol. 340, 1989, pages 245 - 246;;GYURIS ET AL. CELL vol. 75, 1993, pages 791 - 803;;BAI, ELLEDGE METHODS ENZYMOL vol. 283, 1997, pages 141 - 156;;ESTOJAK, J. ET AL. MOL. CELL. BIOL. vol. 15, 1995, pages 5820 - 5829;;ABEDI M.R. ET AL. NA.R. vol. 26, no. 2, 1998, pages 623 - 630;;SANDROCK ET AL. GENETICS vol. 151, 1999, pages 1287 - 1297;;ZHANG ET AL. J. BIOMOL. SCREEN. vol. 4, 1999, pages 67 - 73"
76,WO,A2,WO 2006/019430 A2,174-298-311-389-004,2006-02-23,2006,US 2005/0012653 W,2005-04-15,US 56454304 P 20040420,Methods And Compositions For Enhancing Delivery Of Double-stranded Rna Or A Double-stranded Hybrid Nucleic Acid To Regulate Gene Expression In Mammalian Cells,NASTECH PHARM CO;;AHMADIAN MOHAMMAD;;CUI KUNYUAN;;CHEN LISHAN;;CHEN SHU-CHIH;;HOUSTON MICHAEL E JR,AHMADIAN MOHAMMAD;;CUI KUNYUAN;;CHEN LISHAN;;CHEN SHU-CHIH;;HOUSTON MICHAEL E JR,https://lens.org/174-298-311-389-004,Patent Application,yes,9,18,18,21,A61K47/48123;;A61K31/713;;A61K38/00;;A61K45/06;;A61K48/005;;C07K14/00;;C12N15/111;;C12N15/113;;C12N15/1137;;C12N15/87;;C12N2310/14;;C12N2310/3513;;C12N2310/3515;;C12N2320/30;;C12N2320/32;;C12Y302/01023,C12N15/11;;C12N15/113;;C12N15/87,,12074364;;12746552;;14993376;;9576808,10.1021/BC970176Z;;10.1124/MI.2.3.158;;10.1089/108729002760070849;;10.1385/MB:24:2:111,
77,WO,A2,WO 2004/087918 A2,187-298-681-273-991,2004-10-14,2004,FR 2004000744 W,2004-03-25,FR 0303910 A 20030328,Method For The In Vivo Modification Of The Synthesis Activity Of A Metabolite By Means Of The Modification Of A Gene The Activity Of Which Is Not The Original Activity,PASTEUR INSTITUT;;CENTRE NAT RECH SCIENT;;KAMINSKI PIERRE-ALEXANDRE,KAMINSKI PIERRE-ALEXANDRE,https://lens.org/187-298-681-273-991,Patent Application,yes,3,9,11,15,C12N15/1058;;C12N9/1077;;C12N15/102,C12N9/10;;C12N15/10;;C12N15/54,,11722565;;6975103;;8581428;;8617773;;9788999,10.1073/PNAS.95.22.12825;;10.1038/NBT1191-1073;;10.1074/JBC.271.9.4978;;10.1046/J.0014-2956.2001.02523.X;;10.1016/S0006-291X(88)80570-9;;10.1016/0968-0896(95)00030-K;;10.1016/0006-2952(81)90535-9,"CHANG, H.K. ET AL.: ""Directed Evolution of Comamonas testosterone GZ39 m-hydroxybenzoate hydroxylase for the synthesis of 4-substituted catechols"", ABSTRACTS OF THE GENERAL MEETING OF THE AMERICAN SOCIETY FOR MICROBIOLOGY, 2003, XP002297541;;WAN L. ET AL.: ""In vitro evolution of horse heart myoglobin to increase peroxydase activity"", PNAS, vol. 95, no. 22, 1998, pages 12825 - 12831"
78,US,B2,US 8686049 B2,108-491-848-788-276,2014-04-01,2014,US 30540307 A,2007-05-21,JP 2006173455 A 20060623,Agent For Increasing Testosterone Level,KOMAI MICHIO;;SHIRAKAWA HITOSHI;;OHSAKI YUSUKE;;TAKUMI TADASHI;;ITO ASAGI;;SATO TOSHIRO;;OZAKI RUMI;;UNIV TOHOKU,KOMAI MICHIO;;SHIRAKAWA HITOSHI;;OHSAKI YUSUKE;;TAKUMI TADASHI;;ITO ASAGI;;SATO TOSHIRO;;OZAKI RUMI,https://lens.org/108-491-848-788-276,Granted Patent,yes,0,12,12,2,A61K31/122,A61K31/122;;A23L33/15,514/681,14749457;;16844298,10.1016/J.BBAGEN.2006.05.008;;10.1056/nejmra022251,"Sirakawa et al., Biochemica et Biophysica Acta, 2006, vol. 1760, pp. 1482-1488, available online Jun. 6, 2006.;;Mayo Clinic Staff, ""Male hypogonadism"", MayoClinic.com Reprints, Dec. 9, 2010, pp. 1-10, downloaded from http://www.mayoclinic.com/health/male-hypogonadism/DS00300.;;Merriam-Webster online dictionary, ""andropause"", Merriam-Webster, downloaded from ""http://www.merriam-webster.com/medical/andropause"" on Nov. 19, 2011, p. 1 of 1.;;Rhoden et al., New England Journal of Medicine, 2004, vol. 350, pp. 482-492.;;Vitamin K deficiency reduces testosterone production in the testis through down-regulation of the Cyp11a a cholesterol side chain cleavage enzyme in rats; Hitoshi Shirakawa; Yusuke Ohsaki; Yoshihiko Minegishi; Naofumi Takumi: Kousaku Ohinata; Yuji Furukawa; Takeo Mizutani; Michio Komai; Biochimica et Biophysica Acta 1760 (2006) pp. 1482-1488.;;Recent Topics in the Studies of Laboratory of Nutrition, Tohoku University: Newly Clarified Function of Vitamin K; Michio Komai; Yusuke Ohaski; Yoshihiko Minegishi; Naofumi Takumi; Yuji Furukawa and Hitoshi Shirakawa; Tohoku Journal of Agricultural Research; Vo. 57. No. 1, Nov. 2006; pp. 19-31."
79,US,A1,US 2008/0261304 A1,141-847-218-916-211,2008-10-23,2008,US 1327408 A,2008-01-11,US 56454304 P 20040420,Methods And Compositions For Enhancing Delivery Of Double-stranded Rna Or A Double-stranded Hybrid Nucleic Acid To Regulate Gene Expression In Mammalian Cells,NASTECH PHARM CO,AHMADIAN MOHAMMAD;;CUI KUNYUAN;;CHEN LISHAN;;CHEN SHU-CHIH;;HOUSTON MICHAEL E,https://lens.org/141-847-218-916-211,Patent Application,yes,2,18,18,21,A61K47/48123;;A61K31/713;;A61K38/00;;A61K45/06;;A61K48/005;;C07K14/00;;C12N15/111;;C12N15/113;;C12N15/1137;;C12N15/87;;C12N2310/14;;C12N2310/3513;;C12N2310/3515;;C12N2320/30;;C12N2320/32;;C12Y302/01023,C12N5/02;;C07H21/02;;C12N15/11;;C12N15/113;;C12N15/87,435/375;;536/24.5,,,
80,US,A1,US 2006/0052435 A1,047-775-133-710-276,2006-03-09,2006,US 49921005 A,2005-08-26,GB 0130219 A 20011218,Selective Dopamin D3 Receptor Agonists For The Treatment Of Sexual Dysfunction,VAN DER GRAAF PIETER H;;WAYMAN CHRISTOPHER PETER;;BAXTER ANDREW D;;COOK ANDREW S;;WONG STEPHEN K,VAN DER GRAAF PIETER H;;WAYMAN CHRISTOPHER PETER;;BAXTER ANDREW D;;COOK ANDREW S;;WONG STEPHEN K,https://lens.org/047-775-133-710-276,Patent Application,yes,3,18,18,5,A61K31/5375;;A61K31/00;;A61K45/06,A61K31/405;;A61K45/00;;A61K31/00;;A61K31/5375;;A61K45/06;;A61P15/00;;A61P15/10;;A61P43/00,514/419.000,,,
81,WO,A1,WO 2003/051370 A1,122-717-817-961-968,2003-06-26,2003,GB 0205595 W,2002-12-10,GB 0130219 A 20011218,Selective Dopamin D3 Receptor Agonists For The Treatment Of Sexual Dysfunction,PFIZER LTD;;VAN DER GRAAF PIETER HADEWIJN;;WAYMAN CHRISTOPHER PETER;;BAXTER ANDREW DOUGLAS;;COOK ANDREW SIMON;;WONG STEPHEN KWOK-FUNG;;PFIZER,VAN DER GRAAF PIETER HADEWIJN;;WAYMAN CHRISTOPHER PETER;;BAXTER ANDREW DOUGLAS;;COOK ANDREW SIMON;;WONG STEPHEN KWOK-FUNG,https://lens.org/122-717-817-961-968,Patent Application,yes,10,18,18,5,A61K31/5375;;A61K31/00;;A61K45/06,A61K45/00;;A61K31/00;;A61K31/5375;;A61K45/06;;A61P15/00;;A61P15/10;;A61P43/00,,10082211;;1354263,10.1016/S0014-2999(98)00896-6;;10.1021/JM00094A019;;10.1016/S0090-4295(99)00230-7,"PERRONE, ROBERTO ET AL: ""Oxygen isosteric derivatives of 3-(3-hydroxyphenyl)-N-n- propylpiperidine"" JOURNAL OF MEDICINAL CHEMISTRY (1992), 35(16), 3045-9 , 1992, XP001147043;;BERMAN J R ET AL: ""FEMALE SEXUAL DYSFUNCTION: INCIDENCE, PATHOPHYSIOLOGY, EVALUATION, AND TREATMENT OPTIONS"" UROLOGY, BELLE MEAD, NJ, US, vol. 54, September 1999 (1999-09), pages 385-391, XP000891790 ISSN: 0090-4295 cited in the application;;PERACHON SYLVIE ET AL: ""Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors."" EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 366, no. 2-3, 5 February 1999 (1999-02-05), pages 293-300, XP002238224 ISSN: 0014-2999 cited in the application"
82,US,A1,US 2009/0246785 A1,185-829-757-623-095,2009-10-01,2009,US 40459009 A,2009-03-16,US 67949705 P 20050510,Novel Steroid 5-alpha-reductase,MOHLER JAMES L;;TITUS MARK;;KOZYREVA OLGA;;FORD III O HARRIS;;KAWINSKI ELSBIETA;;LI YUN,MOHLER JAMES L;;TITUS MARK;;KOZYREVA OLGA;;FORD III O HARRIS;;KAWINSKI ELSBIETA;;LI YUN,https://lens.org/185-829-757-623-095,Patent Application,yes,0,6,6,10,C12Q1/26;;C07K2319/21;;C07K2319/40;;C12N9/001;;C12N2799/022;;G01N33/57434,C12Q1/68;;C12Q1/26,435/6;;435/25,,,
83,US,B2,US 9353395 B2,065-114-265-454-977,2016-05-31,2016,US 201213655865 A,2012-10-19,JP 2003340092 A 20030930,Glucose Dehydrogenase/cytochrome Fusion Protein,ARKRAY INC;;ULTIZYME INT LTD,SODE KOJI,https://lens.org/065-114-265-454-977,Granted Patent,yes,0,12,12,6,C12Q1/006;;C07K2319/00;;C12N9/0004;;C12N9/0006;;C12Y101/05002,A61K39/00;;C12N1/15;;C12N1/19;;C12N1/21;;C12N9/02;;C12N9/04;;C12Q1/00,,11714714;;12706581;;14741705;;15197260,10.1016/S0956-5663(03)00037-X;;10.1074/JBC.M109403200;;10.1073/PNAS.0403255101;;10.1016/J.BBRC.2003.12.167;;10.1081/al-120006723,"Oubrie et al., ""Crystal Structure of Quinohemoprotein Alcohol Dehyrdogenase from Comamonas testosteroni,"" Journal of Biological Chemistry, 277: 3727-3732 (2002).;;Okuda et al., ""PQQ glucose dehydrogenase with novel electron transfer ability,"" Biochemical and Biophysical Research Communications, 314: 793-797 (2004).;;International Search Report issued in corresponding International Patent Application No. PCT/JP2004/014575 dated Nov. 30, 2004.;;Guo et al., ""Protein tolerance to random amino acid change,"" PNAS, 101: 9205-9210.;;Okuda et al., ""Glucose enzyme electrode using cytochrome b562 as an electron mediator,"" Biosensors and Bioelectronics, 18, 699-704 (2003).;;Okuda et al., ""The application of cytochromes as the interface molecule to facilitate the electron transfer for PQQ glucose dehydrogenase employing mediator type glucose sensor,"" Analytical letters, 35, 1465-1478 (2002).;;Office Action in Japanese Patent Application No. 2014-121125 issued on Aug. 18, 2015."
84,US,A,US 5786179 A,096-841-702-927-409,1998-07-28,1998,US 48263895 A,1995-06-07,US 48263895 A 19950607;;US 39555495 A 19950228;;US 20296494 A 19940228,Heterologous Protein Comprising Avian Alpha-subunit Inhibin Protein And Methods Of Producing Same,AGRITECH TECHNOLOGIES LTD;;UNIV LOUISIANA STATE,FIORETTI WILLIAM C;;KOUSOULAS KONSTANTIN;;SATTERLEE DANIEL G,https://lens.org/096-841-702-927-409,Granted Patent,yes,13,1,45,4,A61K39/0005;;A01K2217/05;;A01K2227/30;;A01K2267/02;;A61K38/00;;A61K2039/6068;;C07K14/575;;C07K2319/00;;C12N15/8509,A61K38/00;;A61K39/00;;C07K14/575;;C12N15/85,435/69.7;;435/69.4;;435/172.3;;435/320.1;;435/252.3;;435/325;;530/350;;530/397;;530/399;;536/23.4;;536/23.51,1320308;;1500838;;1518004;;1625233;;16726904;;1707868;;2115710;;2231542;;2315699;;2752983;;3082696;;3127517;;3133192;;3136065;;3148911;;3458167;;3655607;;7542343;;7990647;;8030220;;8286568;;8399835;;8405890;;8418903;;8439615;;8464014;;8464018;;8502617;;8504921,10.1095/BIOLREPROD49.5.1026;;10.1530/JRF.0.1030285;;10.1210/ENDO-123-1-120;;10.3382/PS.0671625;;10.1095/BIOLREPROD48.2.262;;10.1677/JOE.0.1160293;;10.1016/0093-691X(91)90284-K;;10.1095/BIOLREPROD49.3.453;;10.1677/JOE.0.1340011;;10.3382/PS.0720955;;10.1016/0303-7207(86)90133-4;;10.1006/GCEN.1993.1058;;10.1006/GCEN.1993.1103;;10.1530/JRF.0.0900199;;10.1126/SCIENCE.2315699;;10.1677/JOE.0.114R001;;10.1530/JRF.0.0970213;;10.1530/JRF.0.0970255;;10.1073/PNAS.83.10.3091;;10.1006/VIRO.1994.1376;;10.1159/000180934;;10.1210/ENDO-125-2-898;;10.1095/BIOLREPROD48.1.15;;10.1016/0024-3205(94)00519-2;;10.1016/0264-410X(92)90356-O;;10.1530/JRF.0.0950489;;10.1530/JRF.0.0950175,"Synthetic Peptide Segments of Inhibin and Subunits: Preparation and Characterization of Polyclonal Antibodies , Saito et al., Endocrinology , 1989, vol. 125, No. 2, pp. 898 905.;;Daniel et al. Virology 202:540 549, 1994.;;Sambrook et al. Molecular Cloning, A Laboratory Manual, Second Edition, Cold Spring Harbor Laboratory Press, Plainview, NY, pp. 17.2 17.9, 1989.;;Murdoch, W.J., Immunoregulation of mammalian fertility, Life Sci., vol. 55 (24), pp. 1871 1886 (1994).;;Forage, R.G. et al., Immunization against an inhibin subunit produced by recombinant DNA techniques results in increased ovulation rate in sheep, J. Endocrinol., vol. 114 (2), pp. R1 R4 (Aug. 1987).;;Morris, D.G. et al., Effect of immunization against synthetic peptide sequences of the alpha N subunit of bovine inhibin on ovulation rate, gonadotrophin concentrations and fertility in heifers, J. Reprod. Fertil., vol. 103 (2), pp. 285 291 (Mar. 1995).;;Bowie et al. 1990. Science 247:1306 1310.;;Forage et al. 1986. PNAS USA 83:3091 3095.;;Brown et al. 1990. J Reprod. 90:199 205.;;Wang et al. 1993. Biol. Reprod. 49:453 458.;;Forage et al. 1987. J. Endocrinol. 114:R1 R4.;;Fraser et al., Does inhibin have an endocrine role during the luteal phase of the primate menstrual cycle , Journal of Reproduction and Fertility, No. 11, Abstract No. 78 (Jul. 1993).;;Webley et al., Inverse relationship between progesterone and inhibin subunit production by marmoset luteal cells in vitro , Journal of Reproduction and Fertility, No. 11, Abstract No. 155 (Jul. 1993).;;Morris et al., Effect of immunization against bovine inhibin peptides on FSH and LH in heifers , Journal of Reproduction and Fertility, No. 11, Abstract No. 156 (Jul. 1993).;;Rivier et al., Studies of the Inhibin Family of Hormones: A Review , Hormone Res., vol. 28, pp. 104 118 (1987).;;Akashiba et al., Secretion of Inhibin by Chicken Granulosa Cells in Vitro , Poultry Science, vol. 67, pp. 1625 1631 (1988).;;Findlay, An Update on the Roles of Inhibin, Activin, and Follistatin as Local Regulators of Folliculogenesis , Biology of Reproduction, vol. 48, pp. 15 23 (1993).;;Johnson et al., The molecular biology and endocrinology of inhibin in the domestic hen , Journal of Endocrinology, pp. 297 308, (1993).;;Johnson et al., Characterization of a Source and Levels of Plasma Immunoreactive Inhibin during the Ovulatory Cycle of the Domestic Hen , Biology of Reproduction, vol. 48, pp. 262 267 (1993).;;Johnson et al., Characterization and Quantitation of mRNA for the Inhibin Subunit in the Granulosa Layer of the Domestic Hen , General and Comparative Endocrinology, vol. 90, pp. 43 50 (1993).;;Johnson et al., Plasma Concentrations of Immunoeractive Inhibin and Gonadotropins following Removal of Ovarian Follicles in the Domestic Hen , Biology and Reproduction, vol. 49, pp. 1 6 (1993).;;McNatty et al., Contrations of immunoreactive inhibin in ovarian and peripheral venous plasma and follicular fluid of Booroola ewes that are homozygous carriers or non carriers of the Fec B gene , J. Reprod. Fert., vol. 95, pp. 489 502 (1992).;;Rivier et al., Age Dependent Changes in Physiological Action, Content, and Immunostaining of Inhibin in Male Rates , Endocrinology, vol. 123, pp. 120 126 (1988).;;Robertson et al., Isolation of a 31 kDa form of inhibin from bovine follicular fluid , Molecular and Cellular Endocrinology, vol. 44, pp. 271 277 (1986).;;Scanlong et al., Active immunization of heifers against a synthetic fragment of bovinc inhibin , Journal of Reproduction and Fertility, vol. 97, pp. 213 222 (1993).;;Tsonis et al., Inhibin bioactivity and pituitary cell mitogenic activity from cultured chicken ovarian granulosa and thecal/stromal cells , Journal of Endocrinology, vol. 116, pp. 293 299 (1988).;;Glencross et al., Effect of active immunization of heifers against inhibin on plasma FSH concentrations, ovarian follicular development and ovulation rate , Journal of Endocrinology, vol. 135, pp. 11 18 (1992).;;Johnson, Inhibin in the Hen , Poultry Sciences, vol. 72, pp. 955 958 (1993).;;Meyer et al., Antiserum to an inhibin alpha chain peptide neutralizes inhibin bioactivity and increases ovulation rate in sheep , J. Anim. Science, vol. 69, pp. 747 754 (1991).;;Morris et al., Effect of immunizing prepuberal lambs of low and high ovulation rate genotypes with inhibin partially purified from bovine follicular fluid , Theriogeneology, vol. 35, No. 2, pp. 339 350 (Feb. 1991).;;Morris et al., Effect of immunization against synthetic peptide sequences of bovine inhibin subunit on ovulation rate and twin calving rate in heifers , Journal of Reproduction and Fertility, vol. 97, pp. 255 261 (1993).;;Risridger et al., Current perspectives of inhibin biology , Acta Endocrinologica ( Copenh ), vol. 122 pp. 673 682 (1990).;;Wang et al., Increase in Ovarian inhibin Gene Expression and Plasma Immunoeractive Inhibin Level Is Correlated with a Decrease in Ovulation Rate in the Domestic Hen , General and Comparative Endocrinology, vol. 91, pp. 52 58 (1993).;;Wang et al., Complementary Deoxyribonucleic Acid Cloning and Sequence Analysis of the Subunit of Inhibin from Chicken Ovarian Granulosa Cells , Biology of Reproduction, vol. 49, pp. 1 6 (1993).;;Wrathall et al., Effects of active immunization against a synthetic peptide sequence of the inhibin subunit on plasma gonadotrophin concentrations, ovalation rate and lambing rate in ewes , J. Reprod. Fert. vol. 95, pp. 175 182 (1992).;;North et al., Flock Recycling , Commerical Chicken Production Manual, Van Nostrand Reinhold, New york, pp. 434 439 (date unknown).;;Chinnah et al., Antigen dependent adjuncant activity of a polydispersed (1 4) linked acetylated mannan (acemannan), vaccine, vol. 10(8), pp. 551 557 (1992).;;Chouljenko et al., Expression and Purification of Chicken and Inhibition as a Fusion Protein with the E. Coli Maltose Binding Protein, Poultry Science, vol. 73 (Suppl. 1), p. 84 (1994)."
85,WO,A2,WO 2002/046386 A2,028-762-535-183-438,2002-06-13,2002,US 0151070 W,2001-10-26,US 24430000 P 20001030,Aspergillus Ochraceus 11 Alpha Hydroxylase And Oxidoreductase,PHARMACIA CORP;;BOLTON SUZANNE;;CLAYTON ROBERT;;EASTON ALAN;;ENGEL LESLIE;;MESSING DEAN,BOLTON SUZANNE;;CLAYTON ROBERT;;EASTON ALAN;;ENGEL LESLIE;;MESSING DEAN,https://lens.org/028-762-535-183-438,Patent Application,yes,5,17,17,65,C12N9/0083;;C07K14/38;;C07K16/40;;C12N1/14;;C12N3/00;;C12N9/0004;;C12N2799/026;;C12P33/10,G01N33/536;;A61K35/74;;A61P9/00;;A61P19/02;;A61P29/00;;A61P35/00;;C07K1/02;;C07K14/38;;C07K16/40;;C07K19/00;;C12N1/14;;C12N1/15;;C12N1/19;;C12N1/21;;C12N3/00;;C12N5/10;;C12N9/02;;C12N15/09;;C12P21/08;;C12P33/10;;C12Q1/26;;G01N33/573,,10852481;;1417773;;3657154;;6409103;;6810893;;7646819;;9484480,10.1016/0022-4731(87)91026-0;;10.1089/DNA.1995.14.719;;10.1016/0006-291X(83)91753-9;;10.1016/0006-291X(82)91248-7;;10.1007/S004380051207;;10.1023/A:1005915507497;;10.1097/00008571-199602000-00002,
86,US,B2,US 7052908 B2,187-904-264-656-016,2006-05-30,2006,US 44275403 A,2003-05-20,US 35422199 A 19990715;;US 9323998 P 19980717;;US 10024398 P 19980914,Androgen Receptor Coactivators,UNIV ROCHESTER,CHANG CHAWNSHANG,https://lens.org/187-904-264-656-016,Granted Patent,yes,9,4,13,12,C07K14/721;;C07K14/4705;;G01N2333/723,C12N5/00;;C07K14/47;;C07K14/72;;C12N5/12;;C12P21/06,435/325;;435/69.1;;435/320.1;;536/23.5;;530/350,10075738;;10085091;;10318905;;10320776;;10400640;;10422847;;10428808;;10438502;;10500149;;10606230;;10611280;;10701889;;10709768;;10987273;;11016951;;11063747;;11248024;;11389051;;1329054;;1423625;;1467876;;1469049;;1631125;;1668832;;1730684;;1825028;;1907890;;2030914;;2062380;;2217208;;2260966;;2300823;;2588006;;2673546;;388439;;5432063;;7508789;;7545954;;7596417;;7681583;;7700385;;7723794;;7724562;;7729428;;7736585;;7776974;;7796903;;7845865;;7929269;;7929412;;7954790;;8152432;;8187068;;8325509;;8380224;;8421085;;8490963;;8552662;;8643607;;8743879;;8799122;;8943817;;8996076;;9121269;;9139732;;9192902;;9252329;;9270977;;9499421;;9576916;;9636157;;9675141;;9736693;;9865729,10.1016/0092-8674(94)90191-0;;10.1073/PNAS.93.11.5517;;10.1073/PNAS.96.10.5458;;10.1073/PNAS.76.9.4350;;10.1126/SCIENCE.7545954;;10.1073/PNAS.190353897;;10.1126/SCIENCE.2300823;;10.1126/SCIENCE.277.5328.965;;10.1016/S0955-0674(96)80002-0;;10.1002/PROS.2990210207;;10.1073/PNAS.061305498;;10.1007/BF00185075;;10.1007/S11745-997-0109-X;;10.1002/PROS.2990260108;;10.1016/0092-8674(95)90385-2;;10.1073/PNAS.93.1.465;;10.1073/PNAS.93.17.8884;;10.1038/374562A0;;10.1016/0092-8674(92)90603-A;;10.1073/PNAS.95.19.11083;;10.1093/HMG/7.4.679;;10.1210/ME.8.1.77;;10.1083/JCB.119.6.1573;;10.1073/PNAS.89.14.6319;;10.1210/ME.9.2.243;;10.1074/JBC.274.12.8316;;10.1111/J.1464-410X.1992.TB15865.X;;10.1073/PNAS.96.20.11173;;10.1073/PNAS.92.8.3328;;10.1074/JBC.274.32.22373;;10.1016/S0140-6736(05)61756-4;;10.1038/42750;;10.1074/JBC.M008207200;;10.1038/227680A0;;10.1110/PS.8.7.1557;;10.1210/JC.76.1.17;;10.1056/NEJM199505253322101;;10.1073/PNAS.95.13.7379;;10.1006/BBRC.1998.8974;;10.1073/PNAS.95.10.5527;;10.1074/JBC.274.33.23270;;10.1016/0092-8674(89)90517-5;;10.1002/(SICI)1096-9896(199609)180:1<65::AID-PATH607>3.0.CO;2-C;;10.1016/0092-8674(81)90019-2;;10.1016/0092-8674(91)90236-R;;10.1385/ENDO:11:2:195;;10.1046/J.1442-2042.2000.00129.X;;10.1016/0014-5793(95)00587-Y;;10.1074/JBC.274.13.8570;;10.1016/S0006-291X(05)80067-1;;10.1074/JBC.272.19.12738;;10.1038/375812A0;;10.1016/0092-8674(93)90137-F;;10.1073/PNAS.90.6.2112;;10.1016/0378-1119(93)90275-8;;10.1038/352077A0;;10.1093/NAR/22.15.3181;;10.1073/PNAS.96.26.14724;;10.1073/PNAS.87.19.7762;;10.3322/CANJCLIN.47.1.5;;10.1126/SCIENCE.2588006;;10.1074/JBC.274.29.20229,"Anderson et al. Retinoblastoma protein in human breast carcinoma: immunohistochemical study using a new monoclonal antibody effective on routinely processed tissues. J Pathol. Sep. 1996;180(1):65-70.;;Anzick et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. Aug. 15, 1997;277(5328):965-8.;;Beddow et al. The Ran/TC4 GTPase-binding domain: identification by expression cloning and characterization of a conserved sequence motif. Proc Natl Acad Sci U S A. Apr. 11, 1995;92(8):3328-32.;;Blake et al. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene. Apr. 1991;6(4):653-7.;;Bookstein et al. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc Natl Acad Sci U S A. Oct. 1990;87(19):7762-6.;;Bookstein et al. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science. Feb. 9, 1990;247(4943):712-5.;;Borden et al. The solution structure of the RING finger domain form the acute promyelocytic leukaemia proto-oncoprotein PML. EMBO J. Apr. 3, 1995;14(7):1532-41.;;Brooks et al. Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas. Prostate. Jan. 1995;26(1):35-9.;;Cardoso et al. Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein. Hum Mol Genet. Apr. 1998;7(4):679-84.;;Chamberlain et al. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. Aug. 11, 1994;22(15):3181-6.;;Chang et al. Suppression of Delta(5)-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells. Proc Natl Acad Sci U S A. Sep. 28, 1999;(20):11173-7.;;Chen et al. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell. Sep. 22, 1989;58(6):1193-8.;;Chen et al. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc Natl Acad Sci U S A. Jan. 9, 1996;93(1):465-9.;;Crawford, Challenges in the management of prostate cancer. Br J Urol. Nov. 1992;70 Suppl 1:33-8.;;Dowdy et al. Physical interaction of the retinoblastoma protein with human D cyclins. Cell. May 7, 1993;73(3):499-511.;;Dynlacht et al. Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation. Cell. Aug. 9, 1991;66(3):563-76.;;Fujimoto et al. Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. J Biol Chem. Mar. 19, 1999;274(12):8316-21.;;Gaddipati et al. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res. Jun. 1, 1994;54(11):2861-4.;;Gregory et al. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. Cancer Res. Dec. 15, 1998;58(24):5718-24.;;Gregory, C.W. et al. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 61, 4315-4319. (2001).;;Gu et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell. Nov. 13, 1992;71(4):701-8.;;Han et al., Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer. J Biol Chem. Apr. 6, 2001;276(14):11204-13.;;Heery et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. Jun. 12, 1997;387(6634):733-6.;;Hillier et al. Wash U-Merck EST Project 1997. EMBL ACC No.: AA448471 (Jun. 10, 1997).;;Hsiao et al. The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator. J Biol Chem. Jul. 16, 1999;274(29):20229-34.;;Hsiao, P., and Chang, C. Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells. J Biol Chem. Aug. 6, 1999;274(32):22373-9.;;Ishida et al. Cloning and chromosome mapping of the human Mel-18 gene which encodes a DNA-binding protein with a new 'RING-finger' motif. Gene. Jul. 30, 1993;129(2):249-55.;;Kaelin et al. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell. Feb. 8, 1991;64(3):521-32.;;Kang et al. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J Biol Chem. Mar. 26, 1999;274(13):8570-6.;;Kang et al. From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells. Proc Natl Acad Sci U S A. Mar. 13, 2001;98(6):3018-23.;;Kemppainen et al. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem. Jan. 15, 1992;267(2):968-74.;;Kokontis et al. Expression and function of normal and LNCaP androgen receptors in androgen-insensitive human prostatic cancer cells. Altered hormone and antihormone specificity in gene transactivation. Receptor. 1991;1(4):271-9.;;Kranenburg et al. Cyclin-dependent kinases and pRb: regulators of the proliferation-differentiation switch. FEBS Lett. Jun. 26, 1995;367(2):103-6.;;La Spada et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. Jul. 4, 1991;352(6330):77-9.;;Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. Aug. 15, 1970;227(259):680-5.;;Lee et al. Convergence of two repressors through heterodimer formation of androgen receptor and testicular orphan receptor-4: a unique signaling pathway in the steroid receptor superfamily. Proc Natl Acad Sci U S A. Dec. 21, 1999;96(26):14724-9.;;Lee et al. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol Endocrinol. Feb. 1995;9(2):243-54.;;Lovering et al. Identification and preliminary characterization of a protein motif related to the zinc finger. Proc Natl Acad Sci U S A. Mar. 15, 1993;90(6):2112-6.;;Ludlow et al. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol Cell Biol. Jan. 1993;13(1):367-72.;;McPhaul et al. Genetic basis of endocrine disease. 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metab. Jan. 1993;76(1):17-23.;;Mihara et al. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science. Dec. 8, 1989;246(4935):1300-3.;;Miki et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. Oct. 7, 1994;266(5182):66-71.;;Mitchell et al. Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer Res. Dec. 1, 1999;59(23):5892-5.;;Miyamoto and Chang, Antiandrogens fail to block androstenedione-mediated mutated androgen receptor transactivation in human prostate cancer cells. Int J Urol. Jan. 2000;7(1):32-4.;;Miyamoto et al. Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells. Proc Natl Acad Sci U S A. Sep. 15, 1998;95(19):11083-8.;;Miyamoto et al. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proc. Natl. Acad. Sci. USA 95:7379-7384 (Jun. 1998).;;Mizokami and Chang, Induction of translation by the 5'-untranslated region of human androgen receptor mRNA. J Biol Chem. Oct. 14, 1994;269(41):25655-9.;;Mizokami et al. Identification of 3',5'-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter. Mol Endocrinol. Jan. 1994;8(1):77-88.;;Mowszowicz et al. Complete androgen insensitivity due to a single base substitution in exon 8 of the steroid-binding domain of the androgen receptor gene. Endocrine 1:203-209 (1993).;;Narusaka et al. In vitro random mutagenesis of the D1 protein of the photosystem II reaction center confers phototolerance on the cyanobacterium Synechocystis sp. PCC 6803. J Biol Chem. Aug. 13, 1999;274(33):23270-5.;;Newmark et al. Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci U S A. Jul. 15, 1992;89(14):6319-23.;;Park et al. Effects of Conjugated Linoleic Acid on Body Composition in Mice Lipids 32(8):853-858 (1997).;;Parker et al. Cancer statistics, 1997. CA Cancer J Clin. Jan.-Feb. 1997;47(1):5-27.;;Pugh, Mechanisms of transcription complex assembly. Curr Opin Cell Biol. Jun. 1996;8(3):303-11.;;Ruckle et al., Prostate-specific antigen and androgen deprivation therapy. World J Urol. 1993;11(4):227-32.;;Sadler et al. Zyxin and cCRP: two interactive LIM domain proteins associated with the cytoskeleton. J Cell Biol. Dec. 1992;119(6):1573-87.;;Sarkar et al. Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas. Prostate. 1992;21(2);145-52.;;Schmeichel & Beckerle, The LIM domain is a modular protein-binding interface. Cell. Oct. 21, 1994;79(2):211-9.;;Schmeichel and Beckerle The LIM domain is a modular protein-binding interface. Cell. Oct. 21, 1994;79(2):211-9.;;Shibanuma et al. Characterization of the TGF beta 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence. J Biol Chem. Oct. 28, 1994;269(43):26767-74.;;Singh et al. A role for retinoblastoma protein in potentiating transcriptional activation by the glucocoticoid receptor. Nature. Apr. 6, 1995;374(6522):562-5.;;Smith et al. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc Natl Acad Sci U S A. Aug. 20, 1996;93(17):8884-8.;;Taplin et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med. May 25, 1995;332(21):1393-8.;;Towbin et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. Sep. 1979:76(9):4350-4.;;Truica et al. Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res. Sep. 1, 2000;60(17):4709-13.;;Ueki et al. Isolation and characterization of a novel human gene (HFB30) which encodes a protein with a RING finger motif. Biochim Biophys Acta. May 14, 1999;1445(2):232-6.;;Van der Reijden, TRIADs: a new class of proteins with a novel cysteine-rich signature. Protein Sci. Jul. 1999;8(7):1557-61.;;Veldscholte et al. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun. Dec. 14, 1990;173(2):534-40.;;Wang, Ph.D. Thesis of University of Wisconsin-Madison (1997).;;Weinberg, The retinoblastoma protein and cell cycle control. Cell. May 5, 1995;81(3):323-30.;;Weintraub et al. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature. Jun. 29, 1995;375(6534):812-5.;;Yeh and Chang, Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci U S A. May 28, 1996;93(11):5517-21.;;Yeh et al. ""Hydroxyflutamide may not always be a pure antiandrogen."" Lancet. Mar. 22, 1997;349(9055):852-3.;;Yeh et al. Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells. Endocrine. Oct. 1999;11(2):195-202.;;Yeh et al. From estrogen to androgen receptor: a new pathway for sex hormones in prostate. Proc Natl Acad Sci U S A. May 12, 1998;95(10):5527-32.;;Yeh et al. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc Natl Acad Sci U S A. May 11, 1999;96(10):5458-63.;;Yeh et al. Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells. Proc Natl Acad Sci U S A. Oct. 10, 2000;97(21):11256-61.;;Yeh et al. Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells. Biochem Biophys Res Commun. Jul. 20, 1998;248(2):361-7.;;Zarkowska and Mittnacht, Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J Biol Chem. May 9, 1997;272(19):12738-46."
87,US,B2,US 7087714 B2,084-113-241-191-281,2006-08-08,2006,US 18508302 A,2002-06-28,US 30207201 P 20010629,Mu-opiod Receptor Splice Variant Polypeptides,SLOAN KETTERING INST CANCER,PASTERNAK GAVRIL W;;PAN YING-XIAN,https://lens.org/084-113-241-191-281,Granted Patent,yes,3,8,8,56,C07K14/705;;C12N15/1138;;C12N2310/11;;G01N33/9486,C07K1/00;;A61K38/00;;A61K38/17;;C07K14/00;;C07K14/705;;C07K17/00;;G01N33/53;;G01N33/567;;G01N33/94,530/350;;435/7.1;;435/7.2,12589820;;1324310;;1388286;;1397330;;14907713;;1652044;;1824728;;2009325;;2531466;;2695901;;2838048;;3920533;;6095112;;6273857;;6436822;;6572959;;7242681;;7491712;;7509520;;7512709;;7532594;;7648268;;7649256;;7667899;;7685116;;7706278;;7752808;;7797593;;7934650;;7957926;;8089277;;8090773;;8093680;;8196473;;8234282;;8393525;;8393575;;8700136;;8782866;;8891615;;8892377;;8898097;;9103486;;9218123;;9316853;;9874806,10.1016/0304-3940(96)12976-1;;10.1073/PNAS.90.11.5162;;10.1038/312604A0;;10.1016/0014-5793(95)00757-Z;;10.1073/PNAS.90.21.10230;;10.1016/S0006-291X(03)00089-5;;10.1016/0006-8993(96)00089-3;;10.1126/SCIENCE.2531466;;10.1016/0006-8993(95)00222-C;;10.1016/0166-2236(93)90194-Q;;10.1016/S0898-6568(96)00174-X;;10.1002/MED.2610110402;;10.1095/BIOLREPROD44.2.238;;10.1016/0014-5793(96)01023-X;;10.1016/S0165-6147(00)89068-9;;10.1002/CNE.903450104;;10.1016/0167-0115(94)90468-5;;10.1146/ANNUREV.IY.06.040188.001251;;10.1073/PNAS.78.10.6181;;10.1074/JBC.270.26.15877;;10.1016/S0165-6147(00)89034-3;;10.1016/0014-5793(94)01129-X;;10.3109/10799899209074796;;10.1038/314452A0;;10.1073/PNAS.91.19.9081;;10.1016/0014-5793(95)00028-8;;10.1073/PNAS.80.7.2026;;10.1016/0014-5793(92)81122-3;;10.1073/PNAS.90.14.6736;;10.1016/0024-3205(94)00794-2;;10.1016/0014-2999(96)00578-X;;10.1097/00002826-199302000-00001;;10.1126/SCIENCE.1824728;;10.1073/PNAS.81.21.6851;;10.1074/JBC.270.13.7354;;10.1038/292154A0;;10.1126/SCIENCE.1388286;;10.1016/0196-9781(89)90020-X;;10.1016/0024-3205(94)00753-5;;10.1016/0304-3959(94)90151-1;;10.1073/PNAS.96.1.260;;10.1016/0024-3205(95)00119-Q,"Abbadie et al. (1999) ""Neurons in the dorsal column white matter of the spinal cord: complex neuropilin an unexpected location"" Proc. Natl. Acad. Sci. USA 96:260-265.;;Bare et al. (1994) ""Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain"" FEBS Lett. 354:213-6.;;Chen et al. (1993)""Molecular cloning and functional expression of a mu-opioid receptor from rat brain"" Mol. Pharmacol. 44:8-12.;;Cole et al. (1985) ""Monoclonal Antibodies and Cancer Therapy"" Alan R. Liss, Inc., pp. 77-96.;;Cote et al. (1983) ""Generation of human monoclonal antibodies reactive with cellular antigens"" Proc. Natl. Acad. Sci. USA 80:2026-2030.;;Delfs et al. (1994) ""Expression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level""0 J. Comp. Neurol. 345:46-68.;;Elliott et al. (1994) ""The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids"" Pain 56:69-75.;;Evans et al. (1981) ""Establishment in culture of pluripotential cells from mouse embryos"" Nature 292:154-6.;;Giros et al. (1995) ""Chromosomal localization of opioid peptide and receptor genes in the mouse"" Life Sci. 56:369-375.;;Guiramand et al. (1995) ""Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins"" J. Biol. Chem. 270:7354-58.;;Huse et al. (1999) ""Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda"" Science 246:1275-81.;;Kolesnikov et al. (1994) ""1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance"" Life Sci. 55:1393-98.;;Kolesnikov et al. (1993) ""Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor"" Proc. Natl. Acad. Sci. USA 90:5162-5166.;;Liang et al. (1995) ""Cloning and characterization of the promoter region of the mouse mu opioid receptor gene"" Brain Res. 679:82-88.;;Lowry et al. (1951) ""Protein measurement with the folin phenol reagent"" J. Biol. Chem. 193:265-75.;;Lucas et al. (1995) ""New players in the 5-HT receptor field: genes and knockouts"" TiPS 16:246-252.;;Lutz et al. (1992) ""Opioid receptors and their pharmacological profiles"" J. Receptor Res. 12:267-286.;;Min et al. (1994) ""Genomic Structure analysis of promoter sequence of a mouse mu opioid receptor gene"" Proc. Natl. Acad. Sci. USA 91:9081-85.;;Morrison et al. (1984) ""Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains"" Proc. Natl. Acad. Sci. USA 81:6851-55.;;Neuberger et al. (1984) ""Recombinant antibodies possessing novel effector functions"" Nature 312:604-8.;;Olson et al. (1989) ""Endogenous opiates: 1988"" Peptides 10:1253-1280.;;Pan et al. (1994) ""Cloning, Expression and Classification of a kappa<SUB>3</SUB>-Related opioid receptor using Antisense Oligodeoxynucleotides"" Regul. Pept. 54:217-218.;;Pan et al. (1996) ""Dissociation of affinity and efficacy in KOR-3 chimeras"" FEBS Lett. 395:207-10.;;Pasternak (1993) ""Pharmacological mechanisms of opioid analgesics"" Clin. Neuropharmacol. 16:1-18.;;Pasternak et al. (1995) ""Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology"" TiPS 16:344-50.;;Reisine et al. (1993) ""Molecular Biology of opioid receptors"" Trends Neurosci. 16:506-510.;;Reisine et al. (1996) ""Opioid analgesics and antagonists"" in Goodman & Gilman's ""The pharmacological basis of therapeutics"" 9th Ed. (Harman et al. eds) McGraw-Hill pp. 521-555.;;Robertson (1991) ""Using embryonic stem cells to introduce mutations into the mouse germ line"" Biol. Reprod. 44:238-245.;;Rossi et al. (1997) ""Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception"" J. Pharmacol. Exp. Ther. 281:109-114.;;Rossi et al. (1996) ""Naloxone sensitive orphanin FQ-induced analgesia in mice""Eur. J. Pharmacol. 311:R7-8.;;Rossi et al. (1995) ""Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6beta-glucuronide receptor"" FEBS Lett. 369:192-196.;;Sibinga et al. (1988) ""Opioid peptides and opioid receptors in cells of the immune system"" Annu. Rev. Immunol. 6:219-49.;;Simon (1991) ""Opioid receptors and endogenous opioid peptides"" Medicinal Res. Rev. 11:357-374.;;Standifer et al. (1997) ""G proteins and opioid receptor-mediated signaling"" Cell. Signal. 9:237-248.;;Standifer et al. (1996) ""Differential blockade of opioid analgesia by antisense oligodeoxy-nucleotides directed against various G protein alpha subunits"" Mol. Pharmacol. 50:293-298.;;Takeda et al. (1985) ""Construction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region sequences"" Nature 314:452-4.;;Trujillo et al. (1991) ""Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801"" Science 251:85-87.;;van den Engh et al. (1992) ""Estimating genomic distance from DNA sequence location in cell nuclei by a random walk model"" Science 257:1410-1412.;;Vanetti et al. (1992) ""Cloning and expression of a novel mouse somatostatin receptor (SSTR2B)"" FEBS Lett. 311:290-294.;;Wang et al. (1993) ""muopiate receptor: cDNA cloning and expression"" Proc. Natl. Acad. Sci. USA 90:10230-34.;;Wolozin et al. (1981) ""Classification of multiple morphine and enkephalin binding sites in the central nervous system"" Proc. Natl. Acad. Sci. USA 78:6181-84.;;Yasuda et al. (1993) ""Cloning and functional comparison of kappa and delta opioid receptors from mouse brain"" Proc. Natl. Acad. Sci. USA 90:6736-6740.;;Zimprich et al. (1995) ""Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B ) which differs in agonist induced desensitization from rMOR1"" FEBS Lett. 359:142-146.;;Du et al. (1996) ""Identification of a novel splice variant of the mouse mu opioid receptor"" Soc. Neurosci. Ab 22:695.5.;;Du et al. (1997) ""A splice variant of the mu opioid receptor is present in human SHSY-5Y cells"" Soc. Neurosci. Ab. 23:479.3.;;Leventhal et al. (1997) ""Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO"" J. Pharmacol. Exp. Ther. 282:1402-1407.;;Leventhal et al. (1996) ""Antisense oligodeoxynucleotides against the MOR-1 clone alter weight and ingestive responses in rats"" Brain Res. 719:78-84.;;Kaufman, D., et al. J. Biol. Chem 270:15877-15883 (1995).;;Rossi et al. (1996) Neurosci. Lett. 216:1-4.;;Rossi et al. (1994) Life Sci. 54:375-379.;;Pan, Y.-X. GenBank Acession #U26915, Submitted May 11, 1995, FEBS Lett. 369 (2-3), 192-196 (1995).;;Pan, Ying-Xian, et al., ""Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1X"", Science Direct, Biochemical and Biophysical Research Communications 301 (2003) 1057-1061."
88,US,A1,US 2014/0228447 A1,088-697-207-843-829,2014-08-14,2014,US 201414178409 A,2014-02-12,JP 2006173455 A 20060623,Agent For Increasing Testosterone Level,KOMAI MICHIO;;SHIRAKAWA HITOSHI;;OHSAKI YUSUKE;;TAKUMI TADASHI;;ITO ASAGI;;SATO TOSHIRO;;OZAKI RUMI;;UNIV TOHOKU;;J OIL MILLS,KOMAI MICHIO;;SHIRAKAWA HITOSHI;;OHSAKI YUSUKE;;TAKUMI TADASHI;;ITO ASAGI;;SATO TOSHIRO;;OZAKI RUMI,https://lens.org/088-697-207-843-829,Patent Application,yes,0,12,12,2,A61K31/122,A61K31/122;;A23L33/15,514/681,,,"Ito et al., Lipids in Health and Disease, 2011, Vol. 10:158, page 1-9 of 9."
89,US,B2,US 8906378 B2,044-598-168-267-696,2014-12-09,2014,US 201313904534 A,2013-05-29,US 201113209954 A 20110815;;US 201113086786 A 20110414;;US 201113036820 A 20110228;;US 41887709 A 20090406;;US 47802106 A 20060629;;US 96402110 A 20101209;;US 63372906 A 20061205;;US 91551510 A 20101029;;US 87134510 A 20100830;;US 86982310 A 20100827;;US 75474010 A 20100406;;US 75264910 A 20100401;;US 73178110 A 20100325;;US 92540807 A 20071026;;US 38935806 A 20060324;;US 37475110 P 20100818;;US 37477210 P 20100818;;US 201161508871 P 20110718;;US 32411110 P 20100414;;US 4393208 P 20080410;;US 10491608 P 20081013;;US 11954208 P 20081203;;US 9048708 P 20080820;;US 29384610 P 20100111;;US 32300110 P 20100412;;US 37444910 P 20100817;;US 78233206 P 20060314;;US 26787709 P 20091209;;US 30268210 P 20100209;;US 41459210 P 20101117;;US 86453006 P 20061106;;US 25836909 P 20091105;;US 25872909 P 20091106;;US 37805910 P 20100830;;US 23847309 P 20090831;;US 26630509 P 20091203;;US 31699610 P 20100324;;US 32396010 P 20100414;;US 23842409 P 20090831;;US 16829009 P 20090410;;US 16865709 P 20090413;;US 16866809 P 20090413;;US 16366609 P 20090326;;US 66860305 P 20050406;;US 72829205 P 20051019;;US 75119605 P 20051216,"Combination Therapy With Anti-cd74 Antibodies Provides Enhanced Toxicity To Malignancies, Autoimmune Disease And Other Diseases",IBC PHARMACEUTICALS INC,CHANG CHIEN-HSING;;GOLDENBERG DAVID M;;ROSSI EDMUND A,https://lens.org/044-598-168-267-696,Granted Patent,yes,1,7,884,151,A61K39/3955;;A61K31/7076;;A61K38/212;;A61K39/39541;;A61K45/06;;A61K47/48384;;A61K47/48415;;A61K47/48561;;A61K47/48569;;A61K47/487;;A61K51/1027;;A61K51/1045;;A61K2039/505;;C07K14/47;;C07K16/2803;;C07K16/2833;;C07K16/2887;;C07K16/2896;;C07K2317/31;;C07K2317/51;;C07K2317/515;;C07K2317/522;;C07K2317/524;;C07K2317/526;;C07K2317/53;;C07K2317/55;;C07K2317/565;;C07K2317/73;;C07K2317/732;;C07K2317/734;;C07K2319/30;;C07K2319/55;;C07K2319/70,A61K39/395;;A61K38/21;;A61K45/06;;A61K47/48;;A61K51/10;;C07K14/47;;C07K16/28;;C07K16/46,424/178.1;;424/130.1;;424/134.1;;424/136.1,10021462;;10074940;;10092109;;10339671;;10508703;;10512619;;10512838;;10665474;;10673721;;10707792;;10751032;;10811870;;10966642;;10969772;;11035090;;11222385;;11274097;;11285229;;11356929;;11437687;;11489514;;1172191;;11829129;;12388634;;12872134;;1350088;;1367550;;14597210;;14695162;;15102696;;15520207;;15573134;;15656592;;15829301;;16006606;;1653962;;16636283;;16778139;;16948636;;1699952;;1706642;;18227543;;18234994;;18593929;;18799723;;18922911;;19196673;;19319024;;20073133;;20628151;;2066752;;2147685;;2411798;;2441862;;2451562;;2531466;;2540040;;2656679;;2678484;;2717640;;3122816;;3320581;;3495036;;3713831;;4298072;;6172550;;6577942;;7493367;;7516563;;7687326;;8075633;;8080996;;8281471;;8348940;;8795695;;8947500;;8993319;;9035142;;9058745;;9076770;;9354445;;9485322;;9488147;;9596485;;9738663;;9865830,10.1038/256495A0;;10.1016/S0001-2998(89)80025-X;;10.2165/00063030-200115040-00002;;10.1007/BF01741331;;10.1016/S0168-3659(01)00343-1;;10.1038/NG0594-13;;10.1042/BJ20060962;;10.1126/SCIENCE.3495036;;10.1097/00006231-199702000-00009;;10.1093/EMBOJ/20.7.1651;;10.1158/1078-0432.CCR-03-0493;;10.1016/J.MOLIMM.2004.11.003;;10.1016/0145-2126(87)90166-4;;10.1182/BLOOD-2006-04-017921;;10.1126/SCIENCE.2531466;;10.1056/NEJMOA0808268;;10.1083/JCB.111.5.2129;;10.1124/JPET.102.037002;;10.1016/S0046-8177(98)90013-2;;10.1021/BI962148U;;10.1038/321522A0;;10.1111/J.1600-0609.1993.TB00599.X;;10.1016/S0923-2494(94)80039-1;;10.1016/0167-7799(91)90044-I;;10.1023/A:1005934621940;;10.1073/PNAS.89.10.4285;;10.1158/0008-5472.CAN-04-1722;;10.1016/0014-5793(89)80253-4;;10.1056/NEJM199308123290703;;10.3322/CANJCLIN.44.1.43;;10.1038/NATURE01850;;10.1038/SJ.GT.3301059;;10.1016/S0006-3495(99)77059-1;;10.1172/JCI5349;;10.1148/RADIOL.2462070229;;10.1099/0022-1317-57-1-233;;10.1016/0163-7258(91)90075-W;;10.1084/JEM.191.10.1777;;10.1158/0008-5472.CAN-08-0037;;10.1354/VP.42-4-468;;10.1158/0008-5472.CAN-08-2033;;10.1093/PROTEIN/10.10.1221;;10.1211/0022357021771913;;10.1038/NRM1527;;10.1182/BLOOD-2008-04-153189;;10.1007/BF00199167;;10.1182/BLOOD.V97.5.1392;;10.1073/PNAS.0600982103;;10.1038/NBT0297-159;;10.1128/JB.183.8.2405-2410.2001;;10.1016/0145-2126(96)00007-0;;10.1021/BC049713N;;10.1021/BI990993H;;10.1021/BI972701N;;10.1111/J.1365-2141.1987.TB06162.X;;10.1007/978-1-4684-6831-1_14;;10.4161/mabs.1.4.9122;;10.3109/08982109809035537;;10.1016/s1521-6616(03)00214-6;;10.1097/fpc.0b013e32832a06bf;;10.3892/ijo.14.6.1143;;10.4049/jimmunol.165.8.4505;;10.1093/annonc/11.suppl_1.s117;;10.1182/blood-2010-03-276857;;10.1042/bj3200293,"Perry et al., J Biomedicine and Biotechnology 2011, pp. 1-19, Epublished Feb. 2011.;;Yu et al., Investigative Ophthalmology & Visual Science 49(2): 522-527, Feb. 2008.;;U.S. Patent No. 6,558,648, filed May 2003, Griffiths et al.;;Bagshawe et al., ""Developments with targeted enzymes in cancer therapy"", Curr. Opin. Immunol. 11(5):579-83 (1999).;;Bally et al. (Eds.), ""Controlling the Drug Delivery Attributes of Lipid-Based Drug Formulations"", Journal of Liposome Research, 1998, vol. 8, No. 3, pp. 299-335.;;Beers et al., The Merck Manual of Diagnosis and Therapy, Ch. 180, p. 1474-1476; 17th Ed., Whitehouse Station, NJ, Merck Research Labs (1999).;;Bendas et al., ""Immunoliposomes: a promising approach to targeting cancer therapy"", BioDrugs 15(4):215-24 (2001).;;Bendig, M., ""Humanization of Rodent Monoclonal Antibodies by CDR Grafting"", Academic Press Inc., New York, NY, vol. 8, (1995), pp. 83-93.;;Bird et al., ""Single chain antibody variable regions"", Trends Biotechnol. 9(4):132-7 (1991).;;Bom et al., ""The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity"", J. Control Release 74(1-3):325-33 (2001).;;Breen et al., ""Non-Hodgkin's B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter -592 C/C genotype"", Clin. Immunol. 109(2):119-29 (2003).;;Burgess et al., ""Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue"", J. Cell Biol. 111:2129-2138 (1990).;;Carter et al., ""Humanization of an anti-p185HER2 antibody for human cancer therapy"", Proc. Natl. Acad. Sci. USA 89(10):4285-9 (1992).;;Chen et al., ""Differential Effects of Milatuzumab on Human Antigen-Presenting Cells in Comparison to Malignant B Cells"", 2009 ASH Annual Meeting Abstracts, vol. 114(22)1073; Abstr # 2744 (Nov. 20, 2009).;;Cochlovius et al., ""Cure of Burkitt's lymphoma in severe combined immunodeficiency mice by T cells, tetravalent CD3×CD19 tandem diabody, and CD28 costimulation"", Cancer Res. 60(16):4336-41 (2000).;;Coligan et al., (Eds.), Current Protocols in Immunology, vol. 1, pp. 2.5.1-2.6.7; pp. 2.7.1.-2.7.12; pp. 2.8.1-2.8.10; pp. 2.9.1-2.9.3; pp. 2.10.-2.10.4; John Wiley & Sons, Inc., 1991.;;Colman, P., ""Effects of amino acid sequence changes on antibody-antigen interactions"", Res. Immunol. 1994, 145:33-36.;;Coloma et al., ""Design and production of novel tetravalent bispecific antibodies"", Nat. Biotechnol. 15(2):159-63 (1997).;;Constantinides et al., ""Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel"", Pharm. Res. 17(2):175-82 (2000).;;Courtenay-Luck, N. S., ""Genetic manipulation of monoclonal antibodies"", Monoclonal Antibodies: Production, Engineering and Clinical Application, p. 166-179, Ritter et al. (Eds.), Cambridge University Press (1995).;;Fitzgerald et al., ""Improved tumour targeting by disulphide stabilized diabodies expressed in Pichia pastoris"", Protein Eng. 10(10):1221-5 (1997).;;Flavell et al., ""Systemic therapy with 3BIT, a triple combination cocktail of anti-CD19, -CD22, and -CD38-saporin immunotoxins, is curative of human B-cell lymphoma in severe combined immunodeficient mice"", Cancer Res. 57:4824-9 (1997).;;Freedman et al., ""Non-Hodgkin's Lymphomas"", Cancer Medicine, 3rd Ed., vol. 2, p. 2028-2068, Holland et al., (Eds.), Lea & Febiger (1993).;;French et al., ""Response of B-cell lymphoma to a combination of bispecific antibodies and saporin"", Leuk. Res. 20 (7):607-17 (1996).;;Ghetie et al., ""Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy"", Cancer Res. 48(9):2610-7 (1988).;;Ghetie et al., ""Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin"", Blood. Mar. 1, 2001;97(5):1392-8.;;Gold et al., ""Expression of CD74 in pancreatic and colorectal carcinomas as a basis for milatuzumab immunotherapy"", Abstract #5485; Proceeding of the American Association for Cancer Research, vol. 50, p. 1322-1323; Apr. 2009.;;Goldenberg, D. M. ""Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy"", Semin. Nucl. Med. 19(4):332-9 (1989).;;Goldenberg et al., ""Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody"", J Clin Oncol. Apr. 1991;9(4):548-64.;;Goldenberg, D. M. ""Radiolabeled antibodies"", Science & Medicine, 1(1):64 (Apr. 1994).;;Goldenberg, D. M. ""New Developments in Monoclonal Antibodies for Cancer Detection and Therapy"", CA Cancer J. Clin. 44(1):43-64 (1994).;;Gondo et al., ""HLA class II antigen associated invariant chain gene expression in malignant lymphoma"", Br. J. Haematol. 67(4):413-7 (1987).;;Goto et al. ""A novel membrane antigen selectively expressed on terminally differentiated human B cells"", Blood 84 (6):1922-30 (1994).;;Green et al., ""Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs"", Nature Genetics 7:13-21 (1994).;;Greenwood et al., ""Effector functions of matched sets of recombinant human IgG subclass antibodies"", Protein Engineering of Antibody Molecules for Prophylactic and Therapeutic Applications in Man, Clark (Ed.), p. 89; p. 97; Academic Titles (1993).;;Griffiths et al., ""Cure of SCID Mice Bearing Human B-Lymphoma Xenografts by an Anti-CD74 Antibody-Anthracycline Drug Conjugate"", vol. 9, 6567-6571, Dec. 15, 2003.;;Hansen et al., ""Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas"", Biochem. J. 1996, 320:293-300.;;Hasan et al., ""Laser-induced selective cytotoxicity using monoclonal antibody-chromophore conjugates"", Prog. Clin. Biol. Res. 288:471-7 (1989).;;Hekman et al. ""Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody"", Cancer Immunol. Immunother. 1991;32(6):364-72.;;Hess et al., ""Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide"", Blood 89(6):2203-9 (1997).;;Hong et al., ""pH-sensitive, serum-stable and long-circulating liposomes as a new drug delivery system"", J. Pharm. Pharmacol. 54(1):51-8 (2002).;;Hua et al., ""Immunoreactivity for LN2 and LN3 distinguishes small cell carcinomas from non-small cell carcinomas in the lung"", Hum. Pathol. 29(12):1441-6 (1998).;;Huse et al., ""Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda"", Science 246:1275-1281 (1989).;;Ibragimova et al., ""Stability of the beta-sheet of the WW domain: A molecular dynamics simulation study"", Biophys. J. 77(4):2191-8 (1999).;;Johnson et al., ""Human antibody engineering"", Current Opin. Struct. Biol. 3:564-571 (1993).;;Jones et al., ""Replacing the complementarity-determining regions in a human antibody with those from a mouse"" Nature 321(6069):522-5 (1986).;;Juweid et al., ""99Tcm-LL1: a potential new bone marrow imaging agent"", Nucl. Med. Commun. 18(2):142-8 (1997).;;Juweid et al., ""Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an antiCD22 monoclonal antibody"", Cancer Res. 55(23 Suppl):5899s-5907s (1995).;;Kaminski et al., ""Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody"", N. Engl. J. Med. 329(7):459-65 (1993).;;Kiesel et al., ""Removal of cells from a malignant B-cell line from bone marrow with immunomagnetic beads and with complement and immunoglobulin switch variant mediated cytolysis"", Leuk. Res. 11(12):1119-25 (1987).;;Kirpotin et al., ""Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro"", Biochemistry 36(1):66-75 (1997).;;Kohler et al., ""Continuous cultures of fused cells secreting antibody of predefined specificity"", Nature 256:495-7 (1975).;;Kolata, G., ""Clinical promise with new hormones"", Science 236:517-519 (1987).;;Foran et al., ""Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response"", Ann Oncol. 2000;11 Suppl 1:117-21.;;Gupta et al., ""Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD201CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemias"", Blood. Oct. 28, 2010;116(17):3258-67.;;Henry et al., ""A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer"", Cancer Res. Nov. 1, 2004;64(21):7995-8001.;;Jefferis et al., ""Human immunoglobulin allotypes: possible implications for immunogenicity"", MAbs 1(4):1-7 (2009).;;Jubala et al., ""CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma"", Vet Pathol. Jul. 2005;42(4):468-76.;;Magdelaine-Beuzelin et al., ""IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab"", Pharmacogenet Genomics. May 2009;19(5):383-7.;;Mecchia et al., ""Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha"", Gene Ther. (2000) 7, 167-179.;;Newlon et al., ""A Novel Mechanism of PKA Anchoring Revealed by Solution Structures of Anchoring Complexes"", Embo J. 2001; 20:1651-1662.;;Newlon et al., ""The molecular basis for protein kinase A anchoring revealed by solution NMR"", Nature Struct. Biol. 1999; 3:222-227.;;Ngo et al., ""Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox"", The Protein Folding Problem and Tertiary Structure Prediction, Ch. 14, pp. 492-495, (Mertz & Le Grand, Eds.), Birkhauser Boston, 1994.;;Osborn et al., ""Pharmacokinetic and Pharmacodynamic Studies of a Human Serum Albumin-Interferon-alpha Fusion Protein in Cynomolgus Monkeys"", J. Pharmacol. Exp. Ther. 303(2):540-548 (2002).;;Oyen et al., ""Human testis cDNA for the regulatory subunit RIIalpha of cAMP-dependent protein kinase encodes an alternate amino-terminal region"", FEBS Letters 246:57-64, 1989.;;Ozzello et al., ""Conjugation of interferon alpha to a humanized monoclonal antibody (HuBrE-3vl) enhances the selective localization and antitumor effects of interferon in breast cancer xenografts"", Breast Cancer Res. Treat. 48: 135-147 (1998).;;Paquette et al., ""Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells"", J. Leukoc. Biol. 64:358-367; 1998.;;Pelham et al., ""Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36"", Cancer Immunol. Immunother. 1983;15(3):210-216.;;Pepinsky et al., ""Improved Pharmacokinetic Properties of a Polyethylene Glycol-Modified Form of Interferon-beta-1a with Preserved in Vitro Bioactivity"", Pharmacol. Exp. Ther. 2001; 297(3):1059-1066.;;Pilling et al., ""Interferon-beta mediates stromal cell rescue of T cells from apoptosis"", Eur. J. Immunol. 29:1041-1050 (1999).;;Rabjohn et al., ""Molecular Cloning and Epitope Analysis of the Peanut Allergen Ara h 3"", J. Clinical Investigation 103 (4):535-542 (1999).;;Raefsky et al., ""Studies of Interferon as a regulator of hematopoietic cells proliferation"", J. Immunol. 135 (4):2507-2512 (1985).;;Riemer et al., Matching of trastuzumab (Herceptin) epitope mimics onto the surface of Her-2/neu-a new method of epitope definition, Mol Immunol. May 2005;42(9):1121-4.;;Rose et al., ""Structural basis of dimerization, coactivator recognition and MODY3 mutations in HNF-1alpha"", Nature Struct. Biol. 2000; 7:744-748.;;Rosendahl et al., ""A Long-Acting, Highly Potent Interferon alpha-2 Conjugate Created Using Site-Specific PEGylation"", Bioconjugate Chem. 2005;16:200-207.;;Rossi et al., ""Novel Designs of Multivalent Anti-CD20 Humanized Antibodies as Improved Lymphoma Therapeutics"", Cancer Res. 68:8384-92, 2008.;;Rossi et al., ""Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting"" Proc. Natl. Acad. Sci. Epub Apr. 24, 2006, vol. 103, No. 18, pp. 6841-6846.;;Rustandi et al., ""The Ca2+-Dependent Interaction of S100B(betabeta) with a Peptide Derived from p53"", Biochemistry 1998; 37: 1951-1960.;;Sabaawy et al., ""Enhancement of 5-fluorouracil cytotoxicity on human colon cancer cells by retrovirus-mediated interferon-alpha gene transfer"", Int. J. Oncol. Jun. 1999; 14(6):1143-51.;;Salles et al., ""Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study"", Blood 2008; 112:4824-4831.;;Santini et al., ""Type I Interferon as a Powerful Adjuvant for Monocyte-derived Dendritic Cell Development and Activity In Vivo and in Hu-PBL-SCID Mice"", J. Exp. Med. 191(10):1777-1788 (2000).;;Scott et al., ""Type II Regulatory Subunit Dimerization Determines the Subcellular Localization of the cAMP-dependent Protein Kinase"", J. Biol. Chem. 265:21561-66 (1990).;;Scott et al., ""Cyclic nucleotide-dependent protein kinases"", Pharmacol. Ther. 1991;50(1):123-45.;;Seffernick et al., ""Melamine Deaminase and Atrazine Chlorohydrolase: 98 Percent Identical but Functionally Different"", J. Bacteriol. 183(8):2405-2410 (2001).;;Sharkey et al., ""Improved Therapeutic Results by Pretargeted Radioimmunotherapy of Non-Hodgkin's Lymphoma with a New Recombinant, Trivalent, Anti-CD20, Bispecific Antibody"", Cancer Res. 68:5282-90, 2008.;;Sharkey et al., ""Metastatic Human Colonic Carcinoma: Molecular Imaging with Pretargeted SPECT and PET in a Mouse Model"", Radiology 246:497-507, 2008.;;Sidky et al., ""Inhibition of Angiogenesis by Interferons: Effects on Tumor- and Lymphocyte-induced Vascular Responses"", Cancer Res. 47:5155-5161, Oct. 1, 1987.;;Stein et al., ""Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin's Lymphoma"", Clin. Cancer Res. vol. 10, 2868-2878, Apr. 15, 2004.;;Stein et al., ""Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab"", Blood 2006;108:2736-2744.;;Stokka et al., ""Characterization of A-kinase-anchoring disruption using a solution-based assay"", Biochem. J. (2006) 400, 493-499.;;Stryer et al., ""Levels of Structure in Protein Architecture"", Biochemistry, 3rd Ed., pp. 31-33, W.H. Freeman & Co., New York, 1988.;;Takaoka et al., ""Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence"", Nature Jul. 31, 2003;424(6948):516-23.;;Taylor, S., ""cAMP-dependent Protein Kinase"", J. Biol. Chem. 1989;264(15):8443-8446.;;Tol et al., ""Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer"", N Engl J Med. Feb. 5, 2009;360(6):563-72.;;Walsh et al., ""An Adenosine 3', 5'Monophosphate-dependant Protein Kinase from Rabbit Skeletal Muscle"", J. Biol. Chem. 243(13):3763-3774 (1968).;;Weck et al., ""Comparison of the Antiviral Activities of Various Cloned Human Interferon-alpha Subtypes in Mammalian Cell Cultures"", J. Gen. Virol. (1981), 57, 233-237.;;Winkler et al., ""Changing the Antigen Binding Specificity by Single Point Mutations of an Anti-p24 (HIV-1) Antibody"", J. Immunol. 165:4505-14, 2000.;;Witkowski et al., ""Conversion of a beta-Ketoacyl Synthase to a Malonyl Decarboxylase by Replacement of the Active-Site Cysteine with Glutamine"", Biochemistry 38(36):11643-50 (1999).;;Wong et al., ""AKAP Signalling Complexes: Focal Points in Space and Time"", Nat. Rev. Mol. Cell Biol. 12:959-70 (2004).;;Zhu et al., ""Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor"", Invest. New Drugs 17:195-212, 1999.;;Patti et al., ""High-dose cyclophosphamide, etoposide and BCNU (CVB) with autologous stem cell rescue in malignant lymphomas"", Eur J Haematol. Jul. 1993;51(1):18-24."
90,WO,A2,WO 2016/164476 A2,176-579-038-373-637,2016-10-13,2016,US 2016/0026240 W,2016-04-06,US 201562143713 P 20150406,Combination Therapy For Treating Disorders Associated With Excess Cortisol Production,MILLENDO THERAPEUTICS INC,MOHIDEEN PHARIS;;OWENS JULIA CHRISTINE,https://lens.org/176-579-038-373-637,Patent Application,yes,0,3,3,6,A61K31/444;;A61K31/17;;A61K31/4184;;A61K31/4188;;A61K45/06;;A61K2300/00,,,12137808;;12750023;;14617738;;18348518;;8201599;;8448837;;24900631;;24423285;;21367932;;25462231;;26288685;;26005536,,"CHIODINI ET AL., J. CLIN. ENDOCRINOL. METAB, vol. 96, 2011, pages 1223 - 1236;;LADA ET AL., J. LIPID RES., vol. 45, 2004, pages 378 - 386;;EHMER ET AL., J. STEROID BIOCHEM. MOL. BIOL., vol. 81, 2002, pages 173 - 179;;BERTAGNA ET AL., J. CLIN. ENDOCRINOL. METAB., vol. 99, 2014, pages 1375 - 1383;;HILLE ET AL., ACS MED. CHEM. LETT., vol. 2, 2011, pages 2 - 6;;STEFANACHI ET AL., EUR. J. MED. CHEM., vol. 89, 2015, pages 106 - 14;;LASALA ET AL., ANAL. BIOCHEM., vol. 394, 2009, pages 56 - 61;;HOYT ET AL., ACS MED. CHEM. LETT., vol. 6, 2015, pages 861 - 5;;ZOLLE ET AL., J. MED. CHEM., vol. 51, 2008, pages 2244 - 2253;;HARTMANN ET AL., EUR. J. MED. CHEM., vol. 38, 2003, pages 363 - 6;;HOYT ET AL., ACS MED. CHEM. LETT, vol. 6, 2015, pages 861 - 865;;MARTIN ET AL., J. MED. CHEM., vol. 58, 2015, pages 8054 - 65;;HOYT ET AL., ACS MED. CHEM. LETT., vol. 6, 2015, pages 573 - 8;;BERTAGNA ET AL., J. CLIN. ENDOCRINOL. METAB, vol. 99, 2014, pages 1375 - 1383;;MEREDITH ET AL., ACS MED. CHEM. LETT, vol. 4, 2013, pages 1203 - 1207;;TRIVEDI, B.K. ET AL., J. MED. CHEM., vol. 37, 2004, pages 1652 - 1659;;FLESERIU ET AL., PITUITARY, vol. 19, 2016, pages 138 - 149;;CARR ET AL., CLIN. BIOCHEM., vol. 26, 1993, pages 39 - 42;;OSOL A.: ""Remington's Pharmaceutical Sciences, 16th ed,"", 1980"
91,US,A1,US 2003/0148420 A1,152-791-919-463-410,2003-08-07,2003,US 2142501 A,2001-10-30,US 24430000 P 20001030,Aspergillus Ochraceus 11 Alpha Hydroxylase And Oxidoreductase,SUZANNE BOLTEN L.;;CLAYTON ROBERT A.;;EASTON ALAN M.;;ENGEL LESLIE C.;;MESSING DEAN M.;;NG JOHN S.;;REITZ BEVERLY;;WALKER MARK C.;;WANG PING T.,SUZANNE BOLTEN L;;CLAYTON ROBERT A;;EASTON ALAN M;;ENGEL LESLIE C;;MESSING DEAN M;;NG JOHN S;;REITZ BEVERLY;;WALKER MARK C;;WANG PING T,https://lens.org/152-791-919-463-410,Patent Application,yes,0,17,17,65,C12N9/0083;;C07K14/38;;C07K16/40;;C12N1/14;;C12N3/00;;C12N9/0004;;C12N2799/026;;C12P33/10,G01N33/536;;A61K35/74;;A61P9/00;;A61P19/02;;A61P29/00;;A61P35/00;;C07K1/02;;C07K14/38;;C07K16/40;;C07K19/00;;C12N1/14;;C12N1/15;;C12N1/19;;C12N1/21;;C12N3/00;;C12N5/10;;C12N9/02;;C12N15/09;;C12P21/08;;C12P33/10;;C12Q1/26;;G01N33/573,435/69.1;;435/189;;435/320.1;;435/254.2;;536/23.2;;X435 6;;435/6,,,
92,US,A1,US 2004/0086898 A1,013-636-550-613-828,2004-05-06,2004,US 43210103 A,2003-12-11,JP 2000351741 A 20001117;;JP 2001038619 A 20010215;;JP 2001077000 A 20010316,"Novel Guanosine Triphosphate (gtp)-binding Protein-coupled Receptor Protein, Bg37",MARUYAMA TAKAHARU;;NAKAMURA TAKAO;;ITADANI HIRAKU;;TANAKA KEN-ICHI,MARUYAMA TAKAHARU;;NAKAMURA TAKAO;;ITADANI HIRAKU;;TANAKA KEN-ICHI,https://lens.org/013-636-550-613-828,Patent Application,yes,4,15,15,38,C07K14/705,C07K14/705;;C12N1/21;;C12N15/12,435/6;;435/69.1;;435/320.1;;435/325;;X53035;;530/388.22;;536/23.5;;435/7.1,,,
93,US,A1,US 2003/0039970 A1,043-004-377-230-673,2003-02-27,2003,US 90639301 A,2001-07-16,US 90639301 A 20010716;;US 21876100 P 20000717,Method For Prognosing Cancer And The Proteins Involved,WANG ZHOU;;XIAO WUHAN,WANG ZHOU;;XIAO WUHAN,https://lens.org/043-004-377-230-673,Patent Application,yes,2,5,5,36,G01N33/57434;;A01K2217/05;;A01K2217/075;;A61K38/00;;C07K14/4702;;C12Q1/6886;;C12Q2600/118;;C12Q2600/136,A61K38/00;;C07K14/47;;C12N15/12;;C12Q1/68;;G01N33/574,435/6;;435/7.23,,,
94,WO,A2,WO 2002/006327 A2,158-673-002-425-755,2002-01-24,2002,US 0122357 W,2001-07-17,US 21876100 P 20000717;;US 90639301 A 20010716,A Method For Prognosing Cancer And The Proteins Involved,UNIV NORTHWESTERN;;WANG ZHOU;;XIAO WUHAN,WANG ZHOU;;XIAO WUHAN,https://lens.org/158-673-002-425-755,Patent Application,yes,10,5,5,36,G01N33/57434;;A01K2217/05;;A01K2217/075;;A61K38/00;;C07K14/4702;;C12Q1/6886;;C12Q2600/118;;C12Q2600/136,A61K38/00;;C07K14/47;;C12N15/12;;C12Q1/68;;G01N33/574,,10498619;;10967322;;9751517;;9858521,10.1016/S0014-5793(00)01771-3;;10.1084/JEM.188.12.2349;;10.1210/EN.139.10.4337,
95,EP,B1,EP 2381957 B1,034-495-539-008-331,2015-01-07,2015,EP 10732051 A,2010-01-13,US 14434409 P 20090113;;US 26040209 P 20091112,Therapeutic Modulation Of Vaginal Epithelium Boundary Lubrication,LUBRIS LLC;;SCHEPENS EYE RES INST,TRUITT EDWARD R III;;SULLIVAN BENJAMIN;;SULLIVAN DAVID,https://lens.org/034-495-539-008-331,Granted Patent,yes,0,14,14,4,A61K9/0034;;A61K9/02;;A61K9/06;;A61K31/70;;A61K31/715;;A61K38/13;;A61K38/1709;;A61K38/1793;;A61K38/20;;A61K38/24;;A61K45/06;;A61K2300/00,A61K38/16;;A61K9/00;;A61K9/02;;A61K9/06;;A61K9/22;;A61K31/70;;A61K31/715;;A61K38/13;;A61K38/17;;A61K38/20;;A61K38/24;;A61K45/06;;A61P17/00;;A61P29/00,,,,
96,US,A1,US 2012/0052077 A1,140-643-086-527-140,2012-03-01,2012,US 201013144203 A,2010-01-13,US 14434409 P 20090113;;US 26040209 P 20091112,Therapeutic Modulation Of Vaginal Epithelium Boundary Lubrication,TRUITT III EDWARD R;;SULLIVAN BENJAMIN;;SULLIVAN DAVID,TRUITT III EDWARD R;;SULLIVAN BENJAMIN;;SULLIVAN DAVID,https://lens.org/140-643-086-527-140,Patent Application,yes,2,14,14,3,A61K9/0034;;A61K9/02;;A61K9/06;;A61K31/70;;A61K31/715;;A61K38/13;;A61K38/1709;;A61K38/1793;;A61K38/20;;A61K38/24;;A61K45/06;;A61K2300/00,A61K38/14;;A61K38/13;;A61K38/24;;A61K39/395;;A61P5/24;;A61P5/26;;A61P15/02;;A61P15/08;;A61P17/00;;A61P17/06;;A61P25/00;;A61P29/00;;A61P31/04;;A61P31/10;;A61P31/22;;A61P35/00;;A61P37/08,424/158.1;;514/20.9;;514/3.1;;514/4.2;;514/3.4;;514/18.7;;514/12.2;;514/9.9;;514/10.1;;514/20.5,18067335;;18684827,10.1021/la702383n;;10.1128/jvi.00931-08;;10.1016/s1570-9124(03)00039-4,"Zappone et al., ""Molecular Aspects of Boundary Lubrication by Human Lubricin: Effects of Disulfide Bonds and Enzymatic Digestion"", Langmuir, 2008, pages 1495-1508;;Thapa et al., ""Herpes Simplex Virus Type 2-Induced Mortality following Genital Infection Is Blocked by Anti-Tumor Necrosis Factor Alpha Antibody in CXCL10-Deficient Mice"", Journal of Virology, 2008, pages 10295-10301;;Berman et al., Female Sexual Dysfunction: New Perspective on Anatomy, Physiology, Evaluation, and Treatment"", EAU Update Series 1, 2003, pages 166-177."
97,US,B2,US 8367806 B2,004-308-416-755-746,2013-02-05,2013,US 99924209 A,2009-07-09,FR 0854683 A 20080710,Protein Disulfide Isomerase Assay Method For The In Vitro Diagnosis Of Colorectal Cancer,BIOMERIEUX SA;;ATAMAN-ONAL YASEMIN;;BEAULIEU CORINNE;;BUSSERET SANDRINE;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;ROLLAND DOMINIQUE,ATAMAN-ONAL YASEMIN;;BEAULIEU CORINNE;;BUSSERET SANDRINE;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;ROLLAND DOMINIQUE,https://lens.org/004-308-416-755-746,Granted Patent,yes,0,19,19,22,C12N9/90;;G01N33/57419;;G01N2333/99,C07K16/00;;A61K35/12;;A61K39/395,530/387.1;;530/388.1;;424/130.1;;424/277.1,10389686;;10462524;;10518104;;10778968;;11410510;;11722587;;11735128;;11745181;;11746103;;11747453;;12379327;;12562854;;1376927;;14500354;;14563446;;15059925;;15065605;;15138477;;15313933;;1563002;;15653098;;15970581;;16011914;;16330944;;16465618;;16570345;;16581821;;16644871;;16952549;;1699834;;17101318;;17512720;;2100569;;2429934;;2542383;;2591371;;2824476;;2872262;;3838309;;4953873;;6426610;;7682766;;8123491;;8139549;;8394326;;8416983;;8428952;;15960882;;8068563;;8687142;;11565796;;240519;;1175300;;1572080;;10417322;;8295527;;16951234;;12661896;;15644144;;12193204;;6582896,10.1002/IJC.2910380508;;10.1006/BBRC.2001.6047;;10.1136/BMJ.288.6429.1479;;10.1128/MCB.14.4.2457;;10.1002/CYTO.1169;;10.1023/A:1026620006078;;10.1073/PNAS.89.12.5635;;10.1002/(SICI)1096-9098(199910)72:2<83::AID-JSO8>3.0.CO;2-C;;10.1023/B:CLIN.0000017204.38807.22;;10.1016/J.JCHROMB.2005.05.024;;10.1172/JCI114125;;10.1086/500563;;10.1084/JEM.122.3.467;;10.1016/J.EJCA.2007.03.021;;10.1038/BJC.1994.106;;10.1158/0008-5472.CAN-04-0746;;10.1373/CLINCHEM.2006.069252;;10.1038/SJ.BJC.6601828;;10.1046/J.0014-2956.2001.02546.X;;10.1074/MCP.M500055-MCP200;;10.1194/JLR.D200034-JLR200;;10.1515/CCLM.1986.24.3.161;;10.1016/J.CCCN.2004.09.001;;10.1021/BI0113925;;10.1083/JCB.120.1.129;;10.1053/J.GASTRO.2006.08.034;;10.1093/CARCIN/BGH155;;10.1053/J.GASTRO.2006.06.006;;10.1016/S0009-9120(03)00096-1;;10.1016/S0022-1759(02)00332-0;;10.1016/0009-8981(75)90046-7;;10.1016/0009-8981(75)90047-9;;10.1002/1522-2683(200108)22:14<3019::aid-elps3019>3.0.co;2-t;;10.1002/(sici)1096-9098(199910)72:2<83::aid-jso8>3.3.co;2-3;;10.1002/1097-0142(20011115)92:10<2493::aid-cncr1599>3.0.co;2-f;;10.1016/0009-8981(92)90008-e;;10.1042/0264-6021:3410593;;10.1158/1078-0432.ccr-06-0274;;10.1111/j.1745-7254.2005.00145.x;;10.1034/j.1600-0463.2002.100601.x;;10.1093/alcalc/agl021;;10.1042/bj3410593;;10.1038/bjc.1984.25;;10.3748/wjg.v12.i10.1536,"Jul. 31, 2012 Office Action issued in U.S. Appl. No. 12/452,048.;;Aug. 3, 2012 Office Action issued in U.S. Appl. No. 12/452,037.;;Jan. 3, 2012 Office Action issued in U.S. Appl. No. 12/452,035.;;Feb. 12, 2009 International Search Report Issued in International Application No. PCT/FR2008/051294.;;Mar. 18, 2009 International Search Report Issued in International Application No. PCT/FR2008/051291.;;Feb. 23, 2009 International Search Report Issued in International Application No. PCT/FR2008/051289.;;Feb. 18, 2009 International Search Report Issued in International Application No. PCT/FR2008/051295.;;Mar. 27, 2009 International Search Report Issued in International Application No. PCT/FR2008/051290.;;Mar. 6, 2009 International Search Report Issued in International Application No. PCT/FR2008/051293.;;Mar. 5, 2009 International Search Report Issued in International Application No. PCT/FR2008/051292.;;Oct. 31, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,035.;;May 13, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,038.;;Sep. 1, 2011 Office Action issued in U.S. Appl. No. 12/452,038.;;Nov. 16, 2011 Election of Species Requirement issued in U.S. Appl. No. 12/452,037.;;Sep. 15, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,042.;;Oct. 28, 2011 Office Action issued in U.S. Appl. No. 12/452,042.;;Oct. 28, 2011 Restriction Requirement issued in U.S. Appl. No. 12/452,047.;;Aug. 1, 2011 Restriction and Election of Species Requirement issued in U.S. Appl. No. 12/452,034.;;Oct. 27, 2011 Office Action issued in U.S. Appl. No. 12/452,034.;;Jan. 9, 2012 Office Action issued in U.S. Appl. No. 12/452,047.;;Feb. 3, 2012 Office Action issued in U.S. Appl. No. 12/452,048.;;Feb. 1, 2012 Office Action issued in U.S. Appl. No. 12/452,037.;;SCORE sequence search result #1, Geneseq Database, ""20110423-191537-us-12-452-038-2.rag,"" Apr. 23, 2011.;;Bruce et al., ""Cancer-Wide Tissue Microarray Survey of Ezrin and Merlin Expression,"" Proc Amer. Assoc. Cancer Res., vol. 46, Abstract #424, 2005.;;Gould et al., ""cDNA Cloning and Sequencing of the Protein-Tyrosine Kinase Substrate, Ezrin, Reveals Homology to Band 4.1,"" The EMBO Journal, vol. 8, No. 13, pp. 4133-4142, 1989.;;Etzioni et al., ""The Case for Early Detection,"" Nature Review, vol. 3, Internet pp. 1-10, Apr. 2003.;;Mercer, ""Use of Multiple Markers to Enhance Clinical Utility,"" Immunol. Ser., vol. 53, pp. 39-54, 1990.;;Delanote et al., ""Plastins: Versatile Modulators of Actin Organization in (patho)physiological Cellular Processes,"" Acta Pharmacologica Sinica, vol. 26, No. 7, pp. 769-779, Jul. 2005.;;Hasselblatt et al., ""Identification of Novel Diagnostic Markers for Choroid Plexus Tumors,"" Am. J. Surg. Pathol., vol. 30, No. 1, pp. 66-74, Jan. 2006.;;Lin et al., ""Identification of I-Plastin, a Human Fimbrin Isoform Expressed in Intestine and Kidney,"" Molecular and Cellular Biology, vol. 14, No. 4, pp. 2457-2467, Apr. 1994.;;Otsuka et al. ""Differential Expression of L-Plastin Gene in Human Colorectal Cancer Progression and Metastasis,"" Biochemical and Biophysical Research Communications, vol. 289, No. 4, pp. 876-881, 2001.;;Carroll et al., ""Liver Fatty Acid-Binding Protein: A Marker for Studying Cellular Differentiation in Gut Epithelial Neoplasms,"" Gastroenterology, vol. 99, pp. 1727-1735, 1999.;;Kayser et al., ""Primary Colorectal Carcinomas and their Intrapulmonary Metastases: Clinical, Glyco-, Immuno- and Lectin Histochemical, Nuclear and Syntactic Structure Analysis with Emphasis on Correlation with Period of Occurrence of Metastases and Survival,"" APMIS, vol. 110, pp. 435-446, 2002.;;Kuusela et al., ""Comparison of CA 19-9 and Carcinoembryonic Antigen (CEA) Levels in the Serum of Patients with Colorectal Diseases,"" Br. J. Cancer, vol. 49, pp. 135-139, 1984.;;Pelsers et al., ""Fatty Acid-Binding Proteins as Plasma Markers of Tissue Injury,"" Clinica Chimica Acta, vol. 352, pp. 15-35, 2005.;;Iurisci et al., ""Concentrations of Galectin-3 in the Sera of Normal Controls and Cancer Patients,"" Clinical Cancer Research, vol. 6, pp. 1389-1393, Apr. 2000.;;Niederkofler et al., ""Novel Mass Spectrometric Immunoassays for the Rapid Structural Characterization of Plasma Apolipoproteins,"" Journal of Lipid Research, vol. 44, pp. 630-639, 2003.;;Hortin, ""The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Peptidome,"" Clinical Chemistry, vol. 52, No. 7, pp. 1223-1237, 2006.;;Hachem, ""Serum Apolipoproteins A-I, A-II and B in Hepatic Metastases Comparison with other Liver Diseases: Hepatomas and Cirrhosis,"" J. Clin. Chem. Clin. Biochem., vol. 24, pp. 161-166, 1986.;;Remold-O'Donnell et al., ""Sequence and Molecular Characterization of Human Monocyte/Neutrophil Elastase Inhibitor,"" Proc. Natl. Acad. Sci., vol. 89, pp. 5635-5639, Jun. 1992.;;Cooley et al., ""The Serpin MNEI Inhibits Elastase-Like and Chymotrypsin-Like Serine Proteases through Efficient Reactions at Two Active Sites,"" Biochemistry, vol. 40, pp. 15762-15770, 2001.;;Algrain et al, ""Ezrin Contains Cytoskeleton and Membrane Binding Domains Accounting for its Proposed Role as a Membrane-Cytoskeletal Linker,"" The Journal of Cell Biology, vol. 120, No. 1, pp. 129-139, Jan. 1993.;;Jiang et al., ""Cytokine Regulation of Ezrin Expression in the Human Colon Cancer Cell Line HT29,"" Anticancer Research, vol. 16, pp. 861-866, 1996.;;Hiscox et al, ""Ezrin Regulates Cell-Cell and Cell-Matrix Adhesion, A Possible Role with E-Cadherin/beta-Catenin,"" Journal of Cell Science, vol. 112, pp. 3081-3090, 1999.;;Xiao et al., ""An Approach to Studying Lung Cancer-Related Proteins in Human Blood,"" Molecular & Cellular Proteomics, vol. 4, pp. 1480-1486, 2005.;;Anders et al., ""Aminoacyclases,"" Advances in Pharmacology, vol. 27, pp. 431-448, 1994.;;Lorentz et al., ""A New Method for the Assay of Aminoacylase: Elaboration of a Fixed-Incubation Method for Routine Measurements,"" Clinica Chimica Acta, vol. 63, pp. 263-269, 1975.;;Lorentz et al, ""Clinical Application of a New Method for the Determination of Aminoacylase in Human Serum,"" Clinical Chimica Acta, vol. 63, pp. 271-274, 1975.;;Cook et al, ""Human Aminoacylase-1,"" The Journal of Biological Chemistry, vol. 268, No. 23, pp. 17010-17017, 1993.;;Miller et al., ""Lack of Expression of Aminoacylase-1 in Small Cell Lung Cancer,"" The Journal of Clinical Investigation, Inc., vol. 83, pp. 2120-2124, Jun. 1989.;;Balabanov et al., ""Tumour-Related Enzyme Alterations in the Clear Cell Type of Human Renal Cell Carcinoma Identified by Two-dimensional Gel Electrophoresis,"" Eur. J. Biochem., vol. 268, pp. 5977-5980, 2001.;;Chan et al, ""Human Liver Fatty Acid Binding Protein cDNA and Amino Acid Sequence,"" The Journal of Biological Chemistry, vol. 260, No. 5, pp. 2629-2632, 1985.;;Das et al., ""Expression Pattern of Fatty Acid-Binding Proteins in Human Normal and Cancer Prostate Cells and Tissues,"" Clinical Cancer Research, vol. 7, 1706-1715, Jun. 2001.;;Stulik et al., ""Proteome Study of Colorectal Carcinogenesis,"" Electrophoresis, vol. 22, pp. 3019-3025, 2001.;;Yamazaki et al., ""Liver Fatty Acid-Binding Protein is a New Prognostic Factor for Hepatic Resection of Colorectal Cancer Metastases,"" Journal of Surgical Oncology, vol. 72, pp. 83-87, 1999.;;Sweetser et al., ""The Human and Rodent Intestinal Fatty Acid Binding Protein Genes,"" The Journal of Biological Chemistry, vol. 262, No. 33, pp. 16060-16071, 1987.;;Pelsers et al, ""Intestinal-Type and Liver-Type Fatty Acid-Binding Protein in the Intestine. Tissue Distribution and Clinical Utility,"" Clinical Biochemistry, vol. 36, pp. 529-535, 2003.;;Xiao et al, ""Dietary Exposure to Soy or Whey Proteins Alters Colonic Global Gene Expression Profiles During Rat Colon Tumorigenesis,"" Molecular Cancer, vol. 4, No. 1, pp. 1-17, Jan. 11, 2005.;;Engwegen et al., ""Identification of Serum Proteins Discriminating Colorectal Cancer Patients and Healthy Controls Using Surface-Enhanced Laser Desorption Ionisation-Time of Flight Mass Spectrometry,"" World J. Gastrenterol., vol. 12, No. 10, pp. 1536-1544, Mar. 14, 2006.;;Zhang et al., ""Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer,"" Cancer Research, vol. 64, pp. 5882-5890, Aug. 15, 2004.;;Lin et al., ""Human Plastin Genes,"" The Journal of Biological Chemistry, vol. 268, No. 4, pp. 2781-2792, 1993.;;Lavabre-Bertrand et al., ""Plasma Proteasome Level is a Potential Marker in Patients with Solid Tumors and Hemopoietic Malignances,"" Cancer, vol. 92, No. 10, pp. 2493-2500, Nov. 15, 2001.;;Schwartz, ""Enzymes as Prognostic Markers and Therapeutic Indicators in Patients with Cancer,"" Clinical Chimica Acta, vol. 206, pp. 77-82, 1992.;;McCool et al., ""Roles of Calreticulin and Calnexin During Mucin Synthesis in LS180 and HT29/A1 Human Colonic Adenocarcinoma Cells,"" Biochem. J., vol. 341, pp. 593-600, 1999.;;Motoo et al., ""Serum Levels of Pancreatitis-Associated Protein in Digestive Diseases with Special Reference to Gastrointestinal Cancer,"" Digestive Diseases and Sciences, vol. 44, No. 6, pp. 1142-1147, Jun. 1999.;;Abe et al., ""Preparation of Recombinant MK-1/EP-CAM and Establishment of an ELISA System for Determining Soluble MK-1/EP-CAM Levels in Sera of Cancer Patients,"" Journal of Immunological Methods, vol. 270, pp. 227-233, 2002.;;Katayama et al., ""Soluble E-Cadherin Fragments Increased in Circulation of Cancer Patients,"" Br. J. Cancer, vol. 69, pp. 580-585, 1994.;;Wilmanns et al., ""Soluble Serum E-Cadherin as a Marker of Tumour Progression in Colorectal Cancer Patients,"" Clinical & Experimental Metastasis, vol. 21, pp. 75-78, 2004.;;Gold et al., ""Specific Carcinoembryonic Antigens of the Human Digestive System,"" J. Exp. Med., pp. 467-481, 1965.;;Kim et al., ""Gastrointestinal Tract Cancer Screening Using Fecal Carcinoembryonic Antigen,"" Annals of Clinical & Laboratory Science, vol. 33, No. 1, pp. 32-38, 2003.;;Holmgren et al., ""Detection by Monoclonal Antibody of Carbohydrate Antigen CA 50 in Serum of Patients with Carcinoma,"" British Medical Journal, vol. 288, pp. 1479-1482, May 19, 1984.;;Klug et al., ""Monoclonal Anitbody Immunoradiometric Assay for an Antigenic Determinant (CA 72) on a Novel Pancarcinoma Antigen (TAG-72),"" Int. J. Cancer, vol. 38, pp. 661-669, 1986.;;Holland et al., ""Testosteroma Serica: Posible Marcador En El Cancer Colorrectal,"" Medicina (Buenos Aires), vol. 53, pp. 117-123, 1993.;;Model et al., ""Detection of Methylated DNA in Plasma from Colorectal Cancer Patients and Controls by Real-Time PCR Analysis of Septin 9,"" World Congress on Gastrointestinal Cancer, Jul. 2006.;;Ebert et al., ""Aristaless-like Homeobox-4 Gene Methylation is a Potential Marker for Colorectal Adenocarcinomas,"" Gastroenterology, vol. 131, pp. 1418-1430, 2006.;;Bianco et al., ""Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon Cancer,"" Clin. Cancer Res., vol. 12, No. 17, pp. 5158-5164, Sep. 1, 2006.;;Mori et al., ""Two-Dimensional Electrophoresis Database of Fluorescence-Labeled Proteins of Colon Cancer Cells,"" Journal of Chromatography B, vol. 823, pp. 82-91, 2005.;;Duffy et al., ""Tumour Markers in Colorectal Cancer: European Group on Tumour Markers (EGTM) Guidelines for Clinical Use,"" European Journal of Cancer, vol. 43, pp. 1348-1360, 2007.;;Rouzier et al., ""Immunocytochemical Detection of Bone Marrow Micrometastases in Colorectal Carcinoma Patients, Using a Monoclonal Antibody to Villin,"" Cytometry (Communications in Clinical Cytometry), vol. 46, pp. 281-289, 2001.;;Nishizuka et al., ""Diagnostic Markers that Distinguish Colon and Ovarian Adenocarcinomas: Identification by Genomic, Proteomic, and Tissue Array Profiling,"" Cancer Research, vol. 63, pp. 5243-5250, Sep. 1, 2003.;;Wang et al., ""Proteomic Dissection of the Molecular Mechanisms Underlying Hepatic Metastasis in Colorectal Cancer,"" XP009093529, Database Accession No. PREV200600505326, AGA Abstracts, p. A-676, W1533, Apr. 2006.;;Mori et al., ""A Genome-Wide Search Identifies Epigenetic Silencing of Somatostatin, Tachykinin-1, and 5 other Genes in Colon Cancer,"" Gastroenterology, vol. 131, pp. 797-808, 2006.;;Fujiwara et al., ""Global Gene Expression Analysis of Rat Colon Cancers Induced by a Food-Borne Carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine,"" Carcinogenesis, vol. 25, No. 8, pp. 1495-1505, 2004.;;Dorudi et al., ""E-Cadherin Expression in Colorectal Cancer,"" American Journal of Pathology, vol. 142, No. 4, pp. 981-986, Apr. 1993.;;Lawrie et al., ""Liver Fatty Acid Binding Protein Expression in Colorectal Neoplasia,"" British Journal of Cancer, vol. 90, pp. 1955-1960, 2004.;;Sass et al., ""Mutations in ACY1, the Gene Encoding Aminoacylase 1, Cause a Novel inborn Error of Metabolism,"" The American Journal of Human Genetics, Mar. 2006, vol. 78, pp. 401-409.;;Tockman et al., ""Considerations in Bringing a Cancer Biomarker to Clinical Application"", Cancer Research, May 1, 1992, vol. 52, pp. 2711s-2718s.;;Freeman et al., ""APO-AII is an Elevated Biotnarker of Chronic Non-Human Primate Ethanol Self-Administration,"" Alcohol & Alcoholism, Mar. 2006, vol. 41, No. 3, pp. 300-305.;;Elsevier Publishing, ""Human PD1A1 Tryptic Peptide-SEQ ID 33,"" Retrieved from EBI Accession No. GSP:ASS06881, Database Accession No. ASS06881, 2003.;;U.S. Appl. No. 12/452,035, filed Dec. 14, 2009, in the name of Corinne Beaulieu et al.;;U.S. Appl. No. 12/452,038, filed Dec. 14, 2009, in the name of Monique Arpin et al.;;U.S. Appl. No. 12/452,037, filed Dec. 14, 2009, in the name of Yasemin Ataman-Onal et al.;;U.S. Appl. No. 12/452,042, filed Dec. 14, 2009, in the name of Monique Arpin et al.;;U.S. Appl. No. 12/452,048, filed Dec. 14, 2009, in the name of Jean-Philippe Charrier et al.;;U.S. Appl. No. 12/452,034, filed Dec. 14, 2009, in the name of Yasemn Ataman-Onal et al.;;U.S. Appl. No. 12/452,047, filed Dec. 14, 2009, in the name of Yasemin Ataman-Onal et al.;;Apr. 17, 2012 Office Action issued in U.S. Appl. No. 12/452,038.;;May 18, 2012 Office Action issued in U.S. Appl. No. 12/452,034.;;Jun. 12, 2012 Office Action issued in U.S. Appl. No. 12/452,042."
98,US,A1,US 2010/0136539 A1,037-234-711-064-997,2010-06-03,2010,US 45203808 A,2008-07-10,FR 0705197 A 20070719,Ezrin Assay Method For The In Vitro Diagnosis Of Colorectal Cancer,ARPIN MONIQUE;;ATAMAN-ONAL YASMIN;;BEAULIEU CORINNE;;BUSSERET SANDRINE;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;ROLLAND DOMINIQUE,ARPIN MONIQUE;;ATAMAN-ONAL YASMIN;;BEAULIEU CORINNE;;BUSSERET SANDRINE;;CHARRIER JEAN-PHILIPPE;;CHOQUET-KASTYLEVSKY GENEVIEVE;;ROLLAND DOMINIQUE,https://lens.org/037-234-711-064-997,Patent Application,yes,2,20,20,23,C07K7/08;;C07K7/06;;G01N33/57419;;G01N2333/705,C12Q1/68;;C07K7/06;;C07K7/08;;C07K16/00;;G01N33/53;;G01N33/573,435/6;;435/7.1;;435/7.4;;530/327;;530/328;;530/329;;530/387.9,15138477;;2100569;;2591371,10.1038/SJ.BJC.6601828,"Bruce et al (Proc Amer Assoc Cancer Res, 2005, 46, abstract #424);;Gould et al (The EMBO Journal, 1989, 8:4133-4142).;;Davies et al (ASCO, 2006 gastrointestinal Cancers Symposium, Abstract 322);;Lawrie et al (British J of Cancer, 2004, 90:1955-1960);;Etzioni et al (Nature Reviews, April 2003, 3: internet pages 1-10);;Mercer (Immunol Ser, 1990, 53:39-54);;Mahipal et al (ASCO, J Clinical Oncology, 2001, 29:suppl 4; abstract 317);;Brattstrom et al (ASCO, 2005 Gastrointestinal Cancers Symposium, 2005, abstract 63);;Kavanagh et al (BMC Cancer, 2009, 9:1-6)"
99,WO,A2,WO 2012/170513 A2,126-140-162-511-860,2012-12-13,2012,US 2012/0041080 W,2012-06-06,US 201161541663 P 20110930;;US 201161493881 P 20110606,He4 Based Therapy For Malignant Disease,WOMEN & INFANTS HOSPITAL OF RHODE ISLAND;;MOORE RICHARD G;;SINGH RAKESH K,MOORE RICHARD G;;SINGH RAKESH K,https://lens.org/126-140-162-511-860,Patent Application,yes,0,6,6,30,A61K33/24;;A61K31/337;;A61K31/4745;;A61K31/568;;A61K31/592;;A61K31/704;;A61K31/7105;;A61K31/713;;A61K38/17;;A61K45/06;;A61K2039/505;;C07K14/47;;C07K16/18;;C12N15/113;;G01N33/57484;;G01N33/57496;;G01N2333/811;;G01N2800/52;;A61K2300/00,A61K38/17;;A61K38/22;;A61K39/395;;A61P35/00,,15781627;;19643734,10.1158/0008-5472.CAN-04-3924;;10.1158/0008-5472.can-09-0061,
100,US,A1,US 2016/0303201 A1,001-132-099-078-861,2016-10-20,2016,US 201615196430 A,2016-06-29,EP 08151231 A 20080208,Liquid Formulation Of Fsh,RATIOPHARM GMBH,STOLZENBERGER SASCHA;;KOHLER ERICH,https://lens.org/001-132-099-078-861,Patent Application,yes,0,39,39,6,A61K47/186;;A61K9/0014;;A61K9/0019;;A61K38/24;;A61K47/02;;A61K47/10;;A61K47/20;;A61K47/26,A61K38/24;;A61K9/00;;A61K47/02;;A61K47/10;;A61K47/18;;A61K47/20;;A61K47/26,,,,
